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Part 1
Conventional Approaches

Chapter 1:
Introduction
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HIStoRy: FRoM uNDERStANDINg to tHERAPy
Clinical cardiac electrophysiology (EP) has progressed significantly since the first invasive elec-
trophysiological studies were performed to study normal impulse formation and conduction in 
the heart and to confirm hypotheses regarding the causation of arrhythmias. 
The first His bundle recordings in 1969,(1) and later, programmed atrial and ventricular stimu-
lation(2) to induce tachycardia made detailed analysis of arrhythmias possible. This led to an 
understanding of reentrant and focal tachycardias on an atrial and ventricular level. 
Subsequently therapeutic options became available when surgery entered the field with a 
approach for ventricular tachycardia (VT)(3) and ventricular preexcitation (WPW syndrome). 
Atrial fibrillation (AF) surgery was also successful but had a relatively high morbidity and a clear 
mortality risk. At this early stage no therapy could be given via the catheter. Subsequently direct 
current (DC) shock ablation of the AV node proved to be very successful and led to catheter abla-
tion of ventricular tachycardia and accessory pathways (4). However, the complications of this 
technique were important. The arrival of radiofrequency was thought to be the solution for the 
more simple arrhythmias such as atrioventricular nodal reentrant tachycardia (AVNRT), WPW, 
idiopathic VT and atrial flutter(5). The development of better catheters allowed for successful 
therapy in excess of 85% in most cases of these arrhythmias(6, 7). The real challenges remained 
VT on a background of underlying heart disease, and AF in both the normal and abnormal 
heart. The arrival of mapping systems allowing detailed electro-anatomical mapping(8) helped 
strategies to develop for more complex arrhythmias. However these approaches are still time 
consuming and there remain some drawbacks. 
WHERE ARE WE NoW: gooD but CoulD Do bEttER
Included in the above mentioned drawbacks are lower success rates for ventricular tachycardia 
and atrial fibrillation and difficulties in complex tachycardias relating to prior surgery whether 
for congenital, or non-congenital heart disease. There are also concerns about radiation expo-
sure and safety of the patient as well as radiation concerns for the physician (9). 
In the present thesis, we start to describe some of the most common arrhythmias in clinical 
cardiac electrophysiology in chapter 2. The diagnostic problems in atrial tachycardia remain 
huge. The role of the 12-lead ECG to assist in strategy and planning is important although 
perhaps less so than for the well known preexcitation syndrome and AV nodal re-entrant tachy-
cardias. AF and atrial flutter are complex, inter-related and should often be treated together as 
we describe in chapters 3 and 4. The therapy of AF is now most often performed by isolating 
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the pulmonary veins (PVs) from the left atrium using a variety of techniques, as described in 
chapter 5 as originally proposed by the group from Bordeaux(10). These procedures are lengthy 
and expose both the patient and physician to significant amounts of ionising radiation. Apart 
from vascular complications, other complications include pericardial effusion, PV stenosis, 
stroke, and atrio-oesophageal fistulas(11). Despite these serious complications, patients with 
AF are often very motivated to undergo such a procedure. Some preliminary data indicate now 
that ablation may be better than drug therapy in normal hearts and should even be considered 
in patients with heart failure(12, 13). Atrial fibrillation ablation will almost certainly become a 
major burden for every electrophysiology centre. 
WHERE ARE WE goINg: 
It is clear from the previous statements that procedures should be improved and that we 
should develop a strategy to diminish the complication rate. One novel approach is remote 
magnetic navigation(14). This idea originated in the domain of clinical neurology in an effort to 
allow catheter access to various parts of the brain, allowing for potential delivery of magnetised 
material to stop bleeding in affected parts of the neurovascular system. It is not surprising that 
the first real developments in cardiology were made in clinical cardiac EP with the develop-
ment of softer, floppy catheters with a magnetised tip. Two strong external magnets cause a 
magnetic field, allowing for the orientation of a magnetically enabled catheter tip in almost any 
direction (figure 1).
Figure 1. Overview of the initial room for magnetic navigation, with the patient lying between the external 
magnets, monitored by a nurse, with operator and technician behind the leaded screen (Niobe I, 
Stereotaxis, as built in the Erasmus MC, Rotterdam).
Theoretically the catheter is flexible enough to reach every part of the heart with a lower poten-
tial for perforation of the heart wall (figure 2). This complication is not uncommon when using 
rigid, multipolar catheters. A further advantage would be that automated mapping becomes 
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possible and that physicians and other personnel would receive lower ionising radiation 
doses.
Figure 2. A 3-magnet ablation catheter. As opposed to conventional catheters it is floppy, because there is 
no internal steering wire.
After a description of potential uses for this technology in our domain of cardiology, chapter 6, 
we report the results of an animal study in chapter 7. It was not clear from the published and 
ongoing animal experiments whether a catheter which moved together with the heart would 
produce lesions that could be compared with those applied through a conventional catheter.
After an initial pilot study in one of the easiest substrates (AVNRT, as described in chapter 8) we 
moved to arrhythmias which required detailed mapping and very careful movements of the 
ablation catheter to detect the area of interest (chapters 9 and 10, addressing ventricular tachy-
cardia). The right ventricular outflow tract (RVOT) sometimes poses difficulties to mapping, and 
is prone to catheter induced arrhythmias and is in a continuum with the pulmonary artery. 
Ablation in the RVOT has led in the past to serious complications. In idiopathic fascicular left 
ventricular VT “bumping” the fascicle may make the tachycardia non-inducible and therefore a 
soft touch is advisable as can be done with the magnetic catheter. Chapters 11 and 12 report 
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our experience with the system in the WPW syndrome. The fact that we could ablate using the 
retrograde (transaortic) approach, opened new perspectives for ablation in the left side of the 
heart.
In contrast to other investigators(15), we remained cautious in approaching atrial fibrillation 
as we felt that we needed better and safer catheters (8 mm tip and more specifically irrigated 
tip magnetically enabled catheters) to avoid thrombus formation(16). In the interim, we were 
able to access the left atrium and cannulate all the pulmonary veins with these catheters in a 
retrograde way, and could successfully ablate a focal left atrial tachycardia using a 4 mm tip 
catheter (chapters 13 and 14). As discussed in these chapters, this approach may be useful 
when transseptal puncture is contraindicated or difficult.
We end this thesis in chapter 15 with an overview of the potential applications in cardiac elec-
trophysiology (as well as in cardiac resynchronisation therapy) and put this therapy in a broader 
perspective in chapter 16.
The availability of newer technologies such as alternative energy sources, mapping systems, 
robotics, magnetic navigation and the integration of real-time imaging into electrophysiology, 
should improve the outcomes as well as safety for both physician and patient. These evolving 
technologies will require new approaches to the techniques for ablation and catheter position-
ing and electrophysiologists will need to move beyond the “mind-sets” of present technology. 
Questions will inevitably arise about the cost-benefit of these technologies and how much they 
add, but this is a difficult subject as their benefit will vary considerably between units, with 
potentially less benefit in experienced high volume units and more benefit in less experienced 
low volume centres. This thesis is a look at early work in some of these new technologies.
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EPIDEMIology
Atrial fibrillation (AF) is the commonest supraventricular arrhythmia encountered in daily clini-
cal practice and is associated with substantial excess in morbidity and mortality. 
Accurately determining the incidence and prevalence of this and other atrial tachycardias is 
complicated by a number of factors.
•	 The	prevalence	varies	depending	on	the	definitions,	especially	for	atrial	fibrillation.	The	fact	
that atrial fibrillation and flutter were often previously classified under one header has also 
increased the uncertainty of the incidence of each individual arrhythmia. 
•	 These	arrhythmias	are	frequently	paroxysmal,	so	that	a	random	measurement	in	time	like	a	
12-lead electrocardiogram (ECG) or even a Holter ECG cannot be relied upon(1). 
•	 The	arrhythmia	may	be	asymptomatic	in	a	significant	number	of	patients,	making	the	his-
tory unreliable, leading to underestimation of the real prevalence(2). 
AtRIAl FIbRIllAtIoN
The prevalence of AF seems to be between 0.4%(3) and 1.9% of the population(4, 5). AF increases 
in prevalence with advancing age. It doubles with each decade beyond 50 years to around 10% 
in persons who reach 80 years(6). Around 70-80% of patients with AF will be in the age group 
65-85 years with the median age of AF patients estimated to be 75 years. The prevalence is 
substantially higher in men than in women at all ages, with a 50% greater likelihood of AF 
in men than in women. Despite this the total number of men and women are almost equal 
because of the longer life expectancy of women. In addition, there may be a racial variation; 
patients of African descent may have a lower prevalence. The prevalence of so-called lone AF 
varies widely in published studies between 2.7% and 30% of all cases of AF(7, 8). 
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The incidence is approximately 0.1% per year in those less than 40 years of age up to greater 
than 1.5-2% per year in those over 80 years. 
 
When one compares early, and later epidemiological studies it appears that the incidence is 
increasing in developed countries. Recent reports have described a 2-to 3-fold rise in the rate 
of hospitalisation for atrial fibrillation in recent years(9). This increase cannot be fully explained 
by the increasing age of the general population, or by an increase in the prevalence of underly-
ing heart disease. One intriguing possibility is that a sharp rise in the incidence of obesity and 
obstructive sleep apnoea (known to be associated with an increased risk of developing atrial 
fibrillation) may be in part responsible(10). A sharp rise in the incidence is predicted for the 
coming five decades(11).
otHER AtRIAl ARRHytHMIAS
The exact prevalence and incidence of the so-called macro-reentrant atrial tachycardias (atrial 
flutters) is not entirely clear. Approximately 10% of patients presenting with supraventricular 
tachycardias do so with atrial flutter(12). What is known, however, is that 60% of atrial flutters 
occur during acute disease processes and may never recur. Approximately 25-35% of patients 
with AF will have atrial flutter at some time, either spontaneously or more commonly, induced 
by medication(13). 
Sustained focal atrial tachycardias are relatively rare and overall make up only 10-15% of 
patients referred for radiofrequency (RF) ablation of SVT(14, 15). They are, however, more com-
mon in a paediatric population and especially in those with congenital heart disease(16, 17). 
Estimates of prevalence vary from 0.34% in asymptomatic patients to 0.46% in symptomatic 
patients(18).
NoSology
Definitions and Classification – Newer Classifications
Earlier classifications of atrial arrhythmias were based almost exclusively on the 12-lead ECG 
findings. A fairly crude classification of the atrial tachyarrhythmias was based on the atrial rate 
alone, as far as this can be assessed on the surface electrocardiogram. It is important to remem-
ber that these classifications refer to atrial rate and not ventricular rate on the 12-lead ECG. 
Atrial fibrillation was defined as an atrial tachycardia with a rate between 350 and 600 beats 
per minute. In atrial flutter the atrial rate was usually between 250 and 350 beats per minute. 
In atrial tachycardia the atrial rate was between 100 and 250 per minute(19). The presence of 
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an isoelectric baseline between atrial deflections was also used to assist classification between 
atrial flutter and atrial tachycardia, with an intermittent isoelectric baseline suggesting atrial 
tachycardia. Atrial tachycardia could be unifocal or multifocal. 
These definitions were the time-honoured definitions traditionally used, however the distinc-
tion between the subtypes of atrial tachyarrhythmias may not always have been as clear as 
suggested. The use of intracardiac electrograms has been of great benefit in confirming some 
of the concepts developed by electrocardiographers as regards the mechanisms of some of 
these arrhythmias. As a result of our increased knowledge, newer definitions for the different 
atrial rhythms as well as sub-classifications of these have been proposed(20-23). 
Atrial tachycardias can be classified as atrial rhythms at a constant rate > 100 beats per minute 
originating outside the sino-atrial node. The atrial arrhythmias can be roughly divided into the 
irregular atrial tachycardias or the atrial fibrillation group, and the atrial flutter and regular atrial 
tachycardia group (Table 1). This correlates to some degree with the concept of multiple circuit/
foci tachycardias and single circuit/focal tachycardias, and also to a group of irregular, and a 
group of regular atrial tachycardia respectively.
One of the problems with any classification is that the characteristics of the arrhythmia may 
change over time or be modified by therapy, especially drug therapy, and conversion from one 
form to another is not uncommon. Furthermore, intracardiac recordings have revealed that 
there may be some overlap between these entities e.g. with left-sided disorganised rhythms 
(fibrillation) and right-sided organised rhythm (flutter). More recently the entity of pulmonary 
Table 1 Classification of Atrial Arrhythmias
Irregular Atrial Tachycardias
Atrial Fibrillation
Initial Event
Paroxysmal
Persistent
Permanent
Multifocal Atrial Tachycardia
Regular Atrial Tachycardias
Isthmus Dependent Flutters
Typical Atrial Flutter
Reverse Typical Atrial Flutter
Non-Isthmus Dependent Flutters
Scar/Incisional Flutter
Left Atrial Flutter
Focal Atrial Tachycardias
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vein foci with tachycardia within the pulmonary veins driving the more clearly seen atrial fibril-
lation has been described(24, 25). 
IRREgulAR AtRIAl tACHyCARDIAS
Irregular atrial tachycardias can be classified as irregular atrial rhythms at a constant rate > 100 
beats per minute originating outside the sino-atrial node. Examples of these tachycardias are 
atrial fibrillation and multifocal atrial tachycardia. 
Atrial Fibrillation
Atrial fibrillation has had numerous classifications applied to it over the years. Much clinical 
research has regarded AF as a single entity, while it clearly is not. In 2000 the Working Group on 
Arrhythmias of the European Society of Cardiology (WGA-ESC) and the North American Society 
for Pacing and Electrophysiology (NASPE) achieved some consensus on the terminology and 
classification of AF(22, 23). Recognising that an ECG classification would be unhelpful, and that 
a number of classifications based on for example epicardial mapping and other intracardiac 
recordings have also been made, it was felt that a clinically based classification would be more 
useful, and would assist both in therapeutic management and in future research. It is important 
to remember that no classification can take into account all features associated with AF, for 
example presence of underlying heart disease or not; associated features of onset etc. 
The consensus defined AF as an atrial tachyarrhythmia with predominantly uncoordinated 
atrial activation with resulting deterioration in atrial mechanical function(26, 27). The classifica-
tion that follows applies only to AF episodes that last longer than 30 seconds. 
Initial Event – this can be self-terminating or non self-terminating and symptomatic or asymp-
tomatic (although it may be difficult to know if prior episodes have been asymptomatic).
Recurrent AF – is defined as recurrent if the patient has two or more episodes. Within the recur-
rent group further subdivisions can be made:
•	 Paroxysmal	–	an	episode	of	AF	usually	terminating	with	48	hours	but	at	longest	in	fewer	
than 7 days, since spontaneous cardioversion is unlikely to occur after this period and 
chemical cardioversion is also less successful.
•	 Persistent	–	an	episode	of	AF	lasting	longer	than	7	days.	In	this	form	sinus	rhythm	can	usu-
ally be restored with electrical cardioversion.
•	 Permanent	(Established)	AF	–	when	AF	has	been	present	for	a	prolonged	period	and	fails	
to terminate with cardioversion or recurs repeatedly within 24 hours of cardioversion. 
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Accepted AF is a form of permanent AF when cardioversion has not been attempted or 
been refused.
In each case this may be the first form of AF or may be preceded by a less severe form.
It must be recognised that not infrequently, the physician may not know the temporal pattern. 
When atrial fibrillation is first diagnosed there is usually no way to know whether it is a persis-
tent episode or a paroxysm that will shortly terminate. Even the distinction between frequent 
paroxysms and permanent atrial fibrillation may be impossible to make clinically. 
This is clearly a time related classification and patients’ AF often evolves from a paroxysmal to a 
persistent pattern and eventually to permanent AF. 
Classifications based on the presence of particular disease states or characteristic onset and 
other associated features e.g. vagal vs. sympathetic, may be useful for choosing a particular 
medical therapeutic option(26, 27), but not in assessing broader management issues. 
The ECG of atrial fibrillation can be characterised by the absence of consistent P waves and 
their replacement by waves that vary constantly in timing and appearance(28). The ventricular 
Figure 1: ECG (leads I, II, II, V1) of atrial fibrillation (2 episodes). Note the completely irregular fibrillatory 
waves in this case of fairly coarse atrial fibrillation. There are no discernible P-waves and no clear 
isoelectric periods. The RR intervals and the rate are dependent on AV nodal conduction properties
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response is generally irregular except in association with AV block and the ventricular rate 
depends on the AV nodal conduction properties (figure 1).
Multifocal Atrial Tachycardia
The diagnosis of multifocal atrial tachycardia is based on the finding of an irregular atrial tachy-
cardia with 3 different P-wave morphologies, each at a different rate(29). It is often confused 
with atrial fibrillation but the atrial rates are usually slower than those in atrial fibrillation.
AtRIAl FluttER AND REgulAR AtRIAl tACHyCARDIAS
The recently published “Classification of Atrial Flutter and Regular Atrial Tachycardias” from 
a Joint Expert Group from the WGA-ESC and NASPE integrates the knowledge gleaned from 
electrophysiological studies with that from electrophysiological mechanisms(20, 21). This 
improved newer classification allows better prognostication as far as possible ablation therapy 
and its outcome are concerned. 
This group includes regular atrial rhythms at a constant rate > 100 beats per minute originating 
outside the sino-atrial node. Basic clinical findings, particularly 12-lead ECG, can be used to 
assist in classification. Two further distinct groups can be defined
1. Macro-reentrant atrial tachycardias, including the various atrial flutters, and incisional and 
scar related “flutters”.
2. Focal atrial tachycardias with an automatic, triggered or micro-reentrant mechanism.
Macro-reentrant Atrial Tachycardias including the Atrial Flutters
The mechanism of these arrhythmias is a single reentrant circuit around a central obstacle 
usually with a narrow area of conduction (isthmus) somewhere in the circuit. The obstacle can 
be a normal or abnormal structure and may be fixed or transient. Activation within the atrium 
is continuous and this is reflected by the lack of an isoelectric line on the surface ECG. These 
circuits can be entrained(30). The well-characterised macro-reentrant atrial arrhythmias are:
•	 The	Inferior	Vena	Cava-Tricuspid	Valve	(IVC-TV)	isthmus	dependent	flutters
•	 Typical	(counter-clockwise)	atrial	flutter
•	 Reverse	typical	(clockwise)	atrial	flutter
•	 Lesion	macro-reentrant	tachycardias	(incisional	and	scar	flutter)
•	 Left	atrial	macro-reentrant	atrial	tachycardia	(Left	atrial	flutter)
•	 Other	variants	such	as	“lower	loop”	and	“double	loop”	reentry.
For practical and therapeutic purposes it is important to recognise the IVC-TV isthmus depen-
dent flutters and lesion reentry flutters, as these are more easily amenable to ablation. 
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Typical atrial flutter (counter clockwise flutter) circulates in a counter clockwise direction around 
the tricuspid annulus in the frontal plane and is constrained by constant anatomical structures 
within the right atrium (figure 2). 
The ECG is characterised by dominant negative flutter waves inferiorly, classically described as 
showing a down sloping plateau, followed by a sharper negative deflection and then a sharp 
positive deflection with overshoot followed by the next down sloping plateau(31). In the chest 
leads there are positive flutter waves in V1 and transition to a negative flutter wave in V6. The 
rate is typically 250-350 bpm.
Reverse typical atrial flutter (also called clockwise or reverse flutter) circulates in the opposite 
direction around the tricuspid annulus but is constrained by the same structures as typical 
flutter (figure 3). 
Figure 2: ECG (leads I, II, II, V1 and V6) of typical (counter-clockwise) atrial flutter. Note the typical features in 
the inferior leads (see also inset of lead III). The inferior leads show negative saw tooth waves and there are 
positive waves in V1 and transition across the V-leads. In this case with AV block, decreasing the ventricular 
pacing rate allows for easier viewing of the flutter waves
Ch
ap
te
r 2
28
Figure 3: ECG (leads I, II, II, V1 and V6) of reverse typical (clockwise) atrial flutter. Note the difference in the 
inferior leads (see also inset of lead III). The inferior leads show positive saw tooth waves and there are 
negative waves in V1 and transition across the V-leads
The ECG shows a rate which is similar to the above, but the flutter waves are now broad and 
positive, often notched in the inferior leads and negative in V1 transitioning to positive in 
V6(32).
The non isthmus dependent flutters include incisional flutter around scars from previous atri-
otomy incisions during cardiac surgery, flutter circulating around areas of fibrosis in the atria 
and flutter circulating around other anatomical or functional conduction barriers in the atria 
(figure 4).
The ECG in these flutters have no isoelectric baseline but do not fit into the above two clearly 
defined patterns, although differentiation may be difficult(32).
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Figure 4: ECG (leads I, II, II, V1 and V6) of a non-isthmus dependent atrial flutter. Note the lack of an 
isoelectric line, but the absence of the features outlined in figures 2 and 3. In this case the patient has a 
surgical scar in the atrium and the flutter is circling around this scar.
Focal Atrial tachycardia
Unifocal and usually regular atrial tachycardias begin in a small area or focus in a rhythmical 
fashion. The commonest sites for these foci are the pulmonary veins, the crista terminalis and 
the entries of the SVC, IVC and coronary sinus(24, 25, 33). The ECG usually reflects the fact that 
there is a period of atrial electrical inactivity during the cycle, so that an isoelectric line can be 
seen on the ECG between P waves (figure 5). The P wave morphology of the individual tachy-
cardia reflects the site of origin(34, 35). Focal atrial tachycardias usually have a rate < 240 bpm 
(typically 130-240 bpm), although rates up to 300 bpm are occasionally seen. The tachycardia 
rate may vary over time. Automatic forms may warm up (progressively increase at onset) and 
cool down (progressively decrease at termination)(36). Adrenergic stimulation will also increase 
the rate in these arrhythmias. Automatic, triggered and re-entrant forms exist, but clinically the 
distinction may be impossible. 
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Figure 5: ECG (leads I, II, II, V1) of a focal atrial tachycardia. There are unifocal P waves with a clear isoelectric 
line between. The morphology of the P-waves suggests an origin in the right upper pulmonary vein.
Other Atrial tachycardias
Unfortunately this classification is not entirely all encompassing as it leaves out inappropriate 
sinus tachycardia, sinus node reentry and what was previously known as type II atrial flutter(20, 
21). Inappropriate sinus tachycardia appears to originate in the sinus node at rates above the 
physiologic range without proportionate relationship to physiologic requirements. Sinus node 
reentry tachycardia is a tachycardia with the same P wave morphology as sinus rhythm, which 
can be induced and terminated consistently by electrophysiogical stimulation. However it is 
possible that this is merely a micro-reentrant tachycardia originating near the sinus node. The 
exact electrophysiological background of type II flutter is not entirely clear.
AEtIology
Atrial arrhythmias are not discrete disease entities, but rather syndromes that may be caused 
by a number of cardiac abnormalities or by a variety of as yet incompletely understood genetic 
abnormalities.
The causes of atrial fibrillation (table 2) can be roughly divided into the acute (sometimes 
referred to as secondary) causes, AF associated with heart disease, AF associated with auto-
nomic triggers also known as neurogenic AF, and AF without associated heart or other systemic 
disease.
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Table 2 Causes of Atrial Arrhythmias
Acute AF Cardiac or other surgery, myocardial infarction, pericarditis,
pulmonary embolism, toxic, metabolic and endocrine causes
AF associated with cardiac disease Electrical – AVNRT, AVRT, Flutter, PV tachy
Non-valvular – hypertension, coronary artery disease, CHF
Valvular – especially rheumatic valvular disease
Autonomic/Neurogenic AF Vagally mediated AF
Adrenergic AF
AF without cardiac/other disease Lone AF
AF due to genetic disease Familial AF with various channelopathies
AVNRT – atrio-ventricular nodal reentry tachycardia, AVRT, atrio-ventricular reentry tachycardia, Flutter – 
atrial flutter, PV tachy – pulmonary vein focal atrial tachycardia, CHF – congestive heart failure
ACutE AF
AF is frequently related to temporary and reversible acute events. Examples include AF associ-
ated with cardiac or other surgery, infarction, pericarditis, pulmonary embolism, toxic, metabolic 
and endocrine causes. Treatment of the associated condition is often associated with resolution 
of the AF without further recurrence. Post-cardiac surgery AF is the commonest complication 
of surgery. The pathogenesis is likely to be multifactorial (postoperative pericarditis, surgical 
trauma to the atria, myocardial ischaemia, inadequate atrial protection during cardiopulmonary 
bypass and high circulating levels of catecholamines)(37). AF associated with acute infarction 
tends to be associated with an adverse outcome in comparison to patients presenting in sinus 
rhythm or with pre-existing AF(38). 
AF ASSoCIAtED WItH HEARt DISEASE
AF may be associated with both electrical, as well as structural cardiac abnormalities. 
In the case of electrophysiological abnormalities it is known that patients with AVNRT(39) and 
AVRT have an increased risk of AF. With timeous therapy the risk can be reduced although not 
necessarily eliminated. Particularly in younger patients with AF an electrophysiological study 
may be an important part of the work up to exclude these potentially easily curable arrhythmias. 
It is also important to remember that AF may occur secondary to another atrial arrhythmia such 
as primary atrial flutter or focal atrial tachycardia (classically from a pulmonary vein focus), and 
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that these tend to be more easily treated by radiofrequency ablation. In addition, bradyarrhyth-
mias and heart block are associated with atrial fibrillation. Pacemaker selection has a significant 
impact on the long-term incidence of AF; with trials having shown an increased risk of AF in 
those subjected to ventricular based pacing as compared to atrial based pacing, particularly 
in the presence of intact AV conduction(40, 41). The effect of this difference has not been as 
convincingly shown on mortality however.
Any process that infiltrates, irritates, inflames, scars or stretches the atria may cause atrial 
arrhythmias. Specific structural abnormalities associated with AF include hypertension, coro-
nary artery disease and valve disease, especially mitral valve disease(5, 6). The ratio of these 
as underlying precipitators of AF varies across regions in the world. By convention the term 
“non-valvular” atrial fibrillation is restricted to cases where there is no rheumatic mitral valve 
disease or a prosthetic heart valve. AF is also associated with cardiomyopathies, hypertrophic 
and dilated, but also restrictive. Congenital cardiac abnormalities are associated with signifi-
cant risk for atrial arrhythmias, as is pulmonary disease. Sleep apnoea syndrome as a cause of 
atrial, as well as ventricular arrhythmias, is increasingly being recognised. Obesity has also been 
associated with an increased incidence of AF, although whether this association is independent 
of other risk factors for AF is not yet clear. The ALFA study characterised the presentations and 
underlying causes of atrial fibrillation in general practice in a population of 756 patients(42). 
Cardiac disorders were found in 534 patients (71%). This included hypertension in 39%, coro-
nary artery disease in 17%, and myocardial disease in 15%. In contrast to some other studies, 
the incidence of rheumatic valvular disease was low: 25% in women and 8% in men.
AutoNoMIC oR NEuRogENIC AF(43)
Some patients tend to develop atrial fibrillation during periods of high vagal tone, such as post-
prandially. So-called vagally mediated paroxysmal atrial fibrillation is typically seen in young 
men. Vagally mediated atrial fibrillation appears to respond more favourably to antiarrhythmic 
drugs with vagolytic properties such as Disopyramide.
In others the onset of atrial fibrillation occurs during periods of high adrenergic drive such as 
after or during exercise or during periods of sinus tachycardia. This is a more heterogeneous 
category and includes patients with ischaemic heart disease. In these patients it is reasonable 
to use adrenergic receptor blocking agents.
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AF WItHout ASSoCIAtED HEARt oR otHER kNoWN SyStEMIC DISEASE
If no structural cardiac or systemic disease known to promote atrial fibrillation is present, it is 
called “lone atrial fibrillation”. This term should however, be used only if no cause can be found 
after a thorough history, physical examination, basic laboratory investigations and echocar-
diography have revealed no predisposing factor. Even so, the diagnosis should repeatedly be 
reassessed and not infrequently, some cause only becomes apparent after a period of follow-
up(8), in which case the term should no longer be applied.
Familial clustering of atrial fibrillation has been well described in a number of studies and is 
associated with a variety of ion channel and connexin abnormalities that affect the impulse 
generation and conduction properties of myocardial tissue(44-46). Affected individuals usu-
ally have structurally normal hearts and so it is reasonable to consider it as a subset of lone 
atrial fibrillation. As further research elucidates the mechanisms responsible, it is likely that the 
pathogenesis of most cases of lone atrial fibrillation will become clear. 
ClINICAl FEAtuRES
Symptoms: The atrial tachyarrhythmias give rise to a number of symptoms with which the 
patient may present including palpitations, dyspnoea, reduced effort tolerance, chest pain 
and presyncope, to mention only a few. The expression of symptoms depends in part on the 
underlying cardiac disease, if present, as well as the characteristics of atrioventricular nodal 
conduction i.e. the rate and regularity of the ventricular response. The presenting symptoms 
may also relate to thromboembolic complications of atrial fibrillation. 
Symptoms may vary between attacks and many episodes may be asymptomatic. In a study of 
symptoms in 600 patients approximately 80% were symptomatic and the symptoms varied 
between groups of patients(47, 48). Factors which seemed to predict symptoms were: young 
age, higher heart rates, higher systolic blood pressure, female gender, and no prior myocardial 
infarction. However individual symptoms were also associated with specific groups: 
•	 Palpitations	-	in	younger	age,	of	female	gender	with	higher	rates	and	normal	LV	function;	
•	 Cerebral	 hypoperfusion	 related	 symptoms	 such	 as	 light-headedness	 and	 dizziness	 -	 in	
those with smaller left atria;
•	 Dyspnoea	-	in	those	as	expected	with	hypertension	and	larger	left	atria	and	ventricles,	but	
also in those of female gender and younger age. 
•	 Asymptomatic	-	those	of	an	older	age,	with	otherwise	normal	hearts	and	slower	and	more	
regular rates.
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Signs: Patients with atrial arrhythmias should be examined for evidence of structural heart 
disease, systemic disease that may explain the occurrence of the arrhythmia and for complica-
tions associated with the arrhythmia itself, such as evidence of peripheral thromboembolism. 
Physical findings of the arrhythmia itself include in the case of atrial fibrillation, a slight variation 
in the intensity of the first heart sound, absence of a waves in the jugular venous pulse and 
an irregular ventricular rhythm with a so-called “pulse deficit” (a higher heart rate auscultated 
precordially than palpated peripherally) if the ventricular response is rapid.
CoMPlICAtIoNS AND PRogNoSIS
Atrial tachyarrhythmias may give rise to a number of serious clinical sequelae:
The most definite and well-researched complication of atrial fibrillation and flutter is systemic 
thromboembolism. The incidence of this complication varies considerably depending on a 
number of modifying factors. Patients with valvular atrial fibrillation appear to have the high-
est risk, in the order of 4 to 6 % per year in patients with mitral stenosis. Young patients (less 
than 60 years) with lone atrial fibrillation have the lowest stroke risk, in the order of 0.5-1,5% 
per year(8, 49). By comparison stroke risk in older (>65years) lone AF patients is still probably 
elevated above that of age matched controls. In the Framingham study the impact of atrial 
fibrillation on the risk of stroke with increasing age was examined in 5184 patients(50). After 30 
years of follow-up, chronic atrial fibrillation appeared in 303 persons. The proportion of strokes 
associated with this arrhythmia was 14.7%, 68 of the total 462 initial strokes, increasing steadily 
with age from 6.7% for ages 50 to 59 years to 36.2% for ages 80 to 89 years. In contrast to the 
impact of cardiac failure, coronary heart disease, and hypertension, which declined with age, 
atrial fibrillation was a significant contributor to stroke at all ages. Patients with paroxysmal 
atrial fibrillation appear to have an annualized stroke rate (3.2%) similar to those with chronic 
atrial fibrillation (3.3%)(51). The ALFA study found a 2.4% incidence of thromboembolism over 
a mean of 8.6 months of follow-up(42). Loss of active atrial transport appears to play some part 
in the risk of thromboembolism, but atrial fibrillation may also be merely a marker rather than 
a risk for thromboembolism in some cases.
Recent trials of rate control versus rhythm control have shown that even in the rhythm control 
group there remains a significant risk for thromboembolism. The underlying risk factors, and 
risk of recurrence therefore need to be carefully assessed when deciding on the duration of 
anticoagulation post cardioversion. Age is often used as a deciding factor for anticoagulation(5). 
An age of 80 years has been used by some as a cut-off age, but it must be remembered that in 
the developed world approximately 30% of patients with AF will be older than 80 years.
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The decision on what form of anticoagulation to give depends on a number of associated risk 
factors (table 3). Echocardiography is useful in risk assessment for thromboembolism but LV 
dysfunction appears to be a better predictor of risk than left atrial (LA) size. Transoesophageal 
echocardiography (TEE) is superior to transthoracic echocardiography, both in assessment of 
LA and left atrial appendage (LAA) thrombus as well as in detection of features such as reduced 
flow velocities in LA and LAA, as well as spontaneous echo contrast associated with increased 
risk of thromboembolism(52). The association of complex aortic atherosclerotic plaque on 
TEE with increased risk of thromboembolism shows that AF is both a risk factor, as well as an 
association with thromboembolism(53).
Table 3 Risk Assessment for Thromboembolism in Non-Valvular Atrial Fibrillation(26, 27) 
Risk Factors Relative Risk
Previous Stroke or TIA 2.5
Diabetes Mellitus 1.7
History of Hypertension 1.6
Coronary Artery Disease 1.5
Congestive Cardiac Failure 1.4
Advanced Age 1.4
TIA – transient ischaemic attack. Relative Risk compared to those with AF, but without these risks. 
Functional deterioration has been well described in patients with persistent or permanent atrial 
fibrillation. Atrial fibrillation appears to be an independent predictor of functional decline and 
to be associated with increased mortality(54) in patients with underlying heart disease. Cardiac 
output can decrease because of loss of AV synchrony, irregular RR intervals(55, 56), and inap-
propriately rapid heart rates. A contribution of so-called tachycardia-induced cardiomyopathy 
in patients with persistently high ventricular response rates has been suggested(57).
Mortality appears to be independently associated with atrial fibrillation in large population 
studies such as the Framingham cohort. The presence of atrial fibrillation is associated with 
a doubling of mortality in both sexes, which is decreased to 1.5 to 1.9-fold after adjusting for 
associated cardiovascular conditions(6, 58). However, studies of lone AF patients suggest no 
difference in mortality between these patients and age matched population controls. Clearly 
however, the mortality in AF also relates to associated cardiac conditions that may be present. 
CoMPlICAtIoNS oF tHERAPy
Even though the atrial tachyarrhythmias are associated with substantial morbidity and mortality 
it should not be forgotten that every form of therapy also carries with it a certain risk of adverse 
events. Antiarrhythmic drugs have a significant risk of proarrhythmia(59-61), anticoagulant 
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therapy a significant risk of bleeding complications and catheter ablation procedures a signifi-
cant risk of a variety of complications inherent to the invasiveness of cardiac catheterisation.
CoNCluSIoN
The frequency of atrial arrhythmias is increasing in the general population. Interventional treat-
ment is available, both for atrial fibrillation and focal, and macroreentrant atrial tachycardias, 
and as the approaches are different, it becomes important to recognise and differentiate the 
different arrhythmias. Electrocardiographic features allow one to assess whether a flutter is 
dependent on the cavo-tricuspid isthmus or not. All the atrial arrhythmias are closely related. 
In atrial fibrillation, therapy is presently more focused on rhythm and frequency control, and 
on prevention of thrombo-embolism. However, there is an increasing focus on intervention for 
atrial fibrillation which was previously reserved predominantly for focal and macroreentrant 
atrial arrhythmias.
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Abstract
Objectives To compare the acute success and short-term
follow-up of ablation of atrial flutter using 8 mm tip
radiofrequency (RF) and cryocatheters.
Methods Sixty-two patients with atrial flutter were ran-
domized to RF or cryocatheter (cryo) ablation. Right atrial
angiography was performed to assess the isthmus. End
point was bidirectional isthmus block on multiple criteria.
A pain score was used and the analgesics were recorded.
Patients were followed for at least 3 months.
Results The acute success rate for RF was 83% vs 69% for
cryo (NS). Procedure times were similar (mean 144±48min
for RF, vs 158±49 min for cryo). More applications were
given with RF than with cryo (26±17 vs. 18±10, p<0.05).
Fluoroscopy time was longer with RF (29±15 vs. 19±
12 min, p<0.02). Peak CK, CK-MB and CK-MB mass were
higher, also after 24 h in the cryo group. Troponin T did not
differ. Repeated transient block during application (usually
with cryoablation) seemed to predict failure. Cryothermy
required significantly less analgesia (p<0.01), and no use of
long sheaths (p<0.005).
The isthmus tended to be longer in the failed procedures
(p=0.117). This was similar for both groups, as was the
distribution of anatomic variations. Recurrences and com-
plaints in the successful patients were similar for both
groups, with a very low recurrence of atrial flutter after
initial success.
Conclusions In this randomized study there was no
statistical difference but a trend to less favorable outcome
with 8 mm tip cryocatheters compared to RF catheters for
atrial flutter ablation. Cryoablation was associated with less
discomfort, fewer applications, shorter fluoroscopy times
and similar procedure times. The recurrence rate was very
low. Cryotherapy can be considered for atrial flutter
ablation under certain circumstances especially when it
has been used previously in the same patient, such as in an
AF ablation.
Keywords Arrhythmia . Catheter ablation . Atrial flutter .
Atrial fibrillation . Radiofrequency . Cryothermy
1 Introduction
Atrial flutter is a common arrhythmia [1], difficult to
suppress with medication [2], and is associated with
significant symptoms. Since it was first proposed [3–5],
ablation for atrial flutter has increasingly been used for its
therapy, especially since induction of bidirectional cavo-
tricuspid isthmus block was shown to be associated with
better immediate outcomes and lower recurrence rates [6–
11]. Failure to successfully ablate atrial flutter in the long-
term may be due to particular anatomic problems [12–14],
poor catheter stability in this region, and incorrect interpre-
tation of isthmus block. Important developments in the field
of atrial flutter ablation have been a better understanding of
the anatomy of the isthmus, refinements of the definition of
bidirectional isthmus block, and the arrival of new catheter
technology.
Numerous studies have compared different energy types,
different catheter tip sizes and different energy settings [15–
19], as well as the use of advanced cardiac mapping
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systems [20]. The preferred tools now are 8 mm, or
irrigated tip catheters [21]. From a recent meta-analysis it
would appear that these two technologies are equally
effective with acute success quoted at 84% and 85% for
the primary catheter chosen before changeover, whereafter
final success rates of up to 99% can be achieved [22]. Not
all studies have this high success rate and the preponder-
ance of studies on ablation of atrial flutter suggest that these
high success rates are not repeated in all centers [23]. Also of
importance is a clinical recurrence rate, in the face of acute
success, of at least 5 to 12% when using radiofrequency [19,
24, 25]. Disadvantages of radiofrequency (RF) energy
include pain, overheating with “popping”, char formation
and risk to coronary arteries.
Cryoablation is a relatively recent addition to the
transvenous ablation armamentarium and has been shown
to be comparable to RF for some arrhythmias. It may have
some advantages over RF, especially as regards discomfort
during ablations [17, 26]. The development of 6 and 8 mm
tip cryocatheters has increased the interest in this technology
for atrial flutter ablation. As far as we are aware there have
been no randomized comparative studies published compar-
ing 8 mm tip cryocatheters with 8 mm tip RF catheters.
2 Methods
2.1 Patient population
Consecutive patients with ongoing symptoms and docu-
mented atrial flutter with or without fibrillation were
included. At least one recent episode of atrial flutter (within
the last 6 months) was documented on a 12 lead ECG and
was suggestive for isthmus dependency. Patients with drug-
induced flutter (and prior AF) could be included, and had
their drug therapy continued after ablation. Patients were
excluded if they had undergone a previous flutter ablation,
if thrombus was present in the atria, or after previous
cardiac surgery for valvular or congenital heart disease.
Baseline investigations included a standard echocardio-
gram, a simple questionnaire asking about clinical well-
being and a subjective assessment of the arrhythmia burden
both in terms of duration and frequency. The study was
approved by the ethics committee of our institution. All
patients signed written informed consent.
2.2 Assessment before ablation
Antiarrhythmic drugs, except for AV nodal slowing agents,
and amiodarone, were discontinued at least five half-lives
prior to ablation. Patients were studied in the fasting, post-
absorptive state. A coronary sinus (CS) catheter was
inserted through the left subclavian vein, and a multipolar
circular right atrial catheter with alternating 2–10–2 mm
interelectrode distance was positioned from the right groin,
with the tip positioned immediately lateral to the planned
position of the isthmus line and anterior to the crista terminalis.
Heparin 100 U/kg was given and a further 5 U/kg given if the
procedure lasted longer than 180 min.
If the patient was in sinus rhythm, isthmus conduction
was confirmed by pacing. If flutter was present, entrain-
ment was performed to confirm isthmus dependence, and
the patient left in flutter. If AF was present, the patient was
cardioverted after a transoesophageal echocardiogram, and
then isthmus conduction confirmed. Absence of isthmus
conduction or non-isthmus dependence was not seen in the
selected patients. No induction of arrhythmia was attempted
if patients had sinus rhythm.
Radiological assessment of the right atrial isthmus was
made in a right anterior oblique (RAO) 30°, and a left anterior
oblique (LAO) 45° view (each with 40 cc at 18 cc/s).
Angiograms were acquired digitally to allow for post-hoc
analysis. The treating physician was able to view the
angiographic findings to optimize the planned ablation line.
The isthmus length was assessed from the inferior hinge point
of the tricuspid valve to the IVC at the end of atrial diastole
(the frame before opening of the tricuspid valve) [14].
Morphology was assessed visually as to the presence of a
Eustachian valve or a recess, as well as to the general shape
i.e. flat or concave.
2.3 Ablation procedure
The catheters were a 9Fr 8 mm tip catheter (FreezorMax,
Cryocath Technologies Inc, Kirkland, Canada) with a
cryoconsole for the cryoablation group, and a 7Fr 8 mm
tip single sensor catheter (EPT Blazer II, Boston Scientific,
Natick, MA, USA) with an EPT-1000XP generator for the
radiofrequency group. A large curve was initially selected
in both groups, with change out of catheter curve during the
study only as necessary. Applications of −75°, for 4 min
were given with cryothermy, and applications of 60 Watt,
for 60 s, targeted at 60°C for RF. Lines were made with
discrete applications between the tricuspid valve and the
inferior vena cava at an approximately 6 o’clock position in
LAO 45°, unless otherwise dictated. If termination of atrial
flutter occurred, or if the patient was in sinus rhythm,
continuous pacing from the proximal coronary sinus was
employed to continually assess isthmus conduction. After
the first line, a new assessment of conduction was
performed. If conduction over the isthmus remained
present, gaps were sought. If there was still isthmus
conduction, a slightly more medial or lateral line was
made. In no patient was an attempt made to perform a
septal ablation line. Final assessment of acute block was
confirmed after 30 min waiting.
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The end point for successful ablation was induction of
complete bidirectional isthmus block, defined as the
presence of reversal of activation on the lateral and septal
wall when pacing the CS os and low lateral RA, the
presence of widely split potentials along the isthmus line,
by activation mapping across the isthmus, and by differen-
tial pacing. All 4 were required before calling the ablation
successful. In the case where bidirectional block was not
achieved, ablation was stopped when no large, sharp signals
could be identified over a broad area of the isthmus.
As pain perception was assessed, sedation was standard-
ized. Before venous puncture 5 mg of diazepam was given
intravenously, and repeated at the patient’s request. Fen-
tanyl 50 μg intravenously was given when the patient
requested pain control and the physician considered this
necessary. This was repeated as needed. Dosages of both
diazepam and fentanyl were recorded.
In the initial 40 patients creatine kinase (CK) and CK-
MB were taken before the procedure, 2 and 24 h after the
start of the procedure. For the final 22 patients the
laboratory had changed the measurement to CK mass. We
then modified the protocol to measure CK-MB mass,
Troponin T, and Myoglobin at 4 and 24 h after the start
of the procedure.
No crossover, other than in catheter curve, was allowed
in an attempt to remove any possible bias. Change over to
an irrigated tip ablation catheter was also not allowed. In
patients in whom no block could be induced, a repeat
procedure was scheduled not earlier than 6 weeks after the
initial ablation, at the physicians’ discretion. The choice of
energy source at that time was at the physicians’ discretion.
Patients were all questioned with regard to pain
perception using a visual analogue score, where patients
are shown a line from 0 to 10, where 0 is no pain, and 10 is
the highest pain level imaginable, and were asked to point
to the position on the line where their pain level during
ablation was.
2.4 Follow-up
All patients received an event-recorder for the first 6 weeks
after the procedure and were requested to send at least daily
strips as well as strips made during symptoms. Patients
visited the outpatient clinic 6 weeks after the procedure.
After this period all patients were asked to report symptoms
and if these were present were given a further event monitor
until documentation of symptoms was obtained. If at all
possible a 12 lead ECG was also obtained. A second
assessment with a questionnaire was performed after
3 months, again asking a question about general clinical
well being and also symptom burden in regard to duration
and frequency. Clinical files were followed up after
9 months.
2.5 Statistical analysis
For patients in whom another ablation was performed
(AVNRT in two, and pulmonary vein ablation in six others)
procedure and fluoroscopy times were limited to the flutter
approach, which was done first, including 30 min waiting
time. Biomarker assessment was not done in these patients.
Continuous variables are expressed as mean ± standard
deviation, with medians as necessary. Parametric and non-
parametric tests were used where appropriate. A p-value of
<0.05 was considered significant.
3 Results
3.1 Patient data
62 patients were included as planned, with clinical
characteristics as outlined in Table 1. There were no
significant differences in any of the parameters between
the group assigned to radiofrequency (RF group) versus
that assigned to cryotherapy (cryo group). The large
number of patients with prior AF is due to the fact that
we had initially taken a decision to perform isthmus
ablation first in all patients with AF who had shown typical
atrial flutter on any 12-lead ECG, prior to performing a left
atrial procedure, initially in a separate procedure and only
later in the same session.
3.2 Angiographic data
Right atrial angiography was not performed in 4 patients
because of mild renal dysfunction or allergy to contrast
material. The angiogram was of insufficient quality in eight
others.
The mean isthmus length was 35.2±14.6 mm and its
topography was assessed as being flat or only mildly
concave in 28, markedly concave in 19 and showed a pit or
aneurysm in 10. A clear Eustachian valve was seen on six
angiograms.
Table 1 Demographics
All Cryo RF p value
Number 62 32 30
Age (years±SD) 56±10 55±11 56±9 NS
Male/female 27/5 27/5 28/2 NS
Atrial fibrillation
history
47 (76%) 25 (78%) 22 (73%) NS
Cryo Cryoablation; NS not significant; RF radiofrequency; SD
standard deviation
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3.3 Ablation data
Assessment of acute results showed bidirectional isthmus
block, using the criteria mentioned, in 47 of 62 patients
(76%). This was in 25 of 30 patients (83%) of the RF group
and in 22 of 32 (69%) of the cryo group (NS). In 1 patient
in the RF group the procedure was terminated because of
recurrent AF with early recurrence and inability to assess
isthmus block. This patient was taken as a failure which
was confirmed at the time of a subsequent AF ablation.
Procedural data for all patients are given in Table 2.
In the successful patients the number of applications to
ensure block in the whole group was 17±11. It was 23±13
in the RF group and 12±6 in the cryo group (p<0.005).
Total ablation time was 1,283±777 s and 2,905±1,245 s
(p=0.0001). In those in whom bidirectional block could not
be achieved, the total number of applications was 33±14.
For RF and cryo the values were 39±21 applications with a
total time of 2,724±1,102 s vs 29±8 applications with a
time of 5,873±1,337 s (p<0.03 and <0.0011, respectively).
In 22 of 30 in the RF group and 25 of 32 in the cryo
group, a single line at approximately 6 o’clock was drawn.
In the RF group two lines were drawn in seven, and three in
one. In the cryo group two lines were made in four, and
three lines in three. The need to draw more than one line
was associated with failure of the procedure in four of eight
in the RF group and five of seven in the cryo group (NS).
Short lived block, either recurring during the application
or immediately thereafter, occurred in one patient in the RF
group and in six in the cryo group, with a trend to statistical
significance (p=0.091), with it being a predictor of failure
if it occurred more than three times. In five patients in the
RF group and one patient in the cryo group, conduction
recurred later during a waiting period (with a median of
15 min) requiring further applications (NS). In only one
patient in the RF group was late recurrence associated with
failure to induce bidirectional block. In no patient in whom
bidirectional block was present at the end of the 30 min
waiting period did isoprenaline change this. The average
power applied in the RF group was 52±6 W.
In the RF group the signal was significantly diminished
at the end of each application whether isthmus block was
present or not, while there tended to be preservation of
signals on the cryoablation catheter after ablation across the
isthmus until block occurred. Only then were low voltage
signals seen.
Failures were not significantly associated with length of
the isthmus (39.2±23.5 vs 34±9.0 mm in success, although
there was a trend to this (p=0.12) There was no significant
difference in anatomy between the two groups.
3.4 Procedure data and complications
The overall procedure time was 160±49 min, with no
difference between 170±48 min in the RF group and 151±
49 min in the cryo group. Overall fluoroscopy times were
28±14 min, with a difference between 33±15 min in the
RF group and 23±11 min in the cryo group (p<0.02).
Change of catheter curve occurred in one patient in the
RF group from large to standard curve. An SL1 sheath
Table 2 Procedure data and recurrent arrhythmias
All Cryo RF p value
Number 62 32 30
Application number 22±13 18±10 25±16 0.05
Ablation time (s) 2,742±1,930 3,792±1,900 1,459±950 <0.001
Acute success 47 (76%) 22 (69%) 25 (83%) NS
Single line 47 (76%) 25 (78%) 22 (73%) NS
2 lines 9 (15%) 2 (6%) 7 (24%) 0.073
3 lines 4 (6%) 3 (9%) 1 (3%) NS
Reversal of block during application 7 (11%) 6 (19%) 1 (3%) 0,091
Reversal of block during 30 min 6 (10%) 1 (3%) 5 (7%) NS
Isthmus length (mm) 35±15 35±17 36±11 NS
Sheath usage 7 (11%) 0 (0%) 7 (23%) <0.005
Recurrent arrhythmias
Flutter (typical)
After success 1 (2%) 0 (0%) 1 (4%) NS
After failure 11 (73%) 7 (70%) 4 (50%) NS
Flutter (atypical) 1 (2%) 0 (0%) 1(3%) NS
Atrial tachycardia 5 (8%) 2 (6%) 3 (10%) NS
Atrial fibrillation 28 (45%) 13 (41%) 15 (50%) NS
The numbers are given with the standard deviation.
Cryo Cryoablation; NS not significant; RF radiofrequency
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(Daig, Minnetonka, MN, USA) was used in seven patients
in the RF group for stability, while no sheath usage
occurred in the cryo group (p=0.005). During the proce-
dure, six patients required cardioversion for induced AF,
four in the RF group and two in the cryo group (NS). There
were two small pericardial effusions seen on echocardiog-
raphy without further significance (one in each group).
For the initial 40 patients there was a significantly higher
peak CK and CK-MB after cryo (Table 3). This remained
so after 24 h. For the last 22 patients we observed the same
for CK-MB mass, but not for Troponin T (Table 3).
In assessing the level of comfort during the procedure
and the pain experienced by patients, similar numbers from
both groups assessed sedation as adequate (67% for RF and
63% for cryo). The pain scores given at the end of the
procedure were not significantly different (42.9±24.0 for
RF and 43.7±15.8 for cryo). Diazepam was given as
standard at the beginning of the procedure and as necessary
thereafter for discomfort related to having to lie still for
protracted periods. The usage of diazepam was statistically
similar in both groups (7.4±3.4 mg in the RF group and
8.0±3.1 mg in the cryo group). However, a significantly
higher usage of fentanyl in the RF group was observed
(70.0±44.9 μg vs 10.0±22.1 μg; p<0.01).
3.5 Follow-up results
Patients were followed up for between 90 and 411 days
(138±81 days, median 90 days), which was similar in both
groups (p=ns).
A total of 6 patients were taking no antiarrhythmic
medication prior to ablation and this increased to 13 post
isthmus ablation.
Recurrent arrhythmias were frequent in both groups of
patients. ECG documented recurrent flutter occurred only
in one patient from the RF group. A further procedure
confirmed recovery of isthmus conduction. This recurrence
was seen at 14 months post ablation, whereas he had
previously had monthly episodes of flutter. One other
patient had symptoms with an apparently non-isthmus
dependent flutter documented on ECG on day 1 post
ablation and not since, and elected not to have a further
procedure. We cannot exclude asymptomatic arrhythmias
but at least during the first 6 weeks, patients sent in daily
event monitor transmissions, which one would hope would
have captured at least some asymptomatic recurrences,
particularly of atrial flutter.
In 11 of 15 patients in whom the initial procedure failed,
a redo procedure was performed after the elected period of
6 weeks because of documented recurrent flutter. The redo
procedure required a small number of point touch ups in
five patients (three in the RF group and two in the cryo
group), while more extensive diffuse isthmus applications
were required in six (one in the RF group and five in the
cryo group). In those undergoing repeat ablation, success
was achieved in all and during follow up no recurrent atrial
flutter was noted.
Previously undocumented atrial tachycardias were also
seen in both groups (three in the RF group, and two in the
cryo group). ECG documented AF recurrence occurred in
28 patients, at a similar rate in both groups (15 in the RF
group and 13 in the cryo group). The likelihood of
asymptomatic recurrences is probably higher for atrial
fibrillation but was not the primary focus of this study.
4 Discussion
4.1 Acute success
This study showed an acute success rate of 83% for an
8 mm tip RF catheter vs. 69% for an 8 mm tip cryocatheter.
This non significant difference is clearly concerning.
However, the cryoablation group required significantly less
applications to achieve success, with a similar procedural
duration, significantly lower fluoroscopy time, and with a
much lower requirement for analgesia with fentanyl.
Arrhythmia recurrences in the initially successful patients
were similar with a very low flutter recurrence rate.
The acute success rate with 8 mm tip RF compares
favorably with that found in the meta-analysis of Da Costa
et al. [22]. However, the acute results for cryotherapy are
lower than in previously published studies. The shorter
fluoroscopy time using cryotherapy is related to cryoadher-
ence during applications [26]. With the catheter firmly
attached, no fluoroscopy to check position is required. This
Table 3 Biomarkers after catheter ablation
All Cryo RF p value
Procedure values
CK (U/l) 141±96 184±102 96±60 0.02
CK-MB (U/l) 27±16 36±17 18±8 0.011
CK-MB mass (μg/l) 18±21 33±24 4.4±1.2 0.004
Troponin T (μg/l) 0.49±
0.32
0.54±
0.38
0.39±
0.27
NS
Values after 24 hrs
CK (U/l) 264±245 289±173 136±74 0.022
CK-MB (U/l) 37±28 51±30 18±6 0.011
CK-MB mass (μg/l) 8.4±7.3 12±10 5.16±3.3 0.07
Troponin T (μg/l) 0.44±
0.30
0.54±
0.36
0.38±
0.29
NS
The numbers are given with the standard deviation.
CK Creatine kinase; Cryo cryoablation; NS not significant; RF
radiofrequency
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is also reflected in the fact that no long sheaths were
necessary. A lower requirement for analgesia has previously
been described and this study confirms this finding [17, 26].
4.2 Difficulties during ablation
Recurrence during or shortly after ablation occurring more
commonly in the cryo group probably relates to a reversible
cooling effect at the periphery of the ice ball which recovers
during or shortly after termination of ablation, while the
central lesion acutely formed is more permanent. The more
common recurrence during the waiting period after RF
ablation probably relates to a longer reversal time of the
acute RF effects (either edema or temperature effect).
4.3 Cryoablation for flutter
Cryoablation may have some advantages over RF in
addition to those mentioned above such as less thrombo-
genicity [27], and maintenance of tissue architecture with
homogenous well delineated lesions [28]. A 10Fr, 6.5 mm
tip catheter showed acute success of 94–100% and 6 month
recurrence rates of 0–25% [17, 29, 30]. A system with 7Fr,
6 mm tip catheters showed success in 87% to 88% using a
septal line, without symptomatic recurrences, but with
resumption of isthmus conduction at repeat study at
6 months in 30–35% [31, 32]. Using a 9Fr, 8 mm tip
increased success rates to100% with symptomatic recur-
rence of 0% to 10% and recurrent conduction at 1 to
3 months in 19% to 32% [32–34]. There is some discussion
as to whether 3, 4 or 8 min of ablation are needed for
adequate lesion formation [33, 35].
Higher peak CK levels, confirmed by the high CK-mass
in the last patients, suggest that the damage caused by
cryotherapy may be more extensive despite the lower
number of applications. Several explanations are possible.
The first is that the CK levels may be underestimated after
RF, which denatures proteins in another way than cryother-
apy. Troponin T levels are more accurate in estimation of
myocardial damage, but they also tended to be higher, be it
not significantly. This may suggest that lesions are equal
with both approaches.
4.4 Future developments
Newer data suggest that ablation per point guided by the
maximal voltage may be a useful technique, but this has not
been confirmed for cryotherapy [36].
4.5 Study limitations
This study was a single centre, largely single operator study
involving a relatively limited number of patients with a
high population of AF patients, making follow-up rather
complicated. In present practice and later in this series,
patients with the combination are often treated in one
session, which still leaves physicians the choice whether
cryo should be used for flutter, following its use for the
pulmonary veins [37]. We only studied the acute and short-
term success, while flutter recurrence may happen at more
than 4 months of follow-up. While we attempted to exclude
asymptomatic recurrences especially in the first 6 weeks,
we cannot exclude the possibility of these, especially of AF
and also late after the ablation. Isthmus conduction
recovery is also possible in asymptomatic cases. In the RF
group we limited the power to 60 W to ensure safety and
this may be too conservative. Further, in our practice
routine use of long sheaths was discouraged. At the time of
this study use of an 8 mm tip with RF was considered as
effective as irrigated tip ablation, so we elected to use this
approach for the RF group. More recent studies have shown
higher success rates than we obtained and have also
suggested alternatives in the approach. These include the
use of irrigated tip catheters and long sheaths as well as
other technical issues and newer techniques such as maximal
voltage guided ablation. A higher success rate for RF would
clearly have been even more prejudicial to cryotherapy in
this study. We were also extremely critical in our assessment
of isthmus conduction, using multiple criteria. Angiograms
were also performed in fixed views and not based on other
catheter positions as has been suggested by others [14].
5 Conclusion
Acute success with cryotherapy for atrial flutter ablation,
while non-statistically less effective in this study, requires
fewer applications and is associated with a significantly
lower requirement for pain relief. While our acute results
for both cryotherapy and RF may not be as high as those in
some comparable studies the recurrence rate was only 2.5%
in the RF group, with no clinical recurrence in the cryo
group. While cryotherapy cannot perhaps be advocated as
first line therapy, it may be useful in certain circumstances.
Certainly, if cryoablation is performed for AF, and if the
isthmus needs to be ablated, cryotherapy might be used as
well [37].
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EDITORIAL
Atrial flutter: Watch and control?
Since the demonstration of the circuit of typical
atrial flutter, and the recognition that an ablation
line across the cavotricuspid isthmus could be
a permanent cure for this arrhythmia [1,2], elec-
trophysiologists have been attempting to improve
the success rates for this procedure. The clarifica-
tion of an acceptable end-point with relatively low
risk for recurrence [3,4] has now led to an attempt
to optimise the acute success rates, and thus also
long-term efficacy, of this procedure. The intro-
duction to the article by Hillock et al. [5] in this
issue highlights some of the frustrations experi-
enced by electrophysiologists attempting to ablate
this region. The isthmus can be irregular and thick,
and anatomical structures such as the Eustachian
valve can make ablation both difficult and long [6].
In experienced centres there are always attempts
to improve success rates. Furthermore, the success
rates in excess of 90% with minimal radiation and
short procedure times described by high volume
units are presumably not always repeated by
operators in less experienced centres, prompting
attempts safely to improve these rates. Thus,
there is a background which encourages operators
to try new techniques not only to improve success
rates, but also to shorten procedure and radiation
times. Numerous authors have compared different
energy types, different catheter tip sizes and
different energy settings [7e11], as well as the
use of advanced cardiac mapping systems [12], but
the search for improved techniques continues.
Clearly it is important to balance the effective-
ness of the procedure with the risks associated
with the use of alternate techniques. As Hillock
et al. have shown, the use of ‘‘un-monitored’’ very
high power settings (O100 W) is associated with
a significant risk of ‘‘pops’’ and subsequently of
perforation and tamponade. These added risks
were apparently not seen in other studies using
long tip catheters and up to 100 W [10,11].
In the ablation of the cavotricuspid isthmus
a number of features could potentially lead to an
improvement in the success rate, while at the
same time also improving safety.
What is needed pre-, or during ablation, is an
accurate picture of the isthmus itself. These
images would demonstrate anatomical variations
which may prove to be an impediment to ablation,
such as a markedly irregular or very thick isthmus,
or the presence of deep pits or a large Eustachian
ridge or valve. Detailed knowledge of the anatomy
would allow for the planning of the best line so as
to avoid difficult areas and move to the easier
areas. Although an electroanatomic mapping sys-
tem can be used to delineate anatomy, potential
anatomical problems and to tag a line [12],
perhaps this visualisation could be done better by
direct imaging. Whether this enhanced anatomical
knowledge is best based on a pre-study CT scan or
MRI, or is made on the basis of intraprocedure
angiography [13,14] or echocardiography [15] will
become clearer in the future. Present techniques
need to be further improved, because the resolu-
tion now is not always optimal (or cost effective)
to make detailed plans.
In addition the optimal delivery of energy to
cause lesions is also important. It is clear that the
use of 4 mm tip radiofrequency catheters has
become antiquated and that at the very least
8 mm tip or irrigated tip catheters are the pre-
ferred tools of most electrophysiologists [16]. The
place of cryotherapy has yet to be fully established
especially with the availability of large tip cryo-
catheters. Our experience of 8 mm tip cryocath-
eters is that the acute success rate over the last
year appears to be as good of that of 8 mm tip
radiofrequency catheters, with less pain experi-
enced by the patients. This is the subject of an
ongoing prospective study at our institution. The
use of ‘‘un-monitored’’ high power radiofrequency
1099-5129/$30 ª 2005 The European Society of Cardiology. Published by Elsevier Ltd. All rights reserved.
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energy has been the subject of a limited number of
studies. It would appear from the present study,
however, that the un-monitored use of energy
greater than 100 W should probably not be at-
tempted. The question is really, what is the
optimal catheter type or energy setting to use,
and whether better monitoring of energy delivery
would assist in the formation of optimal lines of
block. Ablation for atrial fibrillation complicated
by the highly publicised risk of oesophageal fistula
formation has refocused our attention on optimal
energy delivery and optimal monitoring [17]. From
the limited knowledge available, it seems that
power may not be a good indicator of tissue
temperature especially with the use of irrigated
tip catheters, and assessment of micro-bubble
formation for instance may be useful both for
assessment of target tissue temperature and to
decrease complications [18]. The ability to see
lesions acutely and assess their placement and
especially their adequacy, for example by intra-
cardiac contrast ultrasound, helping us to place
and form lesions, might also be a tool in increasing
safety and efficacy in atrial flutter ablation.
All in all, despite what some electrophysiolo-
gists might think, we do need further study to
improve the outcome in ablation of atrial flutter
while improving patient safety and the efficacy of
this ablation technique.
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Pulmonary vein antrum isolation guided by
phased-array intracardiac echocardiography
A third way to do PV ablation
Background. Pulmonary vein isolation (PVI) has
emerged as an important strategy in the treatment
of patients with atrial fibrillation (AF).The two
most frequently used techniques are segmental PVI
and left atrial circumferential ablation.
Aim. To describe and discuss pulmonary vein
antrum isolation guided by phased-array intra-
cardiac echocardiography (ICE) as an alternative
approach, and to present initial results.
Methods. Patients with symptomatic AF were
included. The antra (the larger circumferential area
around the PVs) were isolated guided by ICE. ICE
was also used to titrate the ablation energy.
Results. 38 patients (3 with persistent AF) were
included. Of the 35 patients with paroxysmal AF,
24 are without recurrences, and in six the incidence
of paroxysms was significantly reduced after one
procedure and a mean follow-up of 201 days. No
major complications occurred. 
Conclusion. Pulmonary vein antrum isolation
guided by ICE is a promising technique in AF
ablation and has the potential to avoid severe
complications. (Neth Heart J 2005;13:439-43).
Keywords: atrial fibrillation, PV isolation, intracardiac
echocardiography
Isolation of the pulmonary veins (PVI) has emergedas an important strategy in the treatment of patients
with atrial fibrillation (AF). Several studies have dem-
onstrated freedom from AF after complete PVI in 70%
of patients presenting with paroxysmal AF.1-3 In this
paper we describe an intracardiac echocardiograph-
ically guided technique for PVI and report the initial
results and complications of an ongoing study using
this method, aiming at ablation of the antrum (the
larger circumferential area around the PVs) rather than
at the PV itself, to improve outcome and to prevent
the occurrence of potentially serious complications. 
Methods
Inclusion criteria
Patients with symptomatic paroxysmal AF despite at
least two antiarrhythmic drugs, in the absence of
significant heart disease, were included in an ongoing
prospective clinical trial. Initially, patients with persistent
AF could be included as well. Additional inclusion
criteria were a left atrial dimension <55 mm, willingness
to comply with invasive screening and follow-up
procedures, and the absence of echocardiographic ab-
normalities during transoesophageal echocardiography
(TOE) the day before the procedure. A multislice CT
scan was performed to assess the anatomy and measure
the diameter of the PVs.
Ablation procedure
A general outline of this procedure has already been
given elsewhere.4,5 A 10 Fr intracardiac echocar-
diography (ICE) catheter (Acunav, Siemens AG Inc.,
Malvern, PA, USA) is introduced through the left
femoral vein and positioned in the right atrium. The
subclavian vein is used to advance a decapolar stimula-
tion catheter into the coronary sinus. Two long sheaths
are advanced through the right femoral vein into the
right atrium. Double transseptal puncture is carried
out using a Brockenbrough needle guided by both
ICE and fluoroscopy. ICE is also used to ensure a
posterior transseptal approach. A circular mapping
catheter is advanced and positioned in the antrum of
the pulmonary veins (figure 1).
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Radiofrequency energy is delivered using an 8 mm
ablation catheter aiming at abolishing all PV potentials
registered with the roving circular mapping catheter.
RF energy is set at 30 Watts and 55°C and increased
by 5-Watt steps to a maximum of 70 Watts or until
microbubble formation (figure 2) occurs. 
After isolation of all four PV antra the circular mapping
catheter is placed in the superior caval vein (SVC) and
this vein is also isolated. Ablation in the SVC is only
carried out if there is no phrenic nerve stimulation
while pacing at a high output in this vein. The day after
the procedure a transthoracic echocardiogram is
preformed to exclude pericardial effusion.
Anticoagulation protocol
All patients are treated with the coumadin preparation
acenocoumarol for at least one month before the
procedure, aiming at an INR of 2.5 to 3.5. Two days
before the procedure, patients are admitted to hospital
and the acenocoumarol is replaced by unfractionated
heparin, aiming at an APTT ratio of three times the
normal. A transoesophageal echocardiogram (TOE) is
carried out the day before the ablation to exclude atrial
thrombi. Two hours before the ablation, the heparin is
stopped. After venous puncture and before transseptal
puncture a 5000 E heparin bolus is given. After
successful transseptal puncture another 5000 E heparin
is given and a continuous titrated infusion of heparin is
started. During the procedure the activated clotting time
(ACT) is monitored every 30 minutes and is kept above
350 msec with bolus doses of heparin and adjustment
of the infusion rate. After the procedure the patients are
treated with heparin, and acenocoumarol is restarted.
Heparin is stopped when the INR is above 2.5.
Acenocoumarol is continued for at least six months.
Antiarrhythmic drug treatment after ablation
During the first two months after ablation all patients
are treated with flecainide and bisoprolol to suppress
atrial ectopy caused by the ablation. These drugs are
stopped after two months if AF does not reoccur.
Follow-up methods
All patients are followed intensively in the outpatient
clinic, including daily transtelephonic ECG monitoring
from one month before until three months after
ablation. Multislice CT scans are repeated at three
months to evaluate the possible occurrence of PV
stenosis, defined as a reduction in the diameter of more
than 80%.6
Results 
Patients
A total number of 38 patients (6 females), mean age
50.7 years (23 to 68 years), were included. Three of
these patients had had persistent atrial fibrillation for
more than one year and had to be cardioverted into
sinus rhythm before ablation. Seven patients had
previously undergone a right atrial isthmus ablation
for atrial flutter. The mean LA dimension, as measured
with transthoracic echocardiography, was 44.6 mm
(32-53 mm). One patient had a fifth pulmonary vein
on the right side. As the antra of the pulmonary veins
often merge at the level of the atrium, this often creates
the impression that there is a common origin of
unilateral PVs.
Procedure and complications
All transseptal punctures were uneventful. In the first
38 patients, 150 pulmonary veins could be electrically
isolated. All PVs were isolated in 36 patients. The
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Figure 1. Phased-array intracardiac echocardiogram: circular
multipolar catheter (Lasso) in the antrum of the left inferior
pulmonary vein. LIPV=left inferior pulmonary vein, LSPV=left
superior pulmonary vein.
Figure 2. Phased-array intracardiac echocardiogram: microbubble
formation during ablation, caused by overheating of the tissue,
showing a ‘brisk shower’ and ablation is stopped immediately. 
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average procedural time was 229 minutes (145-396)
and the average fluoroscopy time 94 minutes (52-147).
The average radiofrequency application time was 4098
seconds (1569-7999). The three patients with per-
sistent AF were cardioverted several times during the
ablation procedure. Of the other 35 patients, 17 were
cardioverted once or twice during the procedure. In
two patients, asymptomatic and transient ST elevation
(figure 3) was observed after transseptal puncture.7
No echocardiographic evidence of myocardial infarction
was observed. In four patients a right-sided isthmus
ablation was carried out during the same procedure. In
nine patients the superior caval vein (SVC) was isolated
as well. This was not done in those patients undergoing
phrenic stimulation during pacing in the SVC. In one
patient an asymptomatic hemidiaphragmatic paralysis
was seen immediately after ablation. No other compli-
cations occurred, except for two vagal reactions. 
Follow-up
Mean follow-up in the described patients is 201 days
(SD 10 days, 1-360 days). PV stenosis was not seen.
Only one of the three patients with persistent AF was
in sinus rhythm after the procedure. All three patients
now have permanent AF. AF recurrences were seen in
11 of the 35 patients with paroxysmal AF. In six of
these 11 patients the incidence of AF paroxysms was
significantly reduced. AF was recorded in 34.6% of
transmitted ECG strips before and 6.4% of transmitted
ECG strips after PVI. Two patients developed a
symptomatic atrial flutter, and were treated successfully
with right-sided isthmus ablation.
Discussion
The first successful nonpharmacological treatment
for AF, aiming at changing the substrate, was the
Maze procedure.8 Stimulated by the success of this
procedure, initial ablation attempts were made to
copy the Maze procedure, using transvenous ablation.
The idea was to compartmentalise both atria by
making long linear lesions. These procedures, how-
ever, were not successful because of technical dif-
ficulties in creating linear lesions, morbidity associated
with this approach, long duration of the procedure
and moderate effect on AF burden.9 Two strategies
for PV isolation emerged as more effective, and
became major therapeutic options for patients with
paroxysmal AF.
Classical techniques in radiofrequency AF ablation 
Haissaquerre et al. drew attention to the role of focal
activity within the pulmonary veins in triggering and
maintaining AF.10,11 Based on this knowledge he
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Figure 3. Transient ST elevation in the inferior leads after transseptal puncture.
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originally performed radiofrequency (RF) ablations
only at sites within the PVs where ectopic activity was
recorded.10 It is now accepted that the results of
ablation improve if all PVs are completely isolated from
the left atrium. Because the risk of PV stenosis with
RF energy was substantial, ablation is now targeted at
the ostia of the PVs. The endpoint of this approach
(often referred to as the Haissaquerre approach or
segmental PVI) is the elimination of all ostial PV
potentials and the demonstration of complete entrance
block. In this technique the ostium of the PVs is
assessed by angiography.
Another successful approach in AF ablation,
originally designed to isolate the PVs with a reduction
in the risk of PV stenosis, is the circumferential pul-
monary vein ablation.3 This technique, developed by
Pappone et al., is also known as left atrial radio-
frequency circumferential ablation (LACA). Con-
tinuous circular lesions are made around each PV or
around ipsilateral PVs with the help of a virtual three-
dimensional (3D) electroanatomical mapping system.
The ostium of the PVs is identified by fluoroscopy and
during withdrawal of the catheter from the PV, with
a simultaneous impedance decrease and appearance of
atrial potentials. The endpoint of this approach is a low
peak-to-peak bipolar potential (<0.1 mV) inside the
circular lesion. The results of LACA are better when
complete PV isolation, which can be considered to be
a hybrid endpoint, is reached.12
Possible complications of PVI 
Several complications of PVI have been reported.
Severe thromboembolic complications are possible13
and therefore good anticoagulation is warranted. PV
stenosis has gained a lot of attention.14 The incidence
seems to decline with growing experience and with
more proximal ablation. 
Perforation, pericardial effusion and even tamponade
have been described.15 The left atrial appendage (LAA)
is especially vulnerable to perforation and should be
avoided during ablation. PVI can cause the appearance
of new arrhythmias,16,17 such as atrial tachycardia and left
atrial flutter. The most feared complication nowadays
is perforation at the posterior wall and the subsequent
development of a left atrial-oesophageal fistula.18-21
Rationale for using intracardiac echocardiography
Intracardiac echocardiography (ICE) enables trans-
septal puncture and makes it safer.22 Because ablation
should target the ostia of the PVs, imaging of the
pulmonary veins during the procedure is important.
Angiography shows only the tunnel-shaped portion
of the PVs, while in reality the PV antrum is more
funnel-shaped, as can be seen on 3D multislice CT
scan reconstructions (figure 4). 
Real-time imaging of the PV antrum is currently
only possible with ICE. Overheating of the tissue
carries a risk of perforation and thrombus formation.
Microbubble formation is a good indicator of excessive
temperature and steam formation.23 Monitoring
microbubble formation with ICE can therefore be used
to prevent overheating.24 Ablation within the thin-
walled LAA is prevented by the visualisation of this
structure. ICE is the only tool available today to
provide us with real-time imaging, making it possible
to ablate in the antrum of the PVs and to ensure good
wall contact. The use of ICE also holds promise for
reducing fluoroscopy time; the fact that we could not
demonstrate this is partly due to the learning curve
involved in this technique. The average fluoroscopy
time in more recent cases in our clinic has fallen below
60 minutes. 
Merging techniques to improve efficacy and reduce
complications
The differences between the two most frequently used
techniques (segmental PVI vs. left atrial circumferential
ablation) (figure 5) have often been passionately
discussed. Pioneering groups using the segmental PVI
reported freedom of AF without antiarrhythmic drugs
in 70% of patients presented with paroxysmal AF.25,26
This success rate was definitively lower compared with
the LACA approach of Pappone et al.3 reporting
freedom of AF in 85% of patients. This was attributed
to the reduction of electrically active tissue (substrate)
with the wide encircling lesions. This difference
between the two techniques disappears, however, with
the more proximal ablation used today by those
performing segmental ablation and with the complete
PV isolation achieved with LACA. The electro-
anatomical mapping used in left atrial circumferential
ablation has advantages because it creates a 3D map
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Figure 4. 3D reconstruction multislice CT scan. Posterior view. The
tube-shaped portion of the pulmonary veins becomes funnel-shaped
before entering the left atrium.
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enabling navigation. However, this 3D environment
is virtual and often does not account for the funnel
shape of the proximal part of the PV. The reported
clinical results of the ICE-guided antrum ablation are
very good, even in patients with structural heart
disease.27 The initial results of our ongoing experience
are very promising. Despite the growing experience
with the procedure and the improvement in success
rate, PVI remains an invasive procedure and major and
sometimes life-threatening complications can occur.
We strongly believe that pulmonary vein antrum
ablation guided by ICE has the potential to avoid
several complications because it uniquely provides on-
line visualisation of the left atrium together with the
possibility to titrate energy in order to prevent over-
heating. This results in less PV stenosis and seems
promising to avoid left atrial oesophageal fistulae. �
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Figure 5. Schematic representation of the three described techniques.
The PVs are drawn as four circles and the ablation lesions as dotted
lines. A. Ostial PV isolation originally described by Haissaquerre
et al. B. Circumferential ablation first described by Pappone et al.
C. Typical lesions set after intracardiac echo-guided PV isolation.
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PotENtIAl APPlICAtIoNS oF MAgNEtIC NAvIgAtIoN  
IN ClINICAl ElECtRoPHySIology
L.J.Jordaens, M. Rivero-Ayerza, A. Thornton
Department of Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
In spite of the high reported success rates, catheter ablation for supraventricular arrhythmias 
remains difficult, with early and late recurrences and complications. Several strategies to mini-
mise the latter can be followed, as investigating alternative energy sources, using intracardiac 
echocardiography to monitor catheter handling and transseptal puncture, or as became pos-
sible only recently, stereotactic navigation of the catheter without manual force.
The restrictions of the present radiofrequency technology still are considerable. Apart from 
the fact that lesions are unpredictable and irreversible, catheters need a conductor to bring 
the energy to the tip, and additionally they are equipped with wires to deflect the catheter, 
sometimes in multiple directions. This explains why with such stiff, still poorly maneuverable 
catheters perforations of heart and vessels may occur. This results in hematomas, and pericar-
diac tamponade, not only in unexperienced hands. A further restriction is the lengthy procedure 
time, associated with high X-ray exposure, which is a potential hazard for the patient, and for 
the physician. 
These considerations are especially important in more difficult situations, as in the presence 
of anatomic variations (e.g. complex congenital heart disease) or when a difficult target such 
as atrial fibrillation is approached. A similar problematic situation can be encountered when 
attempts are made to implant a biventricular pacing lead in the coronary sinus in a very large 
heart. 
Automation, and remote navigation of flexible soft catheters might be an answer to some 
of these problems. This is made possible with the development of  the so-called Stereotaxis 
system (St Louis), which makes it possible to steer a soft catheter with a magnetic tip in the 
heart, guided by two external, strong magnets producing a combined field strength of 0,08 
Tesla at the place of interest.
In an experimental set up the tip prolapse push force on catheters was reduced from 240 to 
132 g; the tip curl force (for alignment) was reduced from 45 to 15 g. This indicates indeed how 
the safety profile of this approach is very promising.The potential to advance and retract the 
catheter via robotics, or with a simpler system CardiodriveTM , was also developed by Stereo-
taxis. This combination permits perfect remote control over the catheter, and should result in 
less radiation for the physician.
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Figure 1. EP lab with two large magnets lateral of the patient table. The Cardiodrive advancer is inserted in 
the right femoral vein.
ElECtRoPHySIology (EP) StuDIES
It was shown that all basic steps for a diagnostic EP study can be taken with the described prin-
ciple of magnetic navigation. If one wants to combine pacing and recording, a conventional 
catheter has to be inserted as well.
CAtHEtER AblAtIoN
Supraventricular tachycardia
We completed our learning curve for AVNRT, an arrhythmia with a simple anatomy in about 
20 patients. The results were just as good as with conventional radiofrequency, or cryotherapy 
(table 1), with considerably less radiation for the patient as well. 
Due to the magnetic field, less catheter movement with cardiac and respiratory cycles and dur-
ing junctional rhythm were seen as with conventional approaches.We have used the system 
for ectopic and incisional atrial tachycardia and right and left sided accessory pathways. We used 
a retrograde approach for the latter, even with the actual catheters, which are floppy over the 
entire length, what creates some difficulties at the aortic arch and valve. Others have preferred 
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the transseptal route, which may result in better appositioning of the catheter in the left lateral 
region. 
Ventricular tachycardia
Ventricular tachycardia of non-ischemic origin can be addressed. In RV outflow tract tachycardia, 
conventional ablation poses some difficulties, as two opposite curves have to be accomplished, 
and precise mapping has to be performed in a relatively small area. This makes precision move-
ment difficult, and often induces non-relevant arrhythmias. We have approached both left and 
right-sided idiopathic VT with magnetic navigation. This allows small steps, and very precise 
mapping with the floppy magnet catheter. 
 
Figure 2. Left ventricular fascicular tachycardia.  The upper panel shows the isolines in RAO and LAO, 
as acquired with the RPM mapping system, showing the apico-septal origin of the arrhythmia, with 
reference catheters in the coronary sinus and the right ventricular apex. The lower panel shows how the 
magnetic ablation lead (Helios 2, stereotaxis Inc) is moved from the yellow to the green line by magnetic 
forces. Here was a fascicular potential, and ablation was performed at this site. As both systems are not 
integrated, some imagination is left to the researcher. The angulations in RAO are not exactly the same.
Table 1 – Comparison of ablation variables in AVNRT, using 3 different techniques
 Magnet ablation Cryotherapy RF
Number of ablations (median (range))
Total ablation time (s) (median (range))
6 (1-22) 5 (2-16) 7 (2-28)
240 (60-633) 633 (452-2599) 290 (90-895)
Success   19/ 20 12/12 5/5
Procedure time (min) (median (mean±sd)) 163 (167±46) 148 (167±65) 159 (177±61)
Fluoroscopy time patient (min) (median (mean±sd)) 12 (17±12) 17 (20±11) 30 (30±8.8)
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Atrial fibrillation (AF)
AF is the real challenge today. Some attempts were made by Ernst et al to achieve pulmonary 
vein isolation. People tend to accept now that a wide circumferential approach is the best way 
to proceed. Pappone recently presented the first cases with integrated CARTO imaging, result-
ing in successful ablation of the AF substrate. The perspective should be that even the less 
invasive retrograde transaortic - transmitral approach should be considered.
Complex congenital  heart disease. 
Especially corrected complex congenital heart disease is frequently associated with arrhyth-
mias. These can often be very difficult to control with conventional means. Reconstructed 
chambers, recesses, patches, and tubes make catheter manipulation and ablation very difficult. 
If there is a place for magnetic navigation, it is in these dilated, scarred tissues of operated aging 
hearts. Integration of anatomy, voltage mapping and activation mapping should assist in more 
performant ablation.
ADvANCED CARDIAC MAPPINg
Electro-anatomic maps to guide the ablation process can now automated, more easily, be 
constructed aided by this remote technology. This will shorten the procedure time, and assist 
in assessing the success of otherwise lengthy procedures as pulmonary vein isolation.
Figure 3.  At the left designer lines as suggested by the investigator using the Navigant software 
(Stereotaxis Inc). At the right the CARTO map showing how these lines contributed to an electroanatomic 
map in sinus rhythm.
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Attempts are now undertaken to merge (old) MRI and multislice CT images in on-line electro-
anatomic maps. The overlay seems acceptable. All want to believe hat this is progress. Real 
image integration in the EP domain will be realized when on-line integration of a 3-dimensional 
image with the online EP data becomes a fact. This will probably be realized with 3D echo, but 
if developments in X-ray and MRI are fast, these techniques have a chance to be involved as 
well. 
CARDIAC RESyNCHRoNISAtIoN tHERAPy (CRt)
Implanting a biventricular pacing lead in the coronary sinus (CS) can be very time consuming. 
These procedures can require extensive fluoroscopic screening. This is partly due to difficulties 
in cannulating the CS, and once the guide wire or the lead is in the CS, partly to attempts to 
reach the potentially best side branch, and finally because the lead has to remain there after 
it is advanced over the magnetic guide wire, and when the guide wire is retracted. Further, 
complications as dissection of the CS and pericardiac tamponade exist. The idea to cannulate 
the CS  with a sheath into the mid right atrium or without a sheath at all should be tested with 
dedicated guide wires. 
Figure 4. At the right coronary sinus venogram using dedicated software to reconstruct a 3D image (at the 
left) what can be used to direct the guide wire.
Further, target side branches should be reached with the assistance of magnetic navigation, 
once the vessel is engaged. Magnetic force should be able to keep the guide wire in position 
when advancing the pacing wire. Most of these principles were tested already in our lab, and 
hold great promise.
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FutuRE CoNCEPtS
It is expected that with the incorporation of catheter registration technology or echocardiog-
raphy to this system or using these technologies in parallel procedure and radiation times will 
decrease. Combining this technology with other new technology such as cryotherapy and the 
other mapping technologies mentioned above, may significantly improve outcome, as well as 
reducing the number of applications, and associated collateral tissue damage. The potential 
for other areas in cardiology is there: stem cell therapy, difficult coronary artery procedures, 
congenital heart disease. Even when this system is only a first step on the road to performant 
magnetic navigation, the tested principles so far seem to confirm that the concept is valid, and 
should be considered a milestone in the development of safer and automated procedures.
Potential applications of magnetic navigation in clinical electrophysiology 73
REFERENCES
 1. Hindricks G. The Multicentre European Radiofrequency Survey (MERFS): complications of radiofre-
quency catheter ablation of arrhythmias. The Multicentre European Radiofrequency Survey (MERFS) 
investigators of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart 
J 1993;14:1644-53.
 2. Faddis MN, Blume W, Finney J, et al. Novel, magnetically guided catheter for endocardial mapping 
and radiofrequency catheter ablation. Circulation 2002;106:2980-5.
 3. Faddis MN, Chen J, Osborn J, et al. Magnetic guidance system for cardiac electrophysiology: a pro-
spective trial of safety and efficacy in humans. J Am Coll Cardiol 2003;42:1952-8.
 4. Ernst S, Ouyang F, Linder C, et al. Initial experience with remote catheter ablation using a novel 
magnetic navigation system: magnetic remote catheter ablation. Circulation 2004;109:1472-5.
 5. Ernst S, Ouyang F, Linder C, et al. Modulation of the slow pathway in the presence of a persistent left 
superior caval vein using the novel magnetic navigation system Niobe. Europace 2004;6:10-4.
 6. Thornton AS, Alings M, Scholten MF, Jordaens LJ. Left ventricular lead placement within a coronary 
sinus side branch, using only a floppy guide wire and magnetic navigation. Heart 2005;91;22.
 7. Rivero-Ayerza M, Thornton A, Scholten M, Mekel J, Res J, Theuns D. and Jordaens L.  Left ventricular 
lead placement within a coronary sinus side branch is feasible using remote magnetic navigation of 
a guide wire (abstract). Heart Rhythm 2005; 2: S 281.

Chapter 7
An in-vivo comparison of cardiac 
radiofrequency lesions formed 
by standard, and magnetically 
steered 4 mm tip catheters

An in-vivo comparison of cardiac radiofrequency lesions formed by standard, and magnetically steered 4 mm tip catheters 77
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In preparation
AbStRACt
Background: 
In-vivo comparison of cardiac radiofrequency ablation lesions between standard and 
magnetically steered 4 mm tip catheters has not been reported. We therefore compared 
lesions in the porcine right atrium (RA) and right ventricle (RV) using both techniques. 
Methods:
High and low RA free wall, isthmus, and RV free wall and outflow tract lesions were studied 
macroscopically and microscopically at 5 days after lesion formation in 7 pigs. We compared 
lesions characteristics including shape, size and thrombus formation, as well as ablation param-
eters, using standard and magnetically enabled catheters. The effect of minimal, medium and 
high wall contact was assessed by a contact measurement utility for the magnetically enabled 
catheters.
Results:
All 14 RA free wall lesions were transmural with similar epi- and endocardial surface area. In the 
RV, epicardial surface area usually appeared smaller than endocardial with standard, compared 
to magnetically enabled catheters. Isthmus lesions were difficult to assess for transmurality. 
There was no significant difference in endocardial surface area in the first 4 animals: standard: 
39 mm2 (range 16-82 mm2) vs. magnetic: 36 mm2 (range 23-111 mm2). If the catheter tip was 
perpendicular to the tissue, lesions from magnetically enabled catheters were significantly 
more often round or oval (8) than those from standard catheters (3), which were more often 
elongated (p <0,05). When the catheter tip was parallel to the tissue, such as in the isthmus, 
lesions tended to be elongated with both catheter types. Microscopic characteristics were simi-
lar. The contact utility was not useful. The average impedance (p<0.0001) and average energy 
delivered (p<0,05) were less in the magnetically enabled catheter group.
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Conclusions 
Lesions from magnetically enabled catheters are transmural, of similar size but with less vari-
ability and a more rounded or oval appearance, than standard catheters, especially when the 
tip is perpendicular rather than parallel to the tissue. Microscopic characteristics are similar. 
Lesion formation with magnetically enabled catheters was associated with lower impedance 
and average energy delivery. Magnetically enabled catheters appear to have a more stable tip 
to tissue contact, and may allow for more predictable lesions.
kEy WoRDS
arrhythmias, catheter ablation, radiofrequency energy, magnetic navigation
INtRoDuCtIoN
Radiofrequency (RF) lesions are created during ablation due to resistive heating as RF current 
passes through tissue. Lesion size is dependent on tissue temperature which relates to a number 
of factors, of which some are called controllable or non controllable.(1) The controllable factors 
include catheter tip size and more specifically tip surface area, electrode tip orientation, power 
settings, energy application time, and catheter temperature cut-off. The non-controllable fac-
tors have included cooling of the catheter tip by chamber blood flow and tissue contact. The 
majority of these factors have been studied extensively.(1-6) 
Recently a magnetic system (Niobe, Stereotaxis Inc., St. Louis, MO, USA) was introduced 
which allows for the use of floppy magnetic tip catheters which are steered and advanced 
remotely using an applied magnetic field and an external advancer system. The floppy magnetic 
catheters may have advantages not only in positioning in difficult anatomy, but also by main-
taining position during ablation. Conventional catheters with stiff shafts may pose difficulties 
in maintaining tip contact on a fixed point when the heart is moving during the cardiac cycle 
and with respiration. This movement during ablation may cause elongated or “brush” lesions. 
Improved catheter flexibility with floppy magnetic catheters during the cardiorespiratory cycle, 
may allow for more stable tissue contact during ablation. As the characteristics of standard 
and remote magnetically enabled catheters are so different, it is hypothesized that the lesion 
characteristics will also differ significantly, in favor of the use of magnetic catheters.
A difference between in-vitro and in-vivo models may be the effect of cardiac and respiratory 
motion on catheter tissue contact. A comparison using preparations such as the thigh muscle 
may be very useful for comparing standard catheters with similar construction and different 
energy sources, tip lengths and settings.(4-6) The unique and different way in which Stereotaxis 
directs the catheter against the tissue and the nature of the floppy shaft of this catheter meant 
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that we needed to compare the efficacy of standard versus magnetic catheters using the same 
type of ablation tip and energy settings in an in-vivo model, as there is no other model which 
mimics cardiorespiratory movement. To date there has been no direct in-vivo comparison 
between lesions produced by standard catheters and magnetically steered catheters. 
The magnetic system has also recently been integrated with an electroanatomical map-
ping system (CARTO RMT, Biosense Webster, Diamond Bar, CA, USA), such that information is 
sent from the one to the other. The combined system has a contact indicator monitor which 
attempts to indicate the contact which the catheter makes with the tissue surface. This tissue 
contact utility has also not been assessed in-vivo.
The purpose of this study was therefore to prospectively compare the safety and size of 
lesions produced by standard and magnetically enabled 4 mm tip catheter, in the RA and RV of 
the porcine heart. We also wanted to assess the impact of the CARTO RMT tissue contact utility 
when forming lesions. 
MEtHoDS
Introduction
Eight Yorkshire farm bred pigs with a mean weight of 40 kg, underwent transvenous ablation 
with a predetermined protocol (Figure 1), with sacrifice planned 5 days after the procedure. 
This experimental protocol was approved by the Animal Ethics Committee at the Erasmus 
University, and also conformed to the guidelines published in the “Guide for the Care and Use 
of Laboratory Animals.” (NIH publication No. 85-23, revised 1996). 
Initial Procedure
All animals received pre-procedural sedation with ketamine 20mg/kg and midazolam 0.5 mg/
kg intramuscularly. Once sedated, maintenance anesthesia was instituted with midazolam 2mg/
kg/hour and fentanyl 10 μg/kg/hour supplemented as necessary by isoflurane and an oxygen/
nitrous oxide inhalation (1:2) gas mixture. A cuffed endotracheal tube was introduced after suc-
cessful induction and the animals were then mechanically ventilated with a tidal volume of 13 
ml/kg. Body temperature was maintained at 37 to 38 degrees Celsius with warming blankets.
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Figure 1.  Flow chart of the study. The first 4 animals were a comparison with a conventional (Navistar) 
catheter and a magnetic catheter of the same size, but with magnetic properties (Navistar RMT).The last 
3 animals were submitted to various torque contact settings. IVC = inferior vena cava, RA = right atrium, 
RMT = remote, RV = right ventricle, RVFW = right ventricular free wall, RVOT = right ventricular outflow 
tract, SVC = superior vena cava.
An introducer sheath was placed into the right femoral vein by direct cut-down and the ablation 
catheter under study was advanced to the heart. All animals received a single dose of 150 IU/kg 
of heparin sulfate at the beginning of the procedure, followed after 1 hour with an additional 
500 IU/hr. 
Magnetic Navigation
Magnetic navigation was undertaken as previously described using the Niobe system.(7) In 
short the Niobe I magnetic navigation system (Stereotaxis Inc.) was combined with a mono-
plane angiography system (AXIOM Artis, Siemens, Erlangen, Germany).  The Niobe I system has 
2 large permanent magnets with a combined field strength of 0.08 Tesla in navigation mode, on 
either side of the patient. The magnets and the generated field are controlled via a computer 
workstation (Navigant, Stereotaxis Inc.) to allow for changes in the direction of a stable magnetic 
field within the heart of the patient. The ablation catheters have magnets in the distal shaft and 
these align the catheter tip with the field produced by the external magnets. Remote catheter 
advancement and retraction is performed using a catheter advancer system (CardiodriveTM, 
Stereotaxis Inc.), positioned on the thigh. After the magnets are brought in next to the patient 
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or experimental subject in navigation mode, remote control of all of the components of the 
system can be performed from the control room. 
Ablation – standard vs. magnetic
In the first 4 animals ablation was performed using either a standard Navistar 4 mm tip, (2 
animals) or a magnetic Navistar RMT 4 mm tip catheter (2 animals) both from Biosense Webster 
(Diamond Bar, CA, USA). Serial RF lesions were produced in each of the following areas: high 
right atrial free wall, low right atrial free wall, right ventricular free wall, right ventricular outflow 
tract, and inferior vena cava-tricuspid annulus (IVC-TA) isthmus, in the same sequence in each 
animal. Radiofrequency energy was delivered using an EP Shuttle generator (Stockert GmbH, 
Freiburg, Germany) with maximum set values of 58 degrees Celsius, 50 Watts and 60 seconds. 
Current was applied between the electrode at the distal end of the ablation catheter and a 
standard dispersive electrode placed on the animal’s back. Continuous recording prior to, dur-
ing, and immediately after ablation was made from the ablation catheter. During the ablation, 
recordings were made of the ablation site, both radiologically, as well as on the Stereotaxis 
system when this was used. Adequate tissue contact was determined by the physician on the 
basis of the radiographic images. 
Ablation – contact indicator use
The combined Stereotaxis and CARTO RMT system tries to assess contact by looking at the dif-
ference between the magnetic field orientation, as determined by the Stereotaxis system, and 
the localized catheter orientation, as determined by the CARTO RMT system. As the difference 
between applied magnetic field orientation and the localized catheter orientation increases, 
the contact indicator value increases on a scale from 0 to 4. When advancing a catheter per-
pendicularly into a wall, the contact meter will only rise when the flexible catheter begins to 
prolapse. 
In the last 3 animals ablation was performed at the same sites as noted earlier, using the 
same generator settings, while trying to achieve a predetermined contact indicator setting for 
each given position. Attempts to change the contact indicator setting were made by modifying 
the magnetic vector and/or advancing the catheter into the wall. The attained contact obtained, 
as well as comments in this regard, were recorded.
Lesion formation characteristics
As noted above, during each RF application continuous measurements were taken of steady-
state power, energy, temperature and impedance during ablation. Average measurements 
were then compared.
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Sacrifice
After 5 days the animals were again sedated with ketamine and midazolam with doses as 
described above, and anesthetized with pentobarbitol 12mg/kg after endotracheal intubation. 
The chest was opened and the heart exposed. The animals were euthanized using an overdose 
of pentobarbitol and the heart fibrillated using direct current. The heart was then explanted 
and opened.
Lesion assessment - macroscopic
Both the epicardial and endocardial surfaces of the heart were examined macroscopically for 
lesion characterization and the individual lesions photographed. The qualitative assessment 
included a description of shape (round, oval or elongated), the presence of cavitation and 
surface thrombus and whether the lesion was transmural. Epicardial and endocardial features 
were noted, as was done with evidence of any collateral damage such as to pericardium, pleura 
or lung. A quantitative assessment of endocardial surface area was made by 2 independent 
observers, and included use of planimetric software (Clemex Vision PE software, Clemex Tech-
nologies Inc., Longueuil, Canada).
Lesion assessment - microscopic
The lesions were dissected and fixed in 10% formalin. After processing, the tissue was embed-
ded in paraffin. A section was obtained perpendicular to the surface at the maximum diameter 
and stained with haematoxylin and eosin as a routine stain, and resorcin-fuchsin as elastin 
stain. The lesion was analyzed using the same planimetric software as noted above to assess for 
diameter, maximum depth, area of necrosis and inflammation and the presence of thrombus.
Statistics
Data were expressed as median, with ranges. Comparisons among groups were performed 
with a two-tailed analysis of variance. Comparisons of simple proportions between two groups 
were made with a Fisher’s exact test. A p value of ≤ 0.05 was considered to be statistically 
significant.
RESultS
Animal data 
One animal developed VF and then electromechanical dissociation during the first RF applica-
tion and died. All other animals completed the protocol. In total, 35 lesions were created at the 
high and low RA free wall and isthmus,  the RV free wall and outflow tract in the 7 surviving pigs. 
There were no complications of ablation. In 4 animals we compared 19 lesions using standard 
and magnetically enabled catheters – 1 RV free wall lesion could not be found back. In 3 animals 
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the contact measurement utility was assessed, with 1 high, medium and low contact ablation 
made at each of the 5 predetermined sites (15 lesions).
Macroscopic Lesion Assessment 
Standard vs. magnetically enabled catheters
In the first 4 animals 19 lesions were compared. All RA free wall lesions were transmural with 
similar epi- and endocardial surface area. In the RV, the epicardial surface area appeared smaller 
than the endocardial with both standard, and magnetically enabled catheters. Isthmus lesions 
were difficult to assess as regards transmurality due to the complex anatomy of this region. 
There was no significant difference in endocardial surface area between standard and magnetic 
catheters as assessed with the planimetric technique: 39 mm2 (range 16-82 mm2) vs 36 mm2 
(range 23-111 mm2). Lesions from the 3 other animals were included in the analysis of table 
Table 1: Macroscopic and microscopic assessment of the lesions
Magnetic Conventional p
Macroscopic assessment endocardium
Total number (24) (9)
Area (mm2)
Observer 1 43 (21-83) 38 (20-164) NS
Observer 2
(quantitative analysis) 48(18-120) 39 (16-82) NS
Perpendicular to RA/RV (8) (7)
Round/ Oval* 5 / 3 1 / 2 0,05
Elongated* 0  4 
Microscopic assessment at the middle of the lesion
Total number (24) (9)
Thrombus (nr) 15/24 7 / 9 NS 
Number for analysis (21) (9)
Diameter (mm) 10,59 (5,55-18,6) 8,90 (3,76-15,7) NS
Maximal depth (mm) 3,64 (1,78-8,13) 3,78 (1,32-7,38) NS
Necrotic area (mm2) 17,44 (4,59-57,01) 7,05 (2,32-50,17) NS
Inflammatory area (mm2)   2,84 (4,70-14,34) 3,26 (0,41-10,33) NS
Total area  (mm2) 21,46 (5,26-69,87) 10,22 (2,70-59,80) NS
Thrombotic area  (mm2) 0,25 (0-5,02) 0,33 (0-5,87) NS
The median and range are given. NS: not significant; RA: right atrium; RV: right ventricle 
* isthmus lesions have been excluded
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1. After exclusion of the isthmus, with perpendicular applications to RA and RV, lesions from 
magnetically enabled catheters were significantly more often round or oval (8) than those from 
standard catheters (3)  which were more often elongated (p<0,05). This is also shown in figure 
2.  When the catheter tip was parallel to the tissue, for example in the isthmus, or some lesions 
in the RVOT, lesions tended to be elongated with both catheters, although less so with the 
magnetic catheters. 
Contact utility comparison
In the 3 animals (15 lesions) where the contact measurement utility was assessed (table 2), it 
did not appear particularly useful at assessing high or low contact as compared to radiographic 
assessment. With all three contact assessments there was a similar amount of oval and elon-
gated lesions. 
Figure 2. Macroscopic aspect of lesions in the right ventricle with a conventional catheter (left) and a 
magnetically enabled catheter (right).
Table 2: Comparison of lesion shape with different contact utility settings
Low Medium High
HRA elongated elongated oval
LRA elongated round round
RV oval oval oval
RVOT oval oval elongated
Isthmus oval elongated elongated
HRA: high right atrium; LRA: low right atrium; RV: right ventricle RVOT: right ventricular outflow tract
Microscopic assessment 
Lesions were transmural in 15/24 magnetic cases and in 4/9 conventional procedures. This 
limited correct depth assessment. Three lesions from one animal were excluded from quantita-
tive histological analysis for technical reasons.  Microscopic assessment did not suggest any 
significant difference in lesions caused by standard or magnetically enabled catheters. There 
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was no significant difference in maximum diameter, maximal depth, the area of necrosis, the 
area of inflammation, and the combined area of inflammation and necrosis between magnetic 
and standard catheters respectively. Thrombi were seen in 15 of 24 magnetic lesions and 7 of 
9 conventional lesions. 
Figure 3. Histological aspect of lesions in the right ventricle, as prepared for planimetric analysis. 
Haematoxilin eosin stain. Both sections show a large necrotic area, with an inflammatory margin, with a 
small central thrombus in the upper one. The upper lesion is the result of a magnetic guided application; 
the lower one from a conventional catheter, with a more retracted aspect.
Radiofrequency ablation characteristics
The data on steady-state power and impedance during ablation are presented in table 3. 
Average impedance was significantly lower for lesions created using magnetically enabled 
catheters (p < 0,0001) as was average energy used (p < 0,05). This might suggest more efficient 
lesion formation.
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DISCuSSIoN
General
Catheter ablation is successful in treating a large number of cardiac arrhythmias.  In recent 
years technologies have evolved to treat more complex arrhythmias such as intra-atrial reentry 
tachycardias, atrial fibrillation, and ventricular tachycardia, as well as to improve the results in 
other tachycardias, such as atrial flutter. These technologies include catheter designs allowing 
higher energy usage, and significant developments in arrhythmia mapping systems including 
image integration. New systems for remote navigation, both magnetic and mechanical have 
been incorporated into combined systems.
RF lesions depend on controllable and non-controllable factors, and the Stereotaxis-CARTO 
RMT system described here uses a radically different way of maintaining catheter tissue contact 
than standard catheters or the mechanical remote navigation system, (8, 9) and this has effects 
on how lesions are formed and may make a previously poorly controllable factor, catheter tip 
tissue contact, more controllable. This has as yet not been shown at a clinically obvious level as 
yet, where the clinical effects so far seem similar.(7, 10-16)
Comparison of standard vs. magnet
As can be seen from the results, ablation lesions formed by magnetically enabled catheters 
have similar characteristics to those from standard catheters. The only significant differences 
appears to be that the lesions from magnetically enabled catheters are more round or oval 
rather than elongated, suggesting more constant catheter tissue contact. There is less likeli-
hood of “brush lesions” when the catheter tip is perpendicular to the tissue, but these may still 
occur to a lesser extent when the catheter tip is parallel to the tissue such as in the isthmus. This 
may have advantages when it is important to limit the lesion and disadvantages when “brush 
lesions” are actually advantageous, for example in linear lesions in the isthmus or atria. 
Tissue contact can be better described as the relationship between contact area and contact 
force. With magnetically enabled catheters the contact area appears to be decreased with the 
tip being more constantly related to a specific area, as shown by this study. However there 
have been questions about the tissue force able to be generated by these floppy magnetically 
Table 3: Measured ablation parameters
Magnetic Conventional p
Duration (sec) 60(51-60) 60(60-60) NS
Temperature (°C) 53(51-60) 53(49-53) NS
Power (Watt) 19(5-37) 16(2-42) NS
Impedance (Ohm) 118(105-128) 131(121-225) 0,0001
Energy (Joules) 970(327-2228) 1799(963-2525) 0,05
The median and range are given. NS: not significant
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enabled catheters and available data would suggest that a lower maximum contact force can 
be applied.(11)
RF lesion size relates to the generated tissue temperature, which relates to the amount 
of energy delivered. The energy delivered to the tissue itself relates to the amount of energy 
delivered by the generator and the its proportion entering the tissue. This again depends on 
the electrode tissue contact and the degree of external cooling.(1) Constant tissue area contact 
should mean that the energy is more effectively delivered to the underlying tissue of that area. 
In the case of magnetically enabled catheters the tip contact force may be less, meaning that 
the tip is less deeply buried in the tissue than a standard catheter, allowing for more cooling 
of the exposed area of the tip. However, the tip is almost certainly applied constantly to the 
tissue therefore preventing cooling to this contact area. The question therefore is how much 
one predominates over the other. The lower impedances during ablation may relate to differ-
ent engineering within the catheters, as the internal impedance makes up a significant part 
of the total, but the lower impedance may also confirm the better tissue contact seen visually 
and implied by the macroscopic features seen. Lower system impedance may mean that less 
energy is necessary to cause similar size lesions. The lower average energy may also relate to 
impaired cooling of the tip and thus higher tip-tissue temperatures which inhibit maximum 
energy delivery, but conversely more effective delivery of that lower energy to the tissue may 
mean that lesion formation is as effective as suggested by the comparative findings.
It is important to point out that while thrombus was seen microscopically, we had no sud-
den impedance rises during RF energy application or pops, and no visible thrombus was seen 
macroscopically when using magnetically enabled catheters.
Examining the effects of these differences in tissue contact will require significant further 
evaluation both in-vivo but also in-vitro. Models may need to be developed for in-vitro study 
which take into account cardiac and respiratory movement. 
Contact utility assessment
Use of the contact force utility showed that the entire range of forces was associated with a 
high likelihood of “brush lesions”. In fact, during catheter contact assessed by radiographic and 
electrogram review, the contact utility seemed to show average contact most of the time. It 
was also noted that the tissue contact assessment was perhaps more useful when the tip was 
not perpendicular to the tissue. When the catheter is entirely perpendicular to the tissue the 
mechanical “push” of the catheter into the tissue wall is not measured by the contact indicator.
Study limitations
This study looks at only a relatively limited number of lesions in an animal model. The number of 
lesions formed using a standard catheter was small. It was not feasible to assess lesion volume 
and therefore the findings are unfortunately a little more subjective than those using a thigh 
muscle preparation but we feel reflect more accurately clinical RF lesions.
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CoNCluSIoN
Magnetically enabled 4 mm tip RF ablation catheters perform as well as standard 4 mm tip 
RF ablation catheters as assessed by lesion size. The lesions show less “brush” effect and are 
more predictably oval or round. The contact utility assessment in the system seemed not to 
be very useful in its present form. The finding that impedance was lower and that less energy 
was required is intriguing and needs further assessment. It may be that magnetically enabled 
catheters may need a different set-up than standard catheters. Similar comparisons will need to 
be performed for magnetically enabled 8 mm tip and irrigated tip catheters.
ACkNoWlEDgEMENtS
Our thanks to the staff of experimental cardiology and the electrophysiology laboratory for 
their assistance in this study. Prof. W.J. van der Giessen was so kind to provide us with useful 
comments when writing this paper.
DISCloSuRES
This study was supported by a grant from Stereotaxis, Inc. A. Thornton has received speaker’s 
fees from Stereotaxis, Inc.. L. Jordaens and Erasmus MC have received a research grant from 
Stereotaxis, Inc.
An in-vivo comparison of cardiac radiofrequency lesions formed by standard, and magnetically steered 4 mm tip catheters 89
REFERENCES
 1. Stagegaard N, Petersen HH, Chen X, et al. Indication of the radiofrequency induced lesion size by 
pre-ablation measurements. Europace. 2005;7(6):525-34.
 2. Kongsgaard E, Steen T, Jensen O, et al. Temperature guided radiofrequency catheter ablation of 
myocardium: comparison of catheter tip and tissue temperatures in vitro. Pacing Clin Electrophysiol. 
1997;20(5 Pt 1):1252-60.
 3. Haines DE, Watson DD. Tissue heating during radiofrequency catheter ablation: a thermodynamic 
model and observations in isolated perfused and superfused canine right ventricular free wall. Pac-
ing Clin Electrophysiol. 1989;12(6):962-76.
 4. Petersen HH, Chen X, Pietersen A, et al. Tissue temperatures and lesion size during irrigated tip cath-
eter radiofrequency ablation: an in vitro comparison of temperature-controlled irrigated tip ablation, 
power-controlled irrigated tip ablation, and standard temperature-controlled ablation. Pacing Clin 
Electrophysiol. 2000;23(1):8-17.
 5. Nakagawa H, Yamanashi WS, Pitha JV, et al. Comparison of in vivo tissue temperature profile and 
lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature 
control in a canine thigh muscle preparation. Circulation. 1995;91(8):2264-73.
 6. Petersen HH, Chen X, Pietersen A, et al. Temperature-controlled radiofrequency ablation of cardiac 
tissue: an in vitro study of the impact of electrode orientation, electrode tissue contact pressure and 
external convective cooling. J Interv Card Electrophysiol. 1999;3(3):257-62.
 7. Thornton AS, Janse P, Theuns DA, et al. Magnetic navigation in AV nodal re-entrant tachycardia study: 
early results of ablation with one- and three-magnet catheters. Europace. 2006;8(4):225-30.
 8. Al-Ahmad A, Grossman JD, Wang PJ. Early experience with a computerized robotically controlled 
catheter system. J Interv Card Electrophysiol. 2005;12(3):199-202.
 9. Saliba W, Cummings JE, Oh S, et al. Novel robotic catheter remote control system: feasibility and 
safety of transseptal puncture and endocardial catheter navigation. J Cardiovasc Electrophysiol. 
2006;17(10):1102-5.
 10. Ernst S, Ouyang F, Linder C, et al. Initial experience with remote catheter ablation using a novel 
magnetic navigation system: magnetic remote catheter ablation. Circulation. 2004;109(12):1472-5.
 11. Faddis MN, Blume W, Finney J, et al. Novel, magnetically guided catheter for endocardial mapping 
and radiofrequency catheter ablation. Circulation. 2002;106(23):2980-5.
 12. Faddis MN, Chen J, Osborn J, et al. Magnetic guidance system for cardiac electrophysiology: a pro-
spective trial of safety and efficacy in humans. J Am Coll Cardiol. 2003;42(11):1952-8.
 13. Kerzner R, Sanchez JM, Osborn JL, et al. Radiofrequency ablation of atrioventricular nodal reentrant 
tachycardia using a novel magnetic guidance system compared with a conventional approach. Heart 
Rhythm. 2006;3(3):261-7.
 14. Pappone C, Vicedomini G, Manguso F, et al. Robotic magnetic navigation for atrial fibrillation ablation. 
J Am Coll Cardiol. 2006;47(7):1390-400.
 15. Thornton AS, Jordaens LJ. Remote magnetic navigation for mapping and ablating right ventricular 
outflow tract tachycardia. Heart Rhythm. 2006;3(6):691-6.
 16. Thornton AS, Rivero-Ayerza M, Knops P, et al. Magnetic navigation in left-sided AV reentrant tachycar-
dias: preliminary results of a retrograde approach. J Cardiovasc Electrophysiol. 2007;18(5):467-72.

Chapter 8
Magnetic navigation in AV nodal reentrant 
tachycardia study : early results of ablation 
with 1- and 3-magnet catheters

Potential applications of magnetic navigation in clinical electrophysiology 93
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Aims Steering soft, flexible catheters using an external magnetic field could have advantages for heart
catheterization, especially for therapy of tachyarrhythmias. Our aims were to assess the feasibility of
magnetic navigation to Koch’s triangle and reliable ablation of atrioventricular nodal re-entry tachycar-
dia (AVNRT) with a magnetic catheter.
Methods and results Consecutive patients with AVNRT were mapped and ablated with a magnetically
enabled catheter (Helios I or II), with, respectively, one and three magnets at the tip. The catheter
was remotely advanced with the CardiodriveTM system and orientated with the NavigantTM control
system. After initial positioning with the external magnets, adjustment was made in 58 steps.
Success rates, procedure, and fluoroscopy times were analysed, and compared with a local contempor-
ary series of conventional AVNRT ablations. Magnetic navigation was feasible in all 20 patients. Targets
were easily reached. Catheters remained stable in position during accelerated junctional rhythms.
Ablation was successful in 18/20 procedures (90%). No significant complications occurred. Median
patient fluoroscopy time was 12 min, median physician fluoroscopy time was 4 min. Fluoroscopy times
tended to be shorter than that in the conventionally treated group. Procedure duration decreased
significantly over time, median procedure time was similar to that in the conventional group.
Conclusion AVNRT can be successfully mapped and ablated using magnetic navigation. A learning curve
was evident, unrelated to catheter type, but to increasing operator experience. Physician radiation
times were one-third of patient times. No complications occurred. Procedure time is comparable
with that of conventional ablation.
KEYWORDS
Arrhythmias;
AV nodal re-entrant
tachycardia;
Catheter ablation;
Magnetic navigation;
Stereotactic therapy
Introduction
Although catheter design in electrophysiology has undoubt-
edly improved the handling of standard steerable diagnos-
tic catheters, these are still fairly stiff, and have to be
manoeuvred by means of a catheter handle, from outside
the vascular system and the body. Standard catheters can
be rotated manually and, by use of a pull-wire or wires,
flexed and extended as necessary. Manipulation of these
catheters to certain targets can be almost, or totally
impossible, especially in complex anatomy. Application
of manual force to ensure reliable contact with the
myocardium is associated with a certain risk including
perforation,1 especially in some locations, such as the
left atrial appendage, or in structurally weaker tissue,
such as aneurysms. Maintenance of a constant force can
also be extremely difficult in a moving structure such as
the heart. The ability to steer a soft, flexible catheter
by the use of an external magnetic field may, therefore,
have certain fundamental advantages. Studies have
shown the ability of magnetic navigation to place catheters
in difficult anatomical positions and to maintain good
tissue contact throughout the cardiac and respiratory
cycles, without additional risk of perforation.2,3 This new
technology to map and ablate atrioventricular nodal
re-entry tachycardia (AVNRT) has been used in only a
relatively limited number of patients.3–5 In the largest
series to date by Ernst et al.,4 only a single-magnet
catheter was used.
We report our initial experience in 20 consecutive cases of
AVNRT, 11 with a single-magnet catheter and the other 9
with a similar three-magnet catheter. The goal was to
study the feasibility of magnetic navigation to map a well-
known region in the heart and to assess the possibility of
reliable ablation of AVNRT in both catheter types.
& The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org
* Corresponding author.
E-mail address: a.thornton@erasmusmc.nl
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Methods
Patient population
Between February and August 2004, we enrolled a total of 20
consecutive patients with proven AVNRT at electrophysiological
study. An additional two patients gave consent, but were found to
have left-sided arrhythmias. No patient had a contraindication to
the use of magnetic navigation (such as an implanted metallic
device or claustrophobia). This study forms part of the safety and
efficacy study approved by the Ethics Committee of the Erasmus
Medical Centre. We compared our ablation data, results, procedure,
and fluoroscopy times with those obtained in a contemporary group
of 17 patients treated in 2004 for AVNRT, immediately before and
after this study.
Electrophysiological study
Patients were studied in the fasting, post-absorptive state under
light sedation using intravenous boluses of diazepam and fentanyl
as necessary. A standard conventional, diagnostic, electrophysio-
logical study was performed using three transvenous catheters,
placed from the subclavian and femoral veins in the coronary
sinus, right ventricular apex, and the His bundle region. Standard
techniques were used to measure conduction properties and to
induce tachycardia. In all patients, typical AVNRT was induced
either before or after the use of isoprenaline. The presence of
dual AV-nodal conduction was assessed, and accessory pathways
were excluded. Once the diagnosis was confirmed, an additional
femoral access sheath was used to manually advance a magnetic
navigation ablation catheter with a 4 mm tip to the right atrium.
Catheters used for ablation were the 8 Fr Helios I, with a single
magnet of 1.8 mm at the tip, or Helios II, with three 1.8 mm
magnets at the tip and the distal shaft (Stereotaxis Inc., St Louis,
MO, USA). The choice was determined by availability. Electrograms
were recorded using a standard recording system (Sensis, Siemens,
Erlangen, Germany).
Magnetic navigation
The Niobe magnetic navigation system (Stereotaxis Inc.) is combined
with a monoplane fluoroscopy system (AXIOM Artis, Siemens). The
Niobe system consists of two permanent magnets situated on
either side of the patient, which are computer-controlled via a
workstation (Navigant, Stereotaxis Inc.) to allow for changes in the
orientation of a stable magnetic field within the chest of the
patient. A combined field strength of 0.08 T is produced in navigation
mode. As navigation is best performed with a fixed table position,
this must be optimized prior to the start of magnetic navigation.
When the magnets are positioned next to the patient, only limited
angulation of the C-arm is possible (�288 in the right and left
anterior oblique angulations). Remote catheter advancement and
retraction from the control room was performed using a catheter
advancer system, CardiodriveTM (Stereotaxis Inc.), positioned on
the high anterior thigh (Fig. 1). Remote control of the fluoroscopy
system is also performed from the control room. The ablation
catheters, with a single or multiple magnets within the distal tip
segment, align themselves with the field produced by the external
magnets, allowing effective catheter orientation. After the
magnets are brought in next to the patient, the physician is free to
leave the room and performs the rest of the procedure from the
control room. A single nurse remains with the sedated patient to
monitor vital signs and administer drugs when required.
Mapping and ablation
Mapping of the low right atrial septum in the region of the coronary
sinus os (Koch’s triangle) was performed combining an anatomical
approach with an attempt to obtain electrograms suggestive of a
slow pathway potential. Radiofrequency ablation was delivered
via the 4 mm tip of the Helios I or II catheter using temperature-
controlled ablation from an EP Shuttle RF generator (Stockert
GmbH, Freiburg, Germany) with settings of 558C, 60 s and power
titrated from 15 to 50 W to obtain the set temperature. Radio-
frequency applications were stopped after 20 s if no accelerated
junctional rhythm was seen. These applications were included in
Figure 1 The catheter advancer system (Cardiodrive) is placed on the anterior thigh and used remotely to advance and retract the catheter. It uses a simple
cogwheel system and is driven by a fixed rate motor attached via a flexible drive cable. An adaptor between the Cardiodrive and the sheath prevents buckling of
the catheter.
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the total number of applications. The generator was also operated
remotely from the control room allowing the electrophysiologist
to manage all aspects of the procedure.
Endpoint for ablation
The endpoint for ablation was non-inducibility of tachycardia using
standard electrophysiological manoeuvres and evidence of slow
pathway modification or ablation in those where this was possible.
Isoprenaline was given after all apparent successful applications.
Manoeuvres were repeated after a waiting period of 30 min.
Procedure times were defined from the time the patient was put
on the table until removal of the sheaths, 30 min after the last
application, and include the time for the standard diagnostic
electrophysiological study. Fluoroscopy times were measured for
the patient and separately for the physician.
Statistical analysis
All continuous variables are expressed as mean+ standard devi-
ation. When appropriate, median values are reported and non-para-
metric tests were used.
Results
Patient data
The patient group consisted of 4 males and 16 females, with
a mean age of 54+ 12 years. Apart from inducible typical
AVNRT, a jump in the AH interval of .50 ms was detected
in 16 of the 20 patients. At baseline, isoprenaline was
necessary for reproducible induction in 4/20 patients.
There were no significant differences in clinical data
between the study group and the conventional treatment
group, which consisted of 17 patients, who were treated
with a standard approach (using either standard cryotherapy
or radiofrequency catheters).
Remote navigation and mapping using the magnetic
navigation system
We were able to obtain a satisfactory position using the
advancer and magnetic navigation in all 20 patients
(Fig. 2). This implied that the initial target was situated in
the low septum, at the level of the coronary sinus os.
Modification of the position was based on electrogram
criteria such as the AV relationship and the presence of
potentials. Adjustment was made magnetically in 58 steps,
laterally and vertically.
Ablation data
Ablation was acutely successful in 18/20 patients.
Junctional rhythm was seen in all patients. During this
rhythm, the catheter remained entirely stable, as assessed
on fluoroscopy and assessment of the intracardiac electro-
grams (Fig. 3). In 16 patients, clear dual AV nodal physiology,
as shown by a jump in AH interval, was present at some time
during the procedure. After ablation, no further slow
pathway conduction could be demonstrated in 11 of 15
(73%) successful cases, whereas only modification of
the slow pathway was obtained in the other four patients
in whom this could be completely assessed. There was no
difference on the basis of catheter type.
In the two failed patients, 22 and 15 application attempts
were made, respectively; also there was no difference in the
incidence of junctional rhythm. In one of these patients, in
whom the area of interest appeared close to the region of
the His bundle and in whom RF application was associated
with fast accelerated junctional rhythm, a transient,
minor delay in AV conduction was observed. The transient
AV delay was thought to be due to the initial catheter pos-
ition and not to catheter displacement. Cryocatheter abla-
tion in the same position was associated with slow
pathway ablation without impairment of AV conduction. In
the other, with a very large coronary sinus os, cryotherapy
failed.
The median number of RF applications in the successful
cases was 6 (range 1–22). The total RF ablation time was a
median of 240 s (range 60–633 s). There was no significant
difference between the single- and three-magnet catheter
approach.
Figure 2 Part of the working screen of the Navigant workstation. The two radiographic views, with the His bundle, coronary sinus, and right ventricular cath-
eters, are used with target-based navigation to indicate where the catheter should be placed. Previous positions are indicated by the closed yellow dots. The
predicted catheter position, as shown in green, (with catheter shaft and pivot point in blue) is slightly different from where the catheter has finished and this
sometimes requires some correction. The screen includes some of the tools used for different navigation modes.
Magnetic navigation in ablation of AVNRT 227
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Procedure data
The mean procedure time (including the waiting time) was
167+ 46 min (median 163 min) with a patient fluoroscopy
time of 17+ 12 min (median 12 min). Of the total fluoro-
scopy duration, the physician was exposed only during intro-
duction of the sheaths and positioning of the catheters,
which averaged 5+ 2 min (median 4 min). The evolution
of the procedure and fluoroscopy times is given in Fig. 4.
The procedure time decreased significantly in a linear
fashion (R2 ¼ 0.2541). There was no significant difference
in procedure and fluoroscopy time between those patients
in whom the single-magnet catheter or the three-magnet
catheter was used.
Comparison with the control group
Table 1 shows a comparison of ablation data, results,
procedure, and fluoroscopy times between the magnetically
treated group as a whole, and broken down into one- and
three-magnet groups, and the non-magnetically treated
patients. The control group had the same ablation
settings as those used in the magnetically treated group.
No significant differences were observed between magnet
and conventional groups or between the one- and three-
magnet groups.
Follow-up results
No complications related to the advancer or the magnetic
system occurred. Neither AV block nor distal conduction dis-
turbances were observed. AH and HV intervals remained
comparable. One complication, a pectoral haematoma,
was a sequel of the subclavian puncture and did not
require intervention. During a follow-up of 90 days, there
have been no recurrences of AVNRT in the 19 (18 radio-
frequency and 1 with additional cryotherapy ablation)
successful procedures.
Discussion
Although AVNRT can be successfully ablated with success
rates of the order of 95% and with a 1–2% risk of complete
AV block,1,6 there are other catheter-based procedures
which are much more difficult because of anatomical and
technical issues. Patients with corrected congenital heart
disease and patients requiring left atrial procedures for
atrial fibrillation therapy are good examples.
The possibility of using floppy catheters with new technol-
ogy in association with magnetic navigation and remote
ablation is therefore appealing.
We have shown that using this technology we can achieve
success rates equalling those with more conventional
Figure 3 Accelerated junctional rhythm with leads S1, aVF, and V1 and three intracardiac registrations as noted on the figure. Three sinus beats are followed by
junctional rhythm with a cycle length of 800 ms. The ablation catheter signals remained stable during the transition.
Figure 4 Intervention time (including waiting times) and fluoroscopy time
vs. the consecutive number of patients. Regression lines are plotted, along
with 95% confidence intervals, for procedure and radiation times. For the pro-
cedure time, the R2 ¼ 0.2541, whereas for radiation time, R2 ¼ 0.0077.
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technology without significant complications and with
reasonable patient radiation exposure.
Procedure time
It is important to note that our procedure times are not from
initial sheath placement, but from time on table to removal
of sheaths; this adds approximately 15–20 min. Procedure
time also includes the time for the initial diagnostic study
and an observation period of 30 min after the last
application.
This explains the difference with a prior study using mag-
netic navigation performed in the same substrate.4
However, the procedure time was comparable with that in
our control group. The time to set up the advancer was
short, and it would have been interesting to log the duration
of different parts of the procedure to have a better under-
standing of the time effects of this new technology.
Fluoroscopy time
Of great significance is the fact that in a procedure with
relatively little radiation the physician radiation time was
less than one-third of that of the patient. Although individ-
ual patient radiation exposure is not increased in compari-
son with other trials, it is evident that physician dosage
is significantly decreased. In more complex procedures
with longer exposure times, this will be of even more
significance.
Part of the somewhat long radiation time relates to initial
unease about the stability of the catheter during ablation
and junctional rhythm. The time did not decrease as might
be expected, because of the second learning curve due to
the transition to three-magnet catheters. We wished to
check on the stability of these catheters as well.
Catheter stability
It must be noted that catheter position was extremely stable
when compared with standard catheters, even when
patients tended to take deep breaths, and during acceler-
ated junctional rhythm.
One-magnet vs. three-magnet catheters
A clear learning curve is evident. There was no apparent
benefit in this ablation situation with a three-magnet
when compared with a single-magnet catheter. This may
reflect partly the learning curve, but probably the relative
ease with which a catheter can be placed in the slow
pathway region.
The orientation of the three-magnet catheter appears
somewhat different. With all three magnets orientated in
the field, the distal part of the catheter is straighter than
with the single-magnet catheter. In one patient, this did
seem to cause some instability of the catheter position
as the straightening caused the more proximal portion to
buttress against the IVC–RA junction. The catheter tended
to move backwards and forwards over the annulus during
respiration. This was not a noticeable problem in the
other patients.
It is possible that in more complex anatomy and more
challenging positions the three-magnet catheter may
perform better than the one-magnet version.
Advantages in AVNRT
The slow pathway region is easy to reach and mappable with
the magnetic navigation system. The success rate is in the
range expected with conventional technology. There was
no incidence of permanent AH or PR prolongation. We had
no evidence of any fast pathway modification. The high
ratio of slow pathway ablation vs. modification compares
favourably with that seen with cryoablation7 and is the
inverse of that seen in the only other published magnetically
ablated series.4
Future concepts
Combining standard catheters with systems such as LocaLisa
and CARTO resulted in shorter radiation times in prior
studies.8,9 It is expected that with the incorporation of cath-
eter registration technology or echocardiography10 into this
system, or using these technologies in parallel, procedure
and radiation times will further decrease.
Combining this technology with other new technologies,
such as cryotherapy and the other technologies mentioned
previously, may significantly improve outcome, as well as
reduce the number of applications, and associated collateral
tissue damage.11
Conclusions
AVNRT can be successfully mapped and ablated using mag-
netic navigation with comparable risks and benefits as
obtained when using standard catheters. A learning curve
was evident, not related to the catheter type, but to
increasing experience. Physician radiation times were only
Table 1 A comparison of ablation data, results, procedure, and fluoroscopy times
Total magnet group One-magnet group Three-magnet group Control group
Number of patients 20 11 9 17
Number of ablations [median (range)] 6 (1–22) 4.5 (1–22) 8.0 (1–21) 5 (2–28)
Success 18 (19)/20 10/11 8 (9)/9 17/17
Slow pathway ablation 11 5 6 11
Slow pathway modification 4 1 3 3
No jump pre-ablation 4 4 0 3
Procedure time (min) [median (range)] 163 (69–260) 160 (106–260) 166 (69–235) 159 (83–290)
Fluoroscopy time (min) [median (range)] 12 (4.5–37.4) 11 (4.5–18.3) 19 (7–37.4) 18 (9–51)
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one-third of patient radiation times and are therefore sig-
nificantly reduced. No complications occurred. Our results
show that magnetic navigation in Koch’s triangle is feasible,
easy to learn, and can assist in successful ablation.
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Remote magnetic navigation for mapping and ablating right
ventricular outflow tract tachycardia
Andrew S. Thornton, MBBCh, Luc J. Jordaens, MD, PhD
From the Department of Clinical Electrophysiology, Thoraxcentre, Erasmus Medical Centre, Rotterdam, The Netherlands.
BACKGROUND Navigation, mapping, and ablation in the right
ventricular outflow tract (RVOT) can be difficult. Catheter naviga-
tion using external magnetic fields may allow more accurate map-
ping and ablation.
OBJECTIVES The purpose of this study was to assess the feasibility
of RVOT tachycardia ablation using remote magnetic navigation.
METHODS Mapping and ablation were performed in eight patients
with outflow tract ventricular arrhythmias. Tachycardia mapping
was undertaken with a 64-polar basket catheter, followed by
remote activation and pace-mapping using a magnetically enabled
catheter. The area of interest was localized on the basket catheter
in seven patients in whom an RVOT arrhythmia was identified.
Remote navigation of the magnetic catheter to this area was
followed by pace-mapping. Ablation was performed at the site of
perfect pace-mapping, with earliest activation if possible.
RESULTS Acute success was achieved in all patients (median four
applications). Median procedural time was 144 minutes, with 13.4
minutes of patient fluoroscopy time and 3.8 minutes of physician
fluoroscopy time. No complications occurred. One recurrence oc-
curred during follow-up (mean 366 days).
CONCLUSION RVOT tachycardias can be mapped and ablated us-
ing remote magnetic navigation, initially guided by a basket
catheter. Precise activation and pace-mapping are possible. Re-
mote magnetic navigation permitted low fluoroscopy exposure for
the physician. Long-term results are promising.
KEYWORDS Arrhythmia; Catheter ablation; Magnetic navigation;
Mapping; Right ventricular outflow tract; Ventricular tachycardia
(Heart Rhythm 2006;3:691–696) © 2006 Heart Rhythm Society.
All rights reserved.
Introduction
In normal hearts, idiopathic ventricular tachycardia (VT)
originates most commonly from either the outflow tract
region or the fascicles of the left ventricle.1–3 The right
ventricular outflow tract (RVOT) is the most common site
of origin, although an increasing number of these arrhyth-
mias now are demonstrated to arise from the left ventricular
outflow tract (LVOT) and even from above the pulmonary
valve.2,4,5 Ablation has a high success rate (reportedly 85%–
100%) for both frequent VT and repetitive ventricular ec-
topy.6–11 It usually is performed on the basis of simple
activation and pace-mapping. Some reports have questioned
the use of this approach.12 Changes in autonomic tone
during and after ablation that alter the pattern of spontane-
ous arrhythmias could make activation mapping difficult. In
addition, technical problems with pace-mapping may limit
its accuracy.13,14 Even small changes within the RVOT can
lead to marked changes in the paced QRS.15,16 The ability to
map carefully within such small areas and to return to the
best sites is important. Multielectrode catheters and noncon-
tact mapping systems have been introduced in an attempt to
improve the success rate, in particular to improve the ease of
the procedure and decrease procedural duration.17 Cardiac
perforation and cases of fatal tamponade related to perfora-
tion or late rupture have been described.18,19
Floppy magnetically enabled catheters have been devel-
oped, which can be steered by manipulation of an external
magnetic field and advanced or retracted remotely by means
of a mechanical external advancer system. This technique,
called remote magnetic navigation, may allow easier move-
ment in the RVOT compared with standard catheters. Stan-
dard catheters must be negotiated through two curves before
mapping can be performed (the curve from the right atrium
to the right ventricle, and then the curve from the main right
ventricular cavity to the outflow tract), and this requirement
hinders precise point-by-point navigation within the RVOT.
We postulated that a 64-polar basket catheter in associ-
ation with a floppy magnetically enabled catheter would
allow us to quickly target an area within the RVOT, to
navigate easily to this site, to map more carefully within this
area, and to perform accurate pace-mapping, with success
rates for ablation at least equal to those obtained using
standard catheters and with the potential to decrease proce-
dural and fluoroscopy times.
Methods
Patient selection
Between June 2004 and February 2005, eight consecutive
patients with left bundle branch block, inferior-axis VT
suggestive of RVOT focal origin were admitted for electro-
physiologic mapping and ablation. No patient had a contra-
indication to use of magnetic navigation (such as an im-
planted metallic device or claustrophobia). This study forms
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from, Stereotaxis Inc. Dr. Jordaens has received a research grant from Ster-
eotaxis. Address reprint requests and correspondence: Dr. Andrew S.
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part of the safety and efficacy study approved by the ethics
committee of the Erasmus Medical Centre. All patients gave
informed consent for the procedure.
Electrophysiologic study
Patients were studied in the fasting, postabsorptive state
under little or only light conscious sedation, with intrave-
nous boluses of diazepam and fentanyl administered as
necessary. Electrograms were recorded using a standard
recording system (AXIOM Sensis, Siemens, Erlangen, Ger-
many). Prior to introducing catheters, an attempt was made
to register spontaneous or isoprenaline-induced ventricular
ectopy or nonsustained VT with a morphology similar to the
clinical arrhythmia. This was used as a template for all
mapping. Occasionally, an additional pacing catheter was
introduced for atrial or ventricular burst or for programmed
pacing. A long sheath (5662, Boston Scientific Corporation,
San Jose, CA, USA) was positioned in the RVOT. A 38-
mm, multielectrode basket catheter consisting of eight self-
expanding splines and a total of 64 electrodes (Constella-
tion, Boston Scientific Corporation) was inserted through
the sheath to record and measure intracardiac electrograms
from this region. The site of earliest activation was defined
as the position with the longest interval from the local
ventricular electrogram to onset of the earliest deflection of
the QRS on the surface ECG during tachycardia. Earliest
activation of target ventricular ectopy or VT was localized
on the basket catheter (Figure 1) and marked using two
orthogonal radiologic views on the Navigant system (Ster-
eotaxis Inc., St. Louis, MO, USA). Once a suitable target
area was identified, a second femoral access sheath was
used to advance a three-magnet, 4-mm-tip radiofrequency
(RF) ablation catheter (8Fr Helios II, Stereotaxis Inc.) to the
RVOT. Heparin was given after venous puncture according
to a weight-based nomogram. Activated clotting times
(ACTs) were measured regularly with the aim of maintain-
ing ACT at 250 seconds.
Magnetic navigation
The technique for magnetic navigation has been previously
described.20,21 In brief, the Niobe magnetic navigation sys-
tem (Stereotaxis Inc.) is combined with a monoplane flat-
panel fluoroscopy system (AXIOM Artis, Siemens). The
Niobe system consists of two permanent magnets positioned
on either side of the patient. The magnets are computer
controlled via a workstation (Navigant) to effect a change in
the orientation of a stable magnetic field within the patient’s
chest. A combined field strength of 0.08 Tesla is produced
in navigation mode. Because navigation is best performed
with a fixed table position, the table position should be
optimized and isocentered before starting magnetic naviga-
tion. When the magnets are positioned next to the patient,
only limited angulation of the C-arm is possible (approxi-
mately 28° in the right and left anterior oblique angula-
tions). Remote catheter advancement and retraction from
the control room are performed using a catheter advancer
system (Cardiodrive, Stereotaxis Inc.) positioned on the
high anterior thigh. Remote control of the fluoroscopy sys-
tem also is possible from the control room. The ablation
catheter (Helios II, Stereotaxis Inc.), which contains three
Figure 1 Navigant screen showing the two radiographic views obtained (right anterior oblique [RAO] on the left, left anterior oblique [LAO] on the right). The
basket catheter with its eight splines can be seen within the right ventricular outflow tract with a temporary bipolar ventricular pacing lead. The magnetically enabled
catheter has been navigated to a more anteroseptal position on the horizontal line of blue dots (previous mapping positions). Two of the splines have been marked
on the Navigant software (yellow and red dots). The effect of respiration on the image acquisition can be seen in the RAO radiographic image. The yellow line
indicates a virtual catheter drawn where the software identifies the catheter should be located according to the applied magnetic field.
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magnets within the distal tip segment, aligns with the field
produced by the external magnets, allowing effective cath-
eter orientation. Once the external magnets are in position,
the physician can leave the room and perform the rest of the
procedure from the control room. Only one nurse remains
with the lightly sedated patient to monitor vital signs and
administer drugs when required.
Mapping and ablation
Mapping was performed using a 12-lead ECG of the clinical
tachycardia as the basis. Electrograms with early activation
were combined with a pace-mapping approach. The site of
earliest activation on the multipolar basket catheter was labeled
as a navigation target using the Navigant software (Figure 2).
The ablation catheter was introduced into the right ventricle by
application of sequential magnetic vectors and then to the
target within the RVOT using target-based navigation. When
the general area of interest was reached, pace-mapping was
performed to confirm that the paced QRS corresponded well to
that of the clinical arrhythmia.16 If a good pace-map was not
obtained, the catheter was maneuvered in small increments
around the area of interest using the Navigant software. Pace-
mapping was performed at each site until an acceptable (at
least 11/12) pace-map was obtained, with early activation of
ectopy if possible. RF ablation was delivered using tempera-
ture-controlled ablation from an EP Shuttle RF generator
(Stockert GmbH, Freiburg, Germany) with settings of 55°C,
60 seconds, and power titrated from 15 to 40 W to obtain the
set temperature. The generator was also controlled remotely.
RF applications usually were stopped after 20 to 30 seconds if
no short runs of VT were observed. After apparently successful
ablation, up to three additional applications, guided by the
target site and magnetic navigation, were administered to the
region around the successful site. These applications are in-
cluded in the total number of applications and total RF time.
Procedural time was defined as the period from the beginning
of venous puncture until removal of the sheaths, 30 minutes
after the last application. Fluoroscopy times were measured
separately for the patient and for the physician.
Endpoint for ablation and definition of acute
success
The endpoint for ablation was absence of clinical ventricu-
lar arrhythmias during monitoring and noninducibility of
arrhythmia using isoprenaline and burst pacing. Maneuvers
were repeated after a 30-minute waiting period. All patients
underwent continuous 24-hour monitoring after the proce-
dure, and acute success was defined only if no ventricular
ectopy was observed during this period.
Follow-up
A 24-hour Holter ECG was recorded 6 weeks after ablation.
All patients were followed clinically for at least 9 months
after the procedure.
Statistical analysis
All continuous variables are expressed as mean � SD.
Median values are reported where appropriate.
Results
Patient data
The study group consisted of eight patients (six men and
two women; mean age 44 � 8 years). Ventricular ectopy
and/or bigeminy were the presenting arrhythmia in three
patients; longer runs of nonsustained (n � 4) or sustained
VT (n � 1) were seen in the remaining five patients (Table
1). One patient had undergone one previous procedure, and
another patient had undergone three previous procedures at
two different institutions. One patient had what was de-
scribed as a vague morphologic abnormality of the right
ventricle close to the outflow tract noted on echocardiogra-
phy but no other suggestion of arrhythmogenic right ven-
tricular cardiomyopathy.
Remote navigation and mapping using the
magnetic navigation system
In one patient, no site of early activation could be identified
from the RVOT. This patient refused left-sided mapping. In
the remaining seven patients, a region of early activation
was determined from the electrograms of the basket cathe-
ter. Using pace-mapping, the clinical arrhythmia ultimately
was well matched in all seven patients (Figure 3). The site
of early activation after confirmation with an acceptable
pace-map preceded the QRS by a mean time of 20 ms
(range �12 to �36 ms). This final site was clearly septal in
four patients and in the transition from posteroseptal to free
Figure 2 Angiographic right anterior oblique (RAO) view from the
Navigant software screen showing the two curves. The basket is delineated
in purple, the spline of interest with green dots, the pace-map points in
yellow, and the ablation points as red dots. The blue line is the virtual pivot
point of the catheter.
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wall in three. A satisfactory and stable position for pace-
mapping and ablation was obtained in all seven patients
using the advancer and magnetic navigation. This position
corresponded to the site of earliest activation in six cases.
Ablation data
Ablation was undertaken with the patient in sinus rhythm
with or without ectopic beats or short runs of nonsus-
tained VT, as sustained VT was only inducible with
intravenous isoprenaline. During the early part of suc-
cessful ablations, accelerated ventricular rhythm was al-
ways seen and the catheter remained stable during this
rhythm and the transition to sinus rhythm. Ablation was
acutely successful in all seven patients in whom an early
signal could be defined in the RVOT (Table 2). From 2 to
10 (median 4) RF applications were applied, with a total
RF duration of 174 to 554 seconds (median 240 seconds).
These figures include the one to three extra RF applica-
tions administered to the area around the presumed suc-
cessful site in most cases. After ablation, no further
arrhythmias occurred spontaneously or could be induced.
No arrhythmias were noted during the first 24 hours of
continuous ambulatory monitoring (Figure 4).
Procedure data
The mean procedural time (including waiting time) was 151�
35 minutes (median 144 minutes), with a patient fluoroscopy
time of 12.5� 5.8 minutes (median 13.4 minutes). Of the total
fluoroscopy duration, the physician was exposed only during
introduction of the sheaths and positioning of the catheters
(average 3.5 � 1.3 minutes, median 3.8 minutes).
Follow-up results
No complications related to the advancer or the magnetic
system occurred, and no other complications were noted.
The patient with presumed LVOT origin refused further
interventional therapy. Mean clinical follow-up is now 366
days (310–497 days). Four weeks after initial ablation, one
patient presented with recurrence of symptoms, manifested
as nonsustained VT in contrast to the sustained VT preab-
lation. He subsequently underwent further ablation. Of the
remaining six patients, five have been entirely asymptom-
atic throughout follow-up. The remaining patient initially
had symptoms related to other ventricular and atrial ectopic
beats, but the symptoms ultimately resolved with the patient
off all medication. None of the six patients had any clinical
ventricular ectopy or VT on Holter ECG at 6-week fol-
low-up (Table 2).
Discussion
Pharmacologic therapy for outflow tract tachycardia may
fail in some cases.7,22 Catheter ablation using standard cath-
eters has some limitations. Acute failure may be related to
Table 1 Clinical and Mapping Characteristics
Patient no. Sex Age (yr) Arrhythmia
Twelve-lead ECG
assessment
Position from
basket electrogram Final x-ray position
Pace-map
accuracy
Activation
signal
(ms)
1 M 45 VT High PS-FW Mid S-FW Mid PS to FW 11/12 �13
2 M 37 Ectopy High PS-FW M-L PS to FW M-L PS to FW 11/12 �36
3 M 58 NSVT High PS High AS High AS 12/12 �19
4 F 45 NSVT Mid PS-Mid S M-L PS to S M-L PS 11/12 �35
5 M 30 Ectopy High AS High AS High AS 11/12 �12
6 M 45 NSVT High PS Mid PS Mid PS to FW 12/12 �14
7 F 45 NSVT Septal LVOT/epicardial NA NA NA NA
8 M 49 Ectopy High AS High AS High AS 12/12 �12
AS � anteroseptal; F � female; FW � free wall; LVOT � left ventricular outflow tract; M � male; M-L � mid to low; NA � not applicable; NSVT �
nonsustained ventricular tachycardia; PS � posteroseptal; s � septal; VT � ventricular tachycardia.
Figure 3 Twelve-lead ECG of a pace-map at a successful site obtained
using the magnetic system. The left side of the image shows the QRS
generated by pace-mapping; the right side shows the spontaneous ectopic
beat used as the template. The paced beat is an acceptable pace-map of the
clinical ectopic beat.
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the lack of inducibility of the clinical arrhythmia during the
study, failure to appreciate that the focus lies elsewhere, or
difficulty in manipulating the catheter in the constrained
region of the outflow tract.
Using remote magnetic navigation, we were able to eas-
ily and successfully navigate to selected points in the RVOT
based on initial signals detected by a multielectrode cathe-
ter. The prematurity of the signals obtained with more
detailed mapping was, on average, a little less than reported
in some published studies23–25 but nevertheless was associ-
ated with good pace-mapping. The clinical success rate
achieved in this study is equivalent to the rates reported in
the published studies.
Procedure parameters
The mean procedural time is favorable to the times reported for
standard procedures (mean 99.4–166.9 minutes), especially
when compared with some studies in which advanced mapping
was used (mean 107.1–275 minutes).16,23 The mean total ra-
diation time also compares favorably to values reported in
other studies using standard catheters (mean 15.4–66.5 min-
utes) or advanced mapping systems (mean 45.8–68.4 min-
utes).15,16,23 In addition to the highly favorable patient radia-
tion times, the physician radiation times were significantly less
(�4 minutes), which is beneficial in the long term. The mean
of four RF applications in this study, including the debatable
additional applications, compares well with published figures
(mean 4–7.1 applications).15,23,26–28 The additional applica-
tions probably should be avoided and would further decrease
the number of applications. Both the acute complete success
rate and the low recurrence rate (14%) mirror those of other
studies (85%–100% and 0%–19% respectively).16,23,26,27 The
ease of this new approach is reflected in the short procedural
and radiation times, even considering the learning phase asso-
ciated with applying the remote magnetic navigation system.
Advantages and disadvantages of remote
magnetic navigation
No complications related to these procedures occurred, and
use of a floppy, rather than stiff, ablation catheter should
decrease the risk for perforation.
In this study, we showed that magnetic navigation to a
preselected site in the RVOT is feasible, with the ability to
perform highly accurate mapping, leading to a good pace-
map in all patients. The ability to move the floppy catheter
in extremely small steps is a clear improvement over the
conventional approach where the electrophysiologist repo-
sitions a stiff catheter across two curves and then applies a
force to ensure close contact when applying RF energy.
Such a technique severely limits the ability to move the
catheter in small steps. In addition, more pressure likely is
applied to the myocardium when conventional catheters are
used, which is not without danger in a structure such as the
RVOT, where the wall can be relatively thin. Early and late
perforations have been described, with potentially fatal out-
comes. This complication may be related both to local
catheter trauma as well as to the effects of RF applications.
Therefore, it seems logical that as few applications as pos-
sible should be given. The relatively smooth RVOT may
favor the magnetic catheter by allowing for smooth map-
ping in small increments, but other investigators have
shown that these catheters also are useful in the more
trabeculated parts of the ventricles.20
Advantages and disadvantages of multipolar
recording
Reports of advanced mapping techniques showed longer,
not shorter, procedural and radiation times. Spontaneous
Table 2 Ablation, Procedure and Follow-Up Characteristics
Patient
no.
Application
no.
RF
duration
(s) Outcome
Procedure
duration
(min)
Fluoroscopy time
for patient (min)
Fluoroscopy time
for physician
(min) Clinical follow-up Follow-up Holter
1 3 180 S 154 22.9 6.8 NSVT NSVT and ectopy
2 8 436 S 148 13.8 3.7 Asymptomatic Some ectopy—
different
3 7 358 S 138 9.1 3.5 Asymptomatic Normal
4 4 240 S 160 6.5 3.4 Asymptomatic Left ventricular
ectopy
5 4 240 S 95 11.1 3.2 Asymptomatic Normal
6 10 554 S 156 15.5 3.5 Asymptomatic Normal
7 4 77 F 203 19.9 2.3 Symptomatic No change
8 3 174 S 98 8.4 4.0 Asymptomatic Normal
F � failed ablation; NSVT � nonsustained ventricular tachycardia; RF � radiofrequency; S � successful ablation.
Figure 4 Ambulatory monitoring before and after ablation. Top graph
shows the heart rate (HR) trend. Bottom graph shows the number of
ectopic beats per minute (PVC/min). The gap in the recordings shows the
time when the patient was disconnected during the ablation procedure.
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ectopy can be rare, and its absence may predict failure of the
procedure. Therefore, when designing this approach, we
believed a basket electrode catheter would be useful in
directing us to the general area of interest because simulta-
neous multisite recording for activation mapping is one of
the few solutions for infrequently occurring arrhythmias. A
drawback of this approach is that the basket catheter itself is
quite stiff and may cause perforation or induction of non-
clinical ectopy. In addition, it usually requires use of a long
sheath. The relatively fixed shape may preclude good con-
tact with certain areas of the RVOT. Noncontact mapping
has largely similar disadvantages.
Study limitations
This study involved a limited number of patients, with a
preponderance of men and isolated ectopy. The study
looked only at acute and short-term success, and recurrence
may occur after 6-month follow-up. Late results could be
more disappointing.
Conclusion
In this study, we showed that remote magnetic navigation to
a preselected site in the RVOT is feasible and that success-
ful ablation of foci within the RVOT can be performed with
short procedural and fluoroscopy times. Use of this system
appears to improve efficiency and safety when performing
ablation for this type of arrhythmia.
If this technology shows similar benefit in more complex
procedures, then incremental improvements in efficacy and
safety can be expected. With the recent availability of inte-
grated electroanatomic mapping and image integration, we
are hopeful that the procedure can be further improved.
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Use of Advanced Mapping and Remote Magnetic
Navigation to Ablate Left Ventricular Fascicular
Tachycardia
ANDREW S. THORNTON, JAN RES, JORIS M. MEKEL, and LUC J. JORDAENS
From the Department of Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
Ablation of idiopathic left ventricular, or fascicular tachycardia can be aided by electroanatomical
mapping. The addition of a floppy, magnetically enabled ablation catheter may improve maneuvering
as well as decrease mechanically induced arrhythmias and mechanical block. We describe a case of
fascicular tachycardia in which both these modalities were used in a sequential fashion. Integration of
these modalities should prove even more helpful. (PACE 2006; 29:685–688)
ablation, ventricular tachycardia, mapping, magnetic navigation
Advanced activation mapping can be helpful
for ventricular tachycardia requiring a focal ap-
proach. A typical example is fascicular tachycar-
dia where ablation can be guided by the presence
of Purkinje potentials, both during sinus rhythm
and during tachycardia. However, this is not al-
ways very easy, as patients can be noninducible
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Figure 1. ECGs (25 mm/s) during ventricular tachycardia and in sinus rhythm. Note the inverted T-waves in leads II,
III, and aVF during sinus rhythm.
or other arrhythmias (e.g., catheter-induced) can
interfere with the interpretation of the findings.
This case report shows the use of activation
mapping to guide a magnetically enabled catheter,
retrograde across the aortic valve, to the site of left-
sided fascicular tachycardia, using remote mag-
netic navigation.
Case Report
A57-year-oldwomanwas referred for catheter
ablation. She was known to have ventricu-
lar arrhythmias for the past 5 years. Initially,
heart failure was present and mitral regurgitation
was detected. Coronary arteries were normal at
C�2006, The Authors. Journal compilation C�2006, Blackwell Publishing, Inc.
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Figure 2. RPM screen, showing activation maps in left anterior oblique (LAO) (upper left panel) and right anterior
oblique (RAO) (lower left panel) views, along with the endocardial signal at the right, displaying an early activation
(55 ms before the right ventricular signal and 35 ms before the QRS of the surface ECG) of a ventricular premature
beat. The earliest site on the activation maps is in the yellow-red region.
angiography. She was treated for heart failure, re-
ceived sotalol and improved, but 2 years later was
shown to still have exercise-related sustained ven-
tricular tachycardiawhichwas asymptomatic. She
was readmitted 2 years later in July 2003 with
recurrent symptomatic arrhythmias, and Amio-
darone was administered to suppress the ventric-
ular tachycardia. The tachycardia had a rate of
150 beats/min, showed a right bundle branch block
pattern with left axis (−94◦) and QS pattern in
the inferior leads. The resting ECG was normal.
Fascicular tachycardia from the left posterior fas-
cicle was suspected, and demonstrated during
exercise. Radiofrequency ablation aided by LocaL-
isa (Medtronic, Inc, Minneapolis, MN, USA) was
attempted in August 2003. Mapping guided the
way to fascicular potentials in the mid-posterior
septal region. A total of 43 applications were given
in this area. The radiation time was 70 minutes
with a procedure time of 258 minutes. Two early
short-lasting recurrenceswere a reason to continue
amiodarone therapy. Seven months later amio-
darone was stopped as hyperthyroidism was de-
tected. Ventricular tachycardia then became inces-
sant, albeit at slower rates (Fig. 1).
In October 2004 she was therefore, resubmit-
ted for mapping and ablation, aided by an ad-
vanced mapping system, the real-time position
management system (RPM, Boston Scientific Cor-
poration, Natick, MA, USA). In this way the left
ventricle was mapped retrograde transaortically
during sinus rhythm and tachycardia or prema-
ture beats using a 4-mm tip EPT Blazer RPM
catheter (Boston Scientific Corporation). The site
of interesting Purkinje potentials was again infero-
posterior on the activation map (Fig. 2). Stabil-
ity of the mapping catheter was a problem during
repeated runs of tachycardia and we postulated
686 June 2006 PACE, Vol. 29
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Figure 3. Two Navigant screens, above and below, with RAO and LAO views. In the upper half
of the figure the manual mapping catheter as well as the right ventricular and coronary sinus
catheters can be noted in RAO and LAO views. The tip of the RPM mapping catheter is labeled
by the green dot. In the lower half of the figure the magnetically enabled Helios ablation catheter
is brought to the desired spot (green dot with circle) in approximately the same views. The green
dot and circle is now represented by the yellow dot. The blue and yellow lines are those drawn
by the operator and the software on the navigation screen. The blue line is drawn by the operator
and forms a catheter base reference for the software; because the catheter is not fixed in the aorta
the reference may differ from the actual catheter position. The yellow line is a virtual catheter
representing the applied field needed to navigate the catheter to the desired point. The virtual
and actual catheter positions differ partly due to the change in the reference base and partly
because of a need sometimes for manual correction to get to a point of interest.
that the use of very flexible magnetically steered
catheters might be of benefit in this situation. The
external magnets of the Niobe system were acti-
vated, with the accompanying Navigant software
(Stereotaxis Inc, St Louis, MO, USA). The radio-
graphic position of interest of the initial map-
ping catheter tip was imported into the Navigant
software and labeled in two views (upper half
of Fig. 3). The initial mapping catheter was then
replaced by a 4-mm tip Helios catheter (Stereo-
taxis Inc.) which was introduced and then ad-
vanced across the aortic valve using the catheter
advancer system (Stereotaxis Inc.). Subsequent
magnetic vectors oriented the catheter tip toward
the point of interest (lower half of Fig. 3). A to-
tal number of 17 applications was given in the
region of interest, and no further tachycardia or
premature beats were observed. The radiation
time was 50 minutes with a procedure time of
225 minutes.
She remains without symptoms or docu-
mented tachycardia on multiple Holter ECGs for
more than 12 months now.
Discussion
Fascicular tachycardia can be treated with
conventional radiofrequency catheter ablation.
The presence of Purkinje potentials may guide the
physician in targeting a critical area of the reen-
trant circuit.1,2 Conventional catheters may pose a
problem, as they cannot always be easily directed
PACE,Vol. 29 June 2006 687
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to the site of interest when using a retrograde
approach, and mechanical block may also occur
during manipulation. Using floppy catheters de-
veloped to be guided by externalmagnetsmayhelp
to avoid these problems, as manipulation in the
ventricle becomes easier.3 Furthermore, one may
assume that it is less prone to mechanically in-
duced arrhythmias caused by manipulation. How-
ever, mapping remains necessary, and we present
here a well-described electro-anatomical mapping
tool that functioned well in the magnetic en-
vironment, and assisted in localizing the target
area before introducing the magnetically enabled
catheter.4 Once in the ventricle, the magnetically
guided catheter was maneuvered without diffi-
culty to the target area, where Purkinje potentials
were present.
Drawbacks of the magnetic catheter in this po-
sition include some initial difficulty crossing the
aortic valve, and marked mobility of the magnet
catheter in the left ventricular cavity during con-
traction and relaxation of the left ventricle, be-
fore good left ventricular wall contact was made.
Once good wall contact was achieved the catheter
stability was excellent despite regular transition
between tachycardia and sinus rhythm. Ideally,
the mapping system should be integrated with the
magnetic navigation system.
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Magnetic Navigation in Left-Sided AV Reentrant Tachycardias:
Preliminary Results of a Retrograde Approach
ANDREW S. THORNTON, M.B.B.CH., MAXIMO RIVERO-AYERZA, M.D., PAUL KNOPS, B.Sc.,
and LUC J. JORDAENS, M.D., PH.D.
From the Department of Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
Retrograde Magnetic Ablation of Accessory Pathways. Introduction: A novel magnetic navi-
gation system allows remote guidance of floppy radiofrequency (RF) ablation catheters. We evaluated the
feasibility of mapping and ablation of left-sided accessory pathways (APs) using the retrograde transaortic
approach with this system. This might open the gate to retrograde ablation of left atrial arrhythmias.
Methods and Results: Twenty consecutive patients were included. A Helios II was used in five and in 15
a Celsius RMT RF catheter with higher magnetic mass and different flexibility was used. Mapping and
ablation were attempted. The learning curve was analyzed. Ablation was acutely successful in 60% of the
patients using the Helios II and in 80% using the Celsius RMT. Median procedure time was 158 minutes, with
median patient and physician fluoroscopy times of 26 and 4 minutes. In the last 10 patients, procedure times
became significantly shorter (median 122 minutes, only Celsius RMT catheters) and standard catheters had
to be used only twice. No complications occurred.
Conclusions: Remote retrograde transaortic RF ablation of left-sided APs is feasible, safe, and reduces
the physician’s fluoroscopy exposure. There is a very steep initial learning curve, with the success rate
increasing from 50% in the first 10 cases to 80% in the last 10 cases. Different catheter configurations may
influence the outcome. (J Cardiovasc Electrophysiol, Vol. 18, pp. 467-472, May 2007)
arrhythmias, AV reentrant tachycardia, catheter ablation, magnetic navigation, stereotactic therapy,
Wolff-Parkinson-White syndrome
Introduction
Since transvenous ablation of accessory pathways (APs)
was described,1 more recently with radiofrequency (RF) en-
ergy,2-4 nothing really substantial has changed in the catheter
technique.
Ablation of left-sided pathways can be undertaken in both
a retrograde transaortic fashion as well as via a transsep-
tal approach.5-8 The two approaches have their advantages,
disadvantages, and complications. The success rate is com-
parable. Procedure and fluoroscopy time, and complication
rates are similar.8-13 The choice is therefore mainly dictated
by the preference of the physician and his experience with
transseptal puncture.
The magnetic navigation system (Niobe, Stereotaxis Inc.,
St. Louis, MO, USA) makes it possible to steer soft, flexible
catheters and guide-wires by the use of an external magnetic
field.14-18 These catheters may allow for reliable contact with
the myocardium, without increased risks such as perforation,
and to maintain that contact throughout the cardiac cycle
even in the face of changes in rhythm. In addition, it may
help to access difficult anatomy, for example, in corrected
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complex congenital heart disease. This new technology to
map and ablate has only been described in a relatively limited
number of patients with left-sided APs,19 and then mainly
via a transseptal approach, using first-generation magnetic
catheters.
We assessed the feasibility of a retrograde approach to ab-
lation of left-sided APs using a magnetic navigation system.
We also compared the efficacy of two catheters with different
magnetic mass and configuration and different shaft flexibil-
ity, as well as the learning curve required for this approach.
With increasing experience, this approach opens a route to
less invasive access of left atrial arrhythmias, as transseptal
puncture may become unnecessary.
Methods
Patient Population
We enrolled 20 consecutive patients with proven symp-
tomatic left-sided APs, including 14 with overt pre-
excitation. No patient had a contraindication to the use of
magnetic navigation. This study forms part of the safety and
efficacy study approved by the ethics committee of the Eras-
mus Medical Centre. All patients gave informed consent for
the procedure.
Electrophysiological Study
Patients were studied in the fasting, postabsorptive state
under light sedation. A diagnostic electrophysiological study
confirmed the diagnosis of a left-sided AP. Electrograms were
recorded using a standard recording system (Sensis, Siemens,
Erlangen, Germany). An additional femoral arterial access
sheath was placed and heparin 100 units/kg body weight was
given. We maintained an ACT above 250 s throughout the
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procedure. Through the sheath, a magnetic navigation abla-
tion catheter with a 4-mm tip was advanced manually to the
descending aorta distal to the origin of the left subclavian
artery. The catheter was then inserted into the catheter ad-
vancer system (CardiodriveTM, Stereotaxis, Stereotaxis Inc.)
and the magnets were brought in. The catheters used were
the 3-magnet low magnetic mass catheter, Helios II (Stereo-
taxis, Stereotaxis Inc.), and another 3-magnet, more flexible
and higher magnetic mass catheter, Celsius RMT (Biosense
Webster, Diamond Bar, CA, USA), which became available
later. The choice was determined by availability.
Magnetic Navigation
The Niobe I magnetic navigation system (Stereotaxis Inc.)
is combined with a monoplane angiography system (AXIOM
Artis, Siemens).17 The Niobe I system consists of two large
permanent magnets with a combined field strength of 0.08
Tesla produced in navigation mode, situated on either side of
the patient and controlled via a computer workstation (Navi-
gant, Stereotaxis Inc.) to allow for changes in the orientation
of a stable magnet field within the chest of the patient. The
ablation catheters have magnets in the distal shaft that align
themselves with the field produced by the external magnets,
allowing for effective catheter orientation. Only limited angu-
lation of the C-arm is possible (approximately 28◦ in the right
and left anterior oblique angulations), due to the position of
the magnets. Remote catheter advancement and retraction is
performed using a catheter advancer system (CardiodriveTM,
Stereotaxis Inc.) positioned on the thigh. After the magnets
are brought in next to the patient, remote control of all of the
components of the system, including the RF generator, stim-
ulator, and recording equipment, is performed by the physi-
cian from the control room. A nurse remains with the sedated
patient to monitor vital signs and administer drugs when re-
quired.
Using the Navigant software, the catheter is manipulated
across the aortic valve. The mitral annulus is mapped from
the ventricular side to locate the position of the pathway. If
this fails, the atrial side of the annulus is accessed and the
annulus mapped in this fashion. Crossover to a standard RF
ablation catheter using the retrograde approach during the
same procedure is possible, at the discretion of the treating
physician.
Procedure times are defined from the start of venous ac-
cess until the end of testing after a 30-minute waiting period.
Fluoroscopy times are measured separately for the patient
and the physician.
Mapping and Ablation
RF energy was delivered via the 4-mm tip of the ablation
catheter using an EP Shuttle RF generator (Stockert GmbH,
Freiburg, Germany) with settings of 55◦C, 60 seconds and
power titrated up to 50 W to obtain the set temperature. RF
applications were stopped 10 seconds after adequate temper-
ature was obtained if no effect was seen. Temporary success
was considered as success for mapping with the system. The
end point for ablation was absence of AP conduction and non-
inducibility of tachycardia using standard electrophysiolog-
ical maneuvers and isoprenaline. Maneuvers were repeated
after a waiting period of 30 minutes.
Follow-Up
All patients received heparin intravenously for 24 hours
after the procedure and aspirin 80 mg per day for 6 weeks
following the ablation. Each patient had an echocardiogram
before discharge. All patients were seen at 3 months postab-
lation, when a history was taken and ECG performed.
Statistical Analysis
All continuous variables are expressed as mean± standard
deviation. When appropriate, median values are reported and
nonparametric tests used.
Results
Patient Data
The patient group consisted of 14 males and six females,
with a mean age of 42 ± 15 years (17–70 years), all having
normal hearts. All patients had left-sided APs, with two pa-
tients having two anatomically separate left-sided pathways.
The 22 pathways were left anterolateral (1), left lateral (14),
left posterolateral (1), and left posterior (6). The patients with
two pathways both had a left lateral and a left posterior path-
way and were treated in the Helios II catheter group. Helios II
catheters were initially the only catheters available and were
used in cases 1–4 and 9.
Remote Navigation and Mapping Using the Magnetic
Navigation System
Traversing the aortic arch, we used two vectors to go an-
teriorly and to the right, and then inferiorly, to position the
catheter above the aortic valve. Initially, we attempted to cross
the aortic valve by forming a loop and advancing, or by push-
ing the catheter into one of the sinuses of valsalva and then
trying to prolapse it across the valve. The former often ended
with the catheter tip back in the arch and the most advanced
part still just above the valve, while with the latter the catheter
entered the left ventricle (LV), but with the tip remaining
above the valve (Fig. 1). The LV was accessed in all, but
after the first three cases, we advanced the soft tip catheter
in a straight fashion across the valve, using a vector aimed
at the apex in a left anterior oblique (LAO) view and at the
mid-posterior septum in a right anterior oblique (RAO) view
(Fig. 2), thus avoiding accidental coronary artery cannulation.
Once stabilized, the tip was retracted and freed up, usually
without losing the catheter from the LV. Either target navi-
gation, or recently, the 3-D anatomic model was then used
to target areas around the annulus. The catheter sometimes
moved easily, while in others the catheter would have to be
straightened and then a different target or vector selected. In
the last nine cases, we were able to manipulate the catheter
through the mitral valve into the LA and also map the an-
nulus from the atrial side. This enabled easier mapping but,
visually, contact on the annulus was not good, and trying to
increase contact often caused the catheter to fall back into the
LV. Good contact could be obtained under the mitral valve
by “over-advancing” the catheter until a little buckling was
seen more proximally in the catheter.
Procedure Data
The mean procedure time (including the 30 minutes wait-
ing time) was 162± 56 minutes (median 158 minutes), with
a patient fluoroscopy time of 31 ± 22 minutes (median 26
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Figure 1. Left: LAO view, with the catheter
position after trying to form a loop in the
proximal ascending aorta. The floppy catheter
(Celsius RMT) is completely curled up with
the tip in the distal ascending aorta. Right:
LAO view, with the catheter position after try-
ing to prolapse the catheter across the aor-
tic valve. The floppy catheter (Helios (II) has
prolapsed across the valve, but the tip of the
catheter remains supra-valvar.
minutes). For successful magnetic ablation cases, the mean
procedure time was 130± 41 minutes (median 111 minutes),
with a patient fluoroscopy time of 21 ± 16 minutes (median
14 minutes). Of the total fluoroscopy duration, the physi-
cian was only exposed only during sheath introduction and
diagnostic catheter positioning, or when standard ablation
catheters were used. This was for a mean of 9 ± 11 minutes
(median 4 minutes) in all patients, but only 4 ± 3 minutes
(median 4 minutes) in the cases were only a magnetic catheter
was used.
Ablation Data
Data are shown in Table 1. Ablation was generally per-
formed either during sinus rhythm in those with an overt
pathway or during ventricular pacing in those with concealed
pathways. In one patient with a concealed AP, any ventricular
Figure 2. Crossing of the aortic valve with
a magnetic catheter. The two views above
are from the Navigant screen showing the se-
lected vector with the fluoroscopy on the left
(RAO), updated before advancing across the
valve, and the fluoroscopy on the right (LAO),
showing just after crossing the valve with the
catheter kept straight. The yellow arrows with
green and yellow arrowhead show that the se-
lected vector for crossing the aortic valve has
been applied. The two images below are RAO
and LAO fluoroscopic images (left and right,
respectively), showing how a magnet catheter
has just crossed the aortic valve.
pacing immediately induced tachycardia. He was ablated in
tachycardia. Termination was not associated with displace-
ment of the catheter.
Mapping for ablation was acutely successful with mag-
netic navigation in 15 of 20 patients (75%) and 22 pathways
(68%). In the Helios II group, acute success was achieved
in three of five patients (60%), and seven pathways (43%).
In the Celsius RMT group, 12 of 15 patients and pathways
(80%) were successfully mapped for ablation.
This included one patient (13) with recurrence after 30
minutes. Using the ablation catheter and stored vectors, it
was easy to get back to the area with permanent block. In
two patients, only temporary block was obtained on several
occasions with a magnetic catheter, and the pathways were
easily ablated retrogradely with a standard catheter on the
identified site.
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TABLE 1
Overview of Patient, Catheter, and Procedure Data
Catheter Proc. M Time S Time Fluoro Time Fluoro Time
No. AP Site Type Success Time (Min) # RF M (Sec) # RF S (Sec) Final Success Patient Physician
1 LL Helios II Y 191 6 420 43.9 12.0
2 LL Helios II T 230 5 324 1 21 Y 30.1 7.3
3 LL, LP Helios II N 265 20 405 20 779 Y, Y 24.0 5.1
4 LL, LP Helios II N 197 9 290 13 341 Y, N 58.2 22.1
5 LP C RMT Y 180 8 170 53.5 3.5
6 LP C RMT T 225 29 550 2 145 Y 52.0 3.5
7 LL C RMT Y 130 7 318 14.2 2.6
8 LL C RMT Y 110 4 126 7.8 1.0
9 LL Helios II Y 105 7 199 19.1 3.8
10 LL C RMT N 170 11 204 14 292 N 74.2 41.0
11 LL C RMT Y 103 12 202 12.5 3.6
12 LL C RMT Y 93 5 169 16.0 5.0
13 LP C RMT Y 189 4 163 28.2 8.0
14 LL C RMT Y 136 1 60 10.0 2.3
15 LAL C RMT Y 146 4 104 35.9 2.1
16 LL C RMT Y 108 1 60 7.3 1.1
17 LL C RMT Y 90 1 60 9.3 5.2
18 LPL C RMT N 196 12 221 6 94 N 55.0 16.0
19 LP C RMT Y 112 2 76 4.1 2.6
20 LL C RMT N 260 13 368 18 359 N 66.0 30.3
AP = accessory pathway; C RMT = Celsius RMT catheter; Fluoro time = fluoroscopy time in minutes; LAL = left anterolateral; LL = left lateral; LP
= left posterior; LPL = left posterolateral; M = magnetic catheter; N = no success; No. = patient number; Proc. = procedure; # RF = number of RF
applications; S = standard catheter; T = temporary success; Y = permanent success.
In the five patients in whom no temporary success could
be obtained, crossover to standard catheters with the same
approach was successful in two during the same procedure.
One of these had a left lateral AP ablated with a standard
catheter, but a left posterior AP could not be ablated. She re-
mains completely asymptomatic. This gave a complete pro-
cedural success rate after crossover to a standard catheter of
17 of 20 patients (85%) and 19 of 22 (86%) APs. The three
remaining patients had either left lateral (two) or left pos-
terolateral (one) APs, which were successfully ablated using
a transseptal approach and standard catheters at a subsequent
procedure.
The median number of RF applications was seven (range
1–40), with a median RF time of 201 seconds (range 60–
1,184). In the successful cases using magnetic catheters, the
median number of RF applications was four (range 1–12),
with a median RF time of 163 seconds (range 60–420). If
more than seven applications were not associated with at least
temporary effect, then permanent success was never achieved
with magnetic catheters.
Learning Curve or Catheter Type
There was a significant decrease in procedure and RF time
between the first and last 10 patients, with a tendency to de-
creased patient fluoroscopy time and the number of RF ap-
plications (Table 2). There was also a significant decrease in
procedure and RF time and a tendency to a better outcome
in ablation of APs in the Celsius RMT group compared to
the Helios II group (Table 3). There was no significant differ-
ence in any of the parameters between the first seven and the
second eight patients treated with Celsius RMT catheters.
Follow-Up Results
No complications occurred during the procedure.
Echocardiograms done on the day after the procedure were
normal. A pulmonary embolus, 2 weeks after the procedure,
occurred in the patient with two pathways in whom only one
could be ablated. This was despite adequate anticoagulation
both during the procedure and for 24 hours thereafter. All
patients were seen at 3 months’ follow-up. No recurrences of
tachycardia or delta waves were observed when initial suc-
cess was obtained.
Discussion
Both the transseptal and transaortic approaches to left-
sided APs have been used. Each has its own specific ad-
vantages and disadvantages. Comparisons of these two ap-
proaches using standard catheters have generally shown sim-
ilar success rates, procedure and fluoroscopy times, and com-
plication rates.8-13 There is, however, a greater acceptance of
the transseptal approach. This may be explained by studies
showing somewhat shorter fluoroscopy and procedure times
TABLE 2
Comparison of the First 10 Versus the Last 10 Patients
First 10 Last 10 P Value
No. patients (APs) 10 (12) 10 (10)
Helios/Celsius RMT 5/5 0/10
Success patients 5/10 8/10 NS
Success APs 5/12 8/10 0.099
Proc. time (min) 180 ± 53 137 ± 48 0.038
Patient fluoro time (min) 33.7 ± 21.8 24.4 ± 21.5 0.078
Physician fluoro time (min) 10.2 ± 12.5 7.6 ± 9.1 NS
# RF applications 15.9 ± 12.6 7.9 ± 9.8 0.076
RF time (sec) 458.4 ± 317.7 193.6 ± 204.5 0.028
APs = accessory pathways; Fluoro = fluoroscopy; min = minutes; No. =
number; NS = not significant; Proc. = procedure; RF = radiofrequency;
sec = seconds. Success is defined as permanent success with the magnet
catheter.
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TABLE 3
Comparison of the Two Catheter Groups
Helios II Celsius RMT P Value
No. patients (APs) 5 (7) 15 (15)
Success patients 2/5 11/15 NS
Success APs 2/7 11/15 0.074
Proc. time (min) 198 ± 60 145 ± 47 0.029
Patient fluoro time (min) 35.1 ± 15.9 29.7 ± 24.2 NS
Physician fluoro time (min) 10.1 ± 7.4 8.5 ± 11.8 NS
# RF applications 16.8 ± 14.5 10.9 ± 10.8 NS
RF time (sec) 542 ± 400 249 ± 223 0.026
APs = accessory pathways; Fluoro = fluoroscopy; min = minutes; No. =
number; NS = not significant; Proc. = procedure; RF = radiofrequency;
sec = seconds. Success is defined as permanent success with the magnet
catheter.
with the transseptal approach and more complications in the
transaortic approach.10 It has also been stated that contact is
better via the transseptal approach. On the other hand, some
have demonstrated an increased number of complications,
especially major complications, in the transseptal approach,
although this was not statistically significant.12
The use of a magnetic navigation system to map and ab-
late left-sided pathways has only been described in a rela-
tively limited number of patients,19 and then mainly via a
transseptal approach, using single magnet and low magnetic
mass catheters (Helios). We elected to study the retrograde
approach again using a magnetic navigation system. Mag-
netically enabled catheters may allow us to maintain reliable
contact with the myocardium without increased risk, such as
perforation of the aorta or myocardium, or damage to valves,
and to maintain that contact throughout the cardiac cycle even
in the face of changes in rhythm.
The procedure and fluoroscopy times in this study com-
pare favorably with those in published studies, especially the
radiation time for the physician, which is certainly signifi-
cantly less than that which would normally be experienced.
Our success rates overall and for both catheters, especially the
low magnetic mass catheter, are less than that which would
normally be expected. The success increased to 80% in the
last 10 cases. This may well have related to our learning curve.
There are significant technical differences between standard
and magnetic catheters, which result in different handling
characteristics. Learning how to overcome some of these dif-
ferences and use these to our advantage remains a challenge.
We believe this led to the very steep, but short initial learning
curve. The short learning curve may reflect our experience
with this system in other arrhythmias, but other operators
have also described a short learning curve for this system
for atrial fibrillation.20 While a real comparison of the two
catheters used is not really possible here, subjectively, we are
in no doubt as to the better features of the higher magnetic
mass, more flexible catheter.
Limitations of the Study
This study has been undertaken in a small number of cases
and merely shows feasibility. We cannot reliably compare the
outcome to either a transseptal approach using either mag-
netic or standard catheters, or to a retrograde approach us-
ing standard catheters, as the initial learning curve is steep.
Having climbed the initial hump of the learning curve, we
now need to compare the outcomes with a transseptal ap-
proach using magnetic catheters, as well as to use of standard
catheters.
Conclusions
APs can be successfully mapped and ablated retrogradely,
using magnetic navigation. A very steep initial learning curve
was evident, with an ongoing but less steep curve. The use of
newer, higher magnetic mass, more flexible catheters made
the ablation easier. Procedure and fluoroscopy times are com-
parable to standard approaches even at this early stage, but
physician fluoroscopy times are significantly shorter than
would be expected.
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A Left-Sided Accessory Pathway Revisited with Remote
Retrograde Magnetic Navigation
ANDREW S. THORNTON, M.B.B.CH. and LUC JORDAENS, M.D., PH.D.
From Clinical Electrophysiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
Accessory pathways can be ablated with a high success rate. Occasionally, recurrences appear after suc-
cessful procedures, sometimes shortly after the end of the procedure. We describe a successful ablation
using remote magnetic navigation of a single catheter using stored vectors after recurrence of accessory
pathway conduction while the patient was still in the electrophysiology laboratory. (PACE 2007; 30:573–
576)
accessory pathway, ablation, arrhythmia, magnetic navigation
Introduction
Returning to a given ablation point once one
has moved the catheter can sometimes be quite
challenging, certainly when using radiographic
imaging alone. This can be even more difficult if
using a single catheter approach,1 without other
references. Registration of the successful point
would be useful, and could be done using a map-
ping system. Another possibility is to register the
successful position to radiological images on a
magnetic navigation system and then ask this sys-
tem to return a magnetically enabled catheter to
this point.2
Case Report
A 21-year-old man with a long history of
paroxysmal palpitations with a regular narrow
complex tachycardia and electrocardiographic ev-
idence of preexcitation suggestive of a posterosep-
tal accessory pathway was studied under light
conscious sedation and intravenous heparin. The
left subclavian vein and right femoral vein were
cannulated for right ventricular apex (RVA) and
coronary sinus (CS) catheters. The presence of a
left posterior pathway was confirmed, with an an-
terograde effective refractory period less than 300
ms, and inducible orthodromic atrioventricular re-
entrant tachycardia (AVRT).
A retrograde transaortic approachwith remote
magnetic navigation of a floppy magnetically en-
abled ablation catheter was used. A 3 magnet,
4-mm tip ablation catheter (7 Fr Celsius RMT,
Biosense Webster, Diamond Bar, CA, USA) was in-
serted through an 8-Fr sheath in the left femoral
artery. It was advanced up the aorta as far as the
origin of the left subclavian artery. The magnet-
ically enabled catheter was connected to the re-
Address for reprints: A.S. Thornton, M.B.B.Ch., Depart-
ment of Clinical Electrophysiology, Room Bd416, Thoraxcen-
tre, Erasmus MC, Dr. Molewaterplein 40, Rotterdam 3015
GD, The Netherlands. Fax: +31-10-4634420; e-mail: an-
drewthornt@gmail.com
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mote catheter advancer system (Stereotaxis, St.
Louis, MO, USA) and the external magnets (Niobe,
Stereotaxis) brought in. The rest of the procedure
was performed remotely from the control room us-
ing the Navigant workstation (Stereotaxis).
The ablation catheter was advanced across the
aortic valve using what is known as vector-based
navigation. The mitral valve annulus was mapped
from the ventricular side using target-based nav-
igation. Both the vectors necessary to cross the
aortic valve as well as the targets for success-
ful ablation were stored on the magnetic naviga-
tion system. At a site associated with good sig-
nals, a radiofrequency application was made with
temperature-controlled ablation from a remotely
controlled EP Shuttle radiofrequency (RF) genera-
tor (Stockert GmbH, Freiburg, Germany) with set-
tings of 55◦C, 60 seconds, and power titrated up to
50 W. During the first application, accessory path-
way conduction disappeared after 15 seconds, but
at 21 seconds, the catheter became displaced by
ventricular ectopy induced by the ablation, an un-
usual occurrence as catheter stability is otherwise
usually very good. Conduction returned quickly.
Repositioning the catheter was performed bywith-
drawing and then again advancing the catheter
with a little extra loop in the ventricle. Applica-
tion of energy (application 2) was associated with
disappearance of the accessory pathway within
5 seconds and continued bidirectional accessory
pathway block (see position in Fig. 1). After 10
minutes of accessory pathway block, the ablation
catheter was removed and after 30 minutes block
was still present, even with isoprenaline, andwith
complete atrioventricular (AV) and ventriculara-
trial (VA) block after administration of adenosine.
At this time, the catheters were withdrawn and
venous sheaths removed and preparationsmade to
move the patient back to his room. At this time, the
electrocardiogram (ECG) was again noted to show
preexcitation with the same characteristics as at
the beginning of the procedure.
As the arterial sheath was still in situ be-
cause of the significantly prolongedACT, itwas de-
cided to return to the successful site using the vec-
C�2007, The Authors. Journal compilation C�2007, Blackwell Publishing, Inc.
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Figure 1. Navigant work screen with LAO 24◦ (at the right) and RAO 32◦ (at the left). Catheters
are in the right ventricular apex, the coronary sinus and in the AV ring. The blue line is where the
catheter shaft was based; the yellow line is the vector as programmed; the green line ends within
the orange circle, which is around the successful site of ablation.
tors and target previously stored on the Navigant
system. This was possible as the patient had not
changed position. The CS catheter was not repo-
sitioned as the venous sheaths had already been
removed. The catheter returned easily to the area
of interest (Fig. 2), although with a slightly larger
atrial signal suggesting a slightly more atrial po-
sition on the annulus (Fig. 3A,B). Radiofrequency
Figure 2. RAO view with the single ablation catheter,
similar position as compared to Fig. 1.
application resulted in disappearance of accessory
pathway conduction 8.5 seconds into the applica-
tion (application 3). The accessory pathway con-
duction remained absent for 40 minutes. There
was no delta wave either the following day, or at
6 weeks follow-up.
Discussion
This report is the first describing how stored
magnetic vectors in the Niobe system (Stereo-
taxis Inc) can be used to revisit the area of
successful ablation. No other landmarks were
in place at this time. It was possible to posi-
tion the catheter in the region of interest and to
successfully reablate this pathway in less than
5 minutes, including time for catheter reintroduc-
tion and magnet redeployment. That the signals
at the final position are suggestive of a somewhat
more atrial position show that the vectors are only
part of the positioning process and that slightly
different advancement or retraction of the catheter
also influences the position. The ability to return
to an area of interest using a fewmouse clicks may
prove useful in some cases.
The Stereotaxis system can store previous
magnetic vectors, which are then used, together
with the catheter advancer system, to maneuver
the catheter back to a specific target. How close
the catheter gets to that spot depends on a number
of factors, such as whether the patient has moved,
whether the prespecified catheter pivot point has
moved and whether the catheter advancer system
has been used to advance or retract the catheter
sufficiently to allow it to get to that point. The
Stereotaxis system, as a stand alone system, has
stored fluoroscopic views with superimposed tar-
gets, and other visual clues, as a reference to en-
574 April 2007 PACE, Vol. 30
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Figure 3. (A) Electrograms from the initial
successful site (application 2), before the ab-
lation on the left, and after the ablation on
the right. (B) Electrograms from the final site
(application 3), before the ablation on the
left, and after the ablation on the right.
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sure that the catheter returns to a given location.
While reproducing the catheter movement that
enabled the target to be reached, the stored im-
age is a fairly inaccurate way of ensuring that the
catheter has in fact returned to the target. Elec-
troanatomic mapping systems compute a point in
space using a magnetic, electrical, or ultrasound
field, and if reference catheters have not moved,
we can show with an accuracy of a few millime-
ters whether a catheter has returned to that point.
However, with most of these systems, the catheter
has to be manually returned to that point and this
may or may not be easy. Combining the two sys-
tems i.e. storing the vectors used to manipulate
a catheter to a point as well as accurately storing
the target point would mean easier andmore accu-
rate navigation to a point, and that system is now
available with the combination of the Stereotaxis
system with the CARTO RMT system (Biosense
Webster).
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AbStRACt
background: Left atrial access for electrophysiological procedures may not always be possible 
using a transseptal approach. Other approaches need to be developed. We evaluated the 
feasibility of accessing the left atrium and pulmonary veins in a retrograde transaortic fashion, 
using magnetic navigation.
Methods: Access to the left atrium and pulmonary veins was undertaken via a retrograde 
approach using a magnetically enabled ablation catheter and remote magnetic navigation. 
Once in the left atrium we attempted to cannulate the pulmonary veins using the preset vec-
tors in the system. 
Results: In 9 consecutive patients left atrial access was successfully achieved. The pulmo-
nary veins could be cannulated using the magnetic system and preset vectors (with or without 
minor modification) developed for a transseptal approach in all 5 patients in whom this was 
attempted. The mean time needed to advance the catheter from the aorta to the left atrium 
was 13.8 ± 3.6 minutes with a screening time of 4.9 ± 2.2 minutes. Subsequent cannulation of 
all the pulmonary veins took 1.4 ± 0.2 minutes. No complications occurred. 
Conclusions: In this small, observational series, feasibility of a retrograde transaortic 
approach to the left atrium and pulmonary veins, using a magnetically enabled floppy 
catheter, was successfully demonstrated with no complications in all patients in whom it was 
attempted.
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1. INtRoDuCtIoN
Access to the left atrium for catheter interventions using transseptal puncture was first 
described in the late 1950s and early 1960s.[1-3] Transseptal puncture has increasingly been 
used to access the left atrium for electrophysiological procedures.[4-8] Increased experience, 
and newer techniques, particularly imaging, have increased the safety of this procedure, and 
removed some of the risks associated with this procedure.[9-11] Some contraindications remain 
and a newer contraindication to transseptal puncture relates to closure of atrial septal defects 
(ASD) and patent foramen ovale (PFO) with percutaneous closure devices.[12-14] 
Standard steerable diagnostic catheters introduced in a retrograde fashion can be placed 
on the atrial side of the mitral annulus for ablation of accessory pathways, however there is 
then almost no way of manipulating the catheter further within the left atrium (LA) for atrial 
fibrillation ablation, or for treatment of other complex left atrial arrhythmias.[15] 
The recent development of floppy magnetically steered catheters directed by the use of an 
external magnetic field might allow for this approach. We have been evaluating a retrograde 
approach to left sided accessory pathways using the magnetic navigation system.[16] We will 
discuss the small consecutive series in which we accessed the LA and then the pulmonary veins 
(PVs) in a retrograde fashion to test its feasibility. 
2. MAtERIAlS AND MEtHoDS
2.1  Patient Population: Left atrial access was attempted in 9 consecutive patients undergo-
ing a retrograde transaortic approach to a left sided accessory pathway using remote magnetic 
navigation, for mapping of the atrial side of the mitral annulus. In 5 of these, during the waiting 
period after ablation of the accessory pathway, the catheter was then drawn back to above the 
aortic valve and the LA was again accessed from above the aortic valve, and cannulation of the 
PVs was subsequently attempted. Approval was given by the institutional review board of the 
Erasmus MC to use the system for mapping and ablation. All patients gave written informed 
consent.
2.2 Magnetic Navigation System: The Niobe I magnetic navigation system [16-19], com-
bined with the monoplane AXIOM Artis angiography system (Siemens, Erlangen, Germany) 
was used together with the remote catheter advancer system (CardiodriveTM, Stereotaxis Inc., 
St Louis, MO, U.S.A.), positioned on the anterior thigh, to navigate a 4 mm tip ablation catheter 
(Celsius RMT, Biosense Webster, Diamond Bar, CA, USA). The magnetically enabled ablation cath-
eter was manually advanced up the descending aorta to the origin of the left subclavian artery. 
Remote control of all of the components of the system in the electrophysiology laboratory 
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was then performed from the adjacent control room. Access to the LA via the aortic and mitral 
valves was attempted using the magnetic navigation system. 
2.3 Accessing the left atrium retrogradely: Access was gained to the left ventricle (LV) 
using the technique we have used for a retrograde approach to left sided accessory pathways.
[16] This was done by keeping the catheter straight and choosing a vector aimed at the mid-
posterior septum in RAO and the apex in LAO, while advancing and retracting the catheter with 
minor modification around this (figure 1). Mimicking standard techniques was less successful 
in our hands, with the catheter either curling up even more with the tip moving up into the 
arch, or the catheter body prolapsing into the LV, while the tip remained supra-valvar. Using 
the catheter in this straight orientation ensures that there is little chance of coronary artery 
cannulation, as their initial course is more horizontal or superior.
Figure 1:  
This clip from the Stereotaxis screen shows 34 degree RAO, and 28 degree LAO fluoroscopic views with 
the selected vectors which we found most useful when advancing the catheter in a straight orientation 
across the valve. In the RAO view the catheter is still above the valve, while in the LAO view it has entered 
the LV.
Once across the aortic valve, by loosening the catheter tip from the LV apical wall and then 
choosing a vector aimed at the anterolateral portion of the mitral valve orifice and advancing 
the catheter, the floppy catheter was directed across the mitral valve into the LA (figure 2). All 
these vectors can be stored for repositioning if this is necessary. 
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Figure 2:  
Similar views to those in figure 1 showing the selected vectors for accessing the LA from the LV. In both 
views the catheter has already advanced across the anterolateral mitral valve commissure into the LA.
In the 5 patients in whom left atrial access was gained again during the waiting period, can-
nulation of the PVs was attempted using the preset vectors developed for cannulation of the 
PVs using a transseptal approach, without or with minor modification. We subjectively assessed 
catheter stability and attempted to manipulate the catheter around the ostia of the PVs, on the 
roof of the LA, around the opening of the left atrial appendage and around the body of the LA 
down to the mitral annulus. Electroanatomic mapping was not undertaken in this group.
4. RESultS
3.1 Cannulation of the left atrium: Left atrial access was successful in all 9 patients in whom 
it was attempted, with a retrograde transaortic approach using magnetic navigation. In all 5 
patients in whom left atrial access was again attempted during the waiting period after abla-
tion of the accessory pathway this was successful, as was cannulation of the PVs. In no case did 
we fail to access the LA or the PVs when this was attempted.
3.2 Left atrial access and mapping: Once in the LA, the catheter appeared stable and 
could be manipulated around the ostia of the PVs, on the roof of the LA, around the open-
ing of the left atrial appendage and on the upper parts of the septum, and anterior and 
posterior walls without difficulty and with apparent good stability. In our early experience, 
mapping closer to the mitral annulus seemed to be associated with a risk of falling back into 
the LV. All 4 PVs in each patient were cannulated using the preset vectors for a transseptal 
approach without or with minor modification (figure 3). Minor modification was required 
in 2 patients for the left upper pulmonary vein and in 1 for the left inferior pulmonary 
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vein, with a median number of 4.6 ± 0.9 vectors for all 4 veins. No complications occurred. 
Figure 3:  
This series of figures shows a fluoroscopic view, above – in all cases 28 degrees LAO, and the 
corresponding view from the Navigant system, below, showing the selected vector used to cannulate 
respectively from left to right, the right upper pulmonary vein, the right inferior pulmonary vein, the left 
inferior pulmonary vein and the left upper pulmonary vein. The vector has been selected using a software 
model of the left atrium created by Stereotaxis (the 3D anatomic model). The vectors selected are either 
the presets or minor modifications thereof.
3.3 Procedure and screening times: These are shown in figure 4. The procedure time 
needed to advance the catheter from the aorta to the LV was 4.3 ± 4.2 minutes (median 2.9 
minutes, range 1.7 to 15.0 minutes) with a fluoroscopy time of 3.5 ± 3.9 minutes (median 2.6 
minutes, range 0.6 to 13.6 minutes). The time required to access the LA from the aorta was 13.8 
± 3.6 minutes (median 12.7 minutes, range 11.0 to 20.0 minutes) with a fluoroscopy time of 4.9 
± 2.2 minutes (median 4.8 minutes, range 2.2 to 8.4 minutes). Once in the LA, access time for all 
4 PVs was 1.4 ± 0.2 minutes (median 1.3 minutes, range 1.2 to 1.8 minutes) with a fluoroscopy 
time of 0.1 ± 0.1 minutes (median 0.1 minute, range 0.1 to 0.3 minutes)
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Figure 4: 
Median cumulative access and screening times with a retrograde magnetic approach. Times (in minutes) 
are taken from when the catheter is initially positioned in the aortic root. LA = left atrium, LV = left 
ventricle, min. = minutes, PVs = pulmonary veins.
5. DISCuSSIoN
Access to the LA by transseptal puncture is increasingly being used for electrophysiological 
procedures,[8] and this has recently risen exponentially with the advent of a successful ablation 
therapy for atrial fibrillation.[4-7] Since its introduction there have been some risks associated 
with this procedure,[11] and some contraindications. The risks include perforation of the 
free wall of the heart and of the aorta,[20] air embolism,[21] and cerebrovascular accidents. 
Increased risk may be associated with insufficient landmarks or individual variations in cardiac 
position. Relative contraindications include a dilated aortic root or coronary sinus, cardiac mal-
positions, distorted contours of the interatrial septum and a thick or fibrosed muscular septum.
[8,22] An increase in experience,[9,10] and newer techniques, particularly echocardiography, 
have increased the safety of this procedure, and removed some of the problems.[23] While 
the success rate of attempted transseptal puncture is high, usually above 95%, it occasionally 
fails.[9,10,24] In some patients with congenital heart disease access to the pulmonary venous 
atrium or to the “other” side of a baffle may also be very difficult.[15] 
The increasing use of ASD and PFO closure devices for prevention of recurrent paradoxical 
emboli,[12-14] has led to a new contraindication to transseptal puncture. While newer occlu-
sion devices may be made from biodegradable materials, for the present these are generally 
metallic. With the demonstration of a relationship between migraine and PFO, and the compel-
ling but not yet robust potential to treat this by closing the PFO,[25] the number of young 
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patients who will have absolute or relative contraindications to transseptal puncture may rise 
in the coming years. There is a risk that this same group of patients may continue to be at risk 
for atrial arrhythmias.[26] 
There is a need for another, non-surgical, approach to be found to access the LA, failing which 
an increasing number of patients who are otherwise eligible for percutaneous left atrial abla-
tion as therapy for atrial fibrillation or another atrial arrhythmia but have an impediment to 
transseptal puncture, may have to forego this. 
Magnetic navigation can position catheters despite difficult anatomy and maintain good tissue 
contact throughout the cardiac and respiratory cycles, without additional risk of perforation.
[17,18] In a recent report of successful PV isolation in a porcine model, mention is made in the 
discussion of PV cannulation in 30 of 30 veins in 5 canines using a retrograde transaortic mag-
netic enabled approach.[19] We have now confirmed the feasibility in humans. The procedure 
and fluoroscopy times were acceptable and should decrease further with increased experience. 
No complications occurred and we also felt that the flexible nature of the catheter made the risk 
of complications lower than that when using standard catheters. Specifically we felt that using 
the described method that the risk of inadvertent coronary artery cannulation was lower than 
using either a standard catheter or a floppy catheter when the tip is prolapsed superiorly. There 
have been some concerns about catheter entrapment in the mitral apparatus, but to date that 
has not been reported. We felt that entrapment was less likely as long as with each attempt to 
cross the mitral valve we disengaged the magnets and allowed the catheter tip to return to 
the apex before trying a different vector. We did not feel that there was any more likelihood for 
entrapment with magnetic catheters than with standard catheters. 
Limitations include that this is a small, non-randomised series. The ability to access the LA and 
cannulate the PVs does not necessarily mean that atrial fibrillation ablation will be possible, as 
this was not tested. Additional lines, especially the mitral isthmus line might also be difficult 
due to instability. In addition clearly only the ablation catheter could access the LA, but we 
felt that using intracardiac echocardiography would assist in catheter placement and ensuring 
stability and tissue contact.  We also need to show that it will be as easy to access the LA and 
PVs with 8 mm tip and irrigated tip magnetic catheters which could be used in ablation within 
the LA. 
In conclusion, this small series shows that using a magnetically enabled floppy catheter one 
can gain access to the LA and to the PVs using a retrograde transaortic approach. Access to 
the LA and PVs can be undertaken successfully in a reasonably short time.  Using the approach 
described above and the soft magnetic catheters we feel that the risks are low. In the presence 
of contraindications to, or problems with transseptal puncture, left atrial electrophysiological 
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procedures may still potentially be possible. Further investigation is required to determine 
whether accurate mapping of the LA and ablation of the left atrium or isolation of the pulmo-
nary vein ostia can also be undertaken safely and efficiently.
A retrograde left atrial approach 137
REFERENCES
 1. Brockenbrough EC, Braunwald E, Ross J, Jr. Transseptal left heart catheterization. A review of 450 
studies and description of an improved technic. Circulation 1962;25:15-21.
 2. Cope C. Technique for transseptal catheterization of the left atrium; preliminary report. J Thorac Surg 
1959;37:482-6.
 3. Ross J, Jr. Transeptal left heart catheterization: a new method of left atrial puncture. Ann Surg 
1959;149:395-401.
 4. Haissaguerre M, Hocini M, Sanders P, et al. Catheter ablation of long-lasting persistent atrial fibril-
lation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol 
2005;16:1138-47.
 5. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats 
originating in the pulmonary veins. N Engl J Med 1998;339:659-66.
 6. Ouyang F, Bansch D, Ernst S, et al. Complete isolation of left atrium surrounding the pulmonary 
veins: new insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 
2004;110:2090-6.
 7. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein 
ostia: A new anatomic approach for curing atrial fibrillation. Circulation 2000;102:2619-28.
 8. Sakata Y, Feldman T. Transcatheter creation of atrial septal perforation using a radiofrequency trans-
septal system: novel approach as an alternative to transseptal needle puncture. Catheter Cardiovasc 
Interv 2005;64:327-32.
 9. De Ponti R, Zardini M, Storti C, Longobardi M, Salerno-Uriarte JA. Trans-septal catheterization for 
radiofrequency catheter ablation of cardiac arrhythmias. Results and safety of a simplified method. 
Eur Heart J 1998;19:943-50.
 10. Gonzalez MD, Otomo K, Shah N, et al. Transseptal left heart catheterization for cardiac ablation 
procedures. J Interv Card Electrophysiol 2001;5:89-95.
 11. Libanoff AJ, Silver AW. Complications of transseptal left heart catheterization. Am J Cardiol 
1965;16:390-3.
 12. Bridges ND, Hellenbrand W, Latson L, Filiano J, Newburger JW, Lock JE. Transcatheter closure of patent 
foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902-8.
 13. Thomson JD. Percutaneous PFO closure, further data but many unanswered questions. Eur Heart J 
2006;27:258-9.
 14. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous 
closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-8.
 15. Kalman JM, VanHare GF, Olgin JE, Saxon LA, Stark SI, Lesh MD. Ablation of ‘incisional’ reentrant atrial 
tachycardia complicating surgery for congenital heart disease. Use of entrainment to define a critical 
isthmus of conduction. Circulation 1996;93:502-12.
 16. Thornton AS, Rivero-Ayerza M, Knops P, Jordaens LJ. Magnetic navigation in left sided AV 
reentrant tachycardias: Preliminary results of a retrograde approach. J Cardiovasc Electrophysiol 
2007;18:467-472.
 17. Faddis MN, Blume W, Finney J, et al. Novel, magnetically guided catheter for endocardial mapping 
and radiofrequency catheter ablation. Circulation 2002;106:2980-5.
 18. Faddis MN, Chen J, Osborn J, Talcott M, Cain ME, Lindsay BD. Magnetic guidance system for cardiac elec-
trophysiology: a prospective trial of safety and efficacy in humans. J Am Coll Cardiol 2003;42:1952-8.
 19. Greenberg S, Blume W, Faddis M, et al. Remote controlled magnetically guided pulmonary vein isola-
tion in canines. Heart Rhythm 2006;3:71-6.
 20. Linker NJ, Fitzpatrick AP. The transseptal approach for ablation of cardiac arrhythmias: experience of 
104 procedures. Heart 1998;79:379-82.
 21. Lesh MD, Coggins DL, Ports TA. Coronary air embolism complicating transseptal radiofrequency abla-
tion of left free-wall accessory pathways. Pacing Clin Electrophysiol 1992;15:1105-8.
Ch
ap
te
r 1
3
138
 22. Schneider MB, Zartner PA, Magee AG. Transseptal approach in children after patch occlusion of atrial 
septal defect: first experience with the cutting balloon. Catheter Cardiovasc Interv 1999;48:378-81.
 23. Szili-Torok T, Kimman G, Theuns D, Res J, Roelandt JR, Jordaens LJ. Transseptal left heart catheterisa-
tion guided by intracardiac echocardiography. Heart 2001;86:E11.
 24. Marcus GM, Ren X, Tseng ZH, et al. Repeat Transseptal Catheterization After Ablation for Atrial Fibril-
lation. J Cardiovasc Electrophysiol 2007;18:55-59.
 25. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably 
to atrial septal repair: a case-control study. Stroke 2006;37:430-4.
 26. Silversides CK, Siu SC, McLaughlin PR, et al. Symptomatic atrial arrhythmias and transcatheter closure 
of atrial septal defects in adult patients. Heart 2004;90:1194-8.
Chapter 14
Ablation of a focal left atrial 
tachycardia via a retrograde approach 
using remote magnetic navigation

Ablation of a focal left atrial tachycardia via a retrograde approach using remote magnetic navigation 141
CASE REPORT doi:10.1093/europace/eun080
Ablation of a focal left atrial tachycardia via
a retrograde approach using remote magnetic
navigation
Andrew S. Thornton*, Maximo Rivero-Ayerza, and Luc J. Jordaens
Clinical Electrophysiology Unit, Department of Cardiology, Thoraxcentre, Erasmus MC, ‘s Gravendijkwal 230,
3000 CA, Rotterdam, The Netherlands
* Corresponding author. Tel: þ31 10 4635244; fax: þ31 10 4632701. E-mail address: andrewthornt@gmail.com
Received 7 December 2007; accepted after revision 7 March 2008
Case report
A 66-year-old man who had undergone successful ablation of typical atrial flutter subsequently developed a left atrial
tachycardia. A trans-septal approach was proposed, but not performed due to risk. He was referred to us with the
suggestion that a retrograde procedure could be attempted using a magnetic navigation system (Niobe, Stereotaxis
Inc, St Louis, MO, USA) installed in our institution.
We performed multi-slice computed tomography (CT) with three-dimensional reconstruction to allow for use of the
CARTO RMT Merge system (Biosense Webster, Diamond Bar, CA, USA). The patient was sedated with diazepam and
fentanyl. Heparin was used to maintain the activated clotting time of above 300 s. After placing diagnostic catheters,
we approached the left atrium (LA) in a retrograde fashion using a 4 mm tip magnetically enabled ablation catheter
(Navistar RMT, Biosense Webster), advancing it to just below the subclavian artery manually. The ablation catheter was
then manoeuvred across the aortic and mitral valves using remote magnetic techniques developed while accessing left-
sided accessory pathways in a retrograde fashion.1 Left atrium via the aortic and mitral valves was accessed within
12 min, with 5 min and 24 s of screening. We then performed anatomic and activation mapping of the LA during tachycar-
dia. On assessing the activation map, it was clear that the area of interest was the roof of the LA between the upper
pulmonary veins, towards the right (Figure 1). Mapping was concentrated in this area with an adequate map of the area
of interest completed within a further 15 min (Figure 2). A complete map of the LA was not deemed necessary.
The ‘design-a-line’ facility was used to fill in areas on the CARTO map where points had not been taken. Points on the
Figure 1 Left anterior oblique fluoroscopic view of the site of successful ablation with the catheter positioned in the left atrium roof
via the aortic and mitral valves.
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2008.
For permissions please email: journals.permissions@oxfordjournals.org
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design line are transferred to the Niobe system and this then directs the catheter to these positions. One could also use the
‘click and go’ facility for this purpose. The CARTO RMT map obtained was merged with the reconstructed CT image.
Features suggested a focal tachycardia, and we ablated at the point of earliest activation using settings of 608C, 30 W
for 60 s. This resulted in slowing (at 8 s) and termination of the arrhythmia (at 12 s) during the first application. Catheter
stability was excellent. We were unable to reinduce any atrial arrhythmia even with aggressive pacing and isoproterenol,
and after waiting 20 min. Follow-up to date (20 months) has shown no arrhythmia recurrence. Total procedure time was
157 min and total fluoroscopy time was 27 min.
Discussion
Trans-septal puncture is most often used for electrophysiological procedures in the LA.2 Newer techniques and increased
experience have improved the safety of this procedure and reduced some of the risks.3 Although the success rate of
trans-septal puncture is usually above 95%, it occasionally fails,2,3 especially when repeat trans-septal puncture is
necessary.4 In some patients, contraindications may also be present. Given the number of patients presenting for percu-
taneous left atrial ablation, it is therefore important that alternative, non-surgical approaches be found to access the LA.
Standard steerable catheters can be placed retrogradely on the atrial side of the mitral annulus for the ablation of
accessory pathways, but further manipulation within the atrium is then difficult. Magnetic navigation can place cath-
eters, despite difficult anatomy and maintain good tissue contact throughout the cardiac and respiratory cycles,
without additional risk of perforation.1 In a recent report,5 mentioning is made of cannulation in 30 of 30 pulmonary
veins in five canines using a retrograde transaortic magnetic-enabled approach. We managed LA access in this patient
and were able to successfully ablate an atrial tachycardia, thus moving a further step forward.
Conclusion
Although we would not advocate this approach as a first-line option, this case demonstrates that when trans-septal punc-
ture cannot be undertaken, for whatever reason, alternatives exist. Although this technique proved useful in the ablation
of this focal left atrial tachycardia, it is not yet clear whether ablation around the pulmonary vein ostia, using recently
available irrigated tip catheters, can be undertaken using this approach.
Conflict of interest: A.S.T. and L.J.J. have received speaker’s fees from Stereotaxis Inc., St Louis, MO, USA.
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Advances in the Approaches to Ablation
of Complex Arrhythmias
A. S. THORNTON, M.B.B.CH. and L. J. JORDAENS, PH.D.
From the Department of Cardiology, Thoraxcentre, Erasmus MC, Rotterdam, The Netherlands
Ablation of Complex Arrhythmias. A complex arrhythmia is one where successful ablation repre-
sents a serious challenge to the treating physician, and in this situation an advanced solution such as the
combination of imaging with mapping and the ability to deliver a newer energy form using remote naviga-
tion may be a combined option some may wish was presently available. As will be discussed, there have been
many advancements in the armamentarium of the electrophysiologist, and the above scenario may not be
too far removed. This is not an exhaustive review, but serves to highlight some of the issues. Hopefully some,
if not all, of the advances discussed will assist us in improving success rates, while decreasing risks and
complications. The ability to allow less experienced and busy electrophysiology centers to perform complex
ablation with similar success and risk as more experienced labs may also be a possibility. (J Cardiovasc
Electrophysiol, Vol. 18, pp. S2-S10, Suppl. 1, January 2007)
catheter ablation, ventricular tachycardia, voltage mapping, interventional navigation, magnetic navigation,
atrial fibrillation, atrial tachycardia
Introduction
The topic of this manuscript begs the questions: What are
advances and what is complex?
The definition of complex, or difficult, is not defined and
will vary from center to center. Some have suggested its
use for redo ablations using advanced mapping after failed
conventional ablation,1 others as patients where more than
one arrhythmia is present,2 and yet others as ablation rest-
ing on anatomic considerations where extensive lesions are
required.3 Cosio et al. described complex re-entrant circuits
as those that demand of the electrophysiological team a deep
knowledge of anatomy and a great deal of experience in the
correlation of activation patterns with anatomic landmarks.4
Undoubtedly, everyone will have his or her own opinion, and
it could be defined merely as a case in which successful abla-
tion represents a serious challenge to the treating physician.
Complexity would seem to relate best to two areas: substrate
complexity and intellectual complexity. Substrate complexity
includes normal but challenging anatomic areas such as the
left atrium, small hearts such as in children, and also altered
hearts either due to disease, surgery or both (e.g., corrected
congenital hearts). Substrate complexity may also relate to
areas where pathological structures lie close to normal struc-
tures, for example septal accessory pathways.5 The ability to
create complete linear lines of block is increasingly required
for ablation of arrhythmias and presents both an anatomical
and, frequently, an intellectual challenge. Substrate complex-
ity also relates to unstable arrhythmias, either hemodynamic
instability or arrhythmias that are difficult to initiate or main-
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tain. Intellectual complexity relates partly to the number of
channels required to be displayed on an EP system in arrhyth-
mias where the circuit itself is complex. In addition, the entire
circuit is not always endocardial, but may be subendocardial
or even epicardial, or there may not be adequate access to be
able to record electrograms at all sites. In these cases, it can
be an intellectual challenge to picture the focus or circuit in
a particular arrhythmia.
The definition of advances is also a personal one and de-
pends from where one is starting. If one only has a limited
recording system, then a simple mapping system is advanced,
while if one already has a mapping system, then advanced is
perhaps the combination of imaging with mapping and the
ability to deliver newer energy forms using remote naviga-
tion. In both cases the aim is to improve ablation outcome
while improving safety. The focus of this paper will be on
various techniques that may be used, singly or in combina-
tion, in complex cases of arrhythmia.
While we are looking to improve outcome and safety, it
should not be forgotten that one aspect of safety is a de-
crease in fluoroscopy exposure for patient and physician.
Long fluoroscopy times are associated with a small but mea-
surable increase in the long-term risk of malignancy,6 and
keeping this to a minimum is essential both for patient and
staff.
In a recent editorial it was asked whether many of the
modalities mentioned here should be considered as “tool or
toy.” It must be remembered (to paraphrase) that many toys
of yesterday are the tools of tomorrow.7
It would be presumptuous to attempt to cover all aspects
of these topics, so only a few have been selected. These in-
clude advances used in the treatment of intra-atrial re-entry
(predominantly post surgical congenital heart disease), atrial
fibrillation ablation and ablation of ventricular tachycardia,
particularly of ischemic origin.
Imaging
Perhaps the dream of all electrophysiologists is to have
good imaging. We have adapted over the years to the use
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of fluoroscopic images and have become relatively adept at
interpreting two-dimensional (2D) images in combination
with electrogram signals to tell us where we are in the
heart. Fluoroscopy does not show us complex anatomy and
anatomic variations though and is unable to show whether
lesion sets are contiguous in order to form complete lines
of block. Use of a model (computer generated), or better
still actual anatomy, to show both spatial and activation de-
tail simultaneously would obviously be enormously helpful
(Fig. 1). Clearly, there are advances in imaging that are tak-
ing us further in the treatment of arrhythmias, not only by
allowing for treatment of ever more complex arrhythmias,
but at the same time by improving the safety of these same
ablations. They also decrease radiation exposure for both pa-
tient and physician, which can be substantial in ablation of
complex substrates.8
Nonfluoroscopic Mapping Systems
The arrival of nonfluoroscopic mapping systems, roughly
10 years ago, was one of the initial developments that al-
lowed for advances in cardiac mapping. CARTO (Biosense-
Webster, Diamond Bar, CA, USA), RPM (Boston Scien-
tific, Natick, MA, USA), LocaLisa (Medtronic, Minneapolis,
MN, USA), and EnSite-NavX (St. Jude Medical, St. Paul,
MN, USA) have all been used to allow for positioning of
catheters in virtual three-dimensional (3D) space in an on-
line fashion with decreased use of fluoroscopy and with en-
hanced safety of procedures.9,10 All of these systems have
been well described elsewhere, as have their advantages and
disadvantages,11 but all of these mapping systems primar-
ily require catheter movement to form geometry and cannot
predict anatomy on their own. It has been increasingly real-
ized that the 3D geometry created was definitely virtual and
very operator dependent; and they have not been as effective
as initially thought, especially in preventing some complica-
tions, e.g., pulmonary vein (PV) stenosis during PV isolation
procedures.12 The 3D surfaces drawn by these maps rely on
detection of the catheter tip, and the surface is formed by the
maximum excursion of the catheter within the chamber of in-
Figure 1. This figure is in four sections with the left two sections showing a 3D reconstruction from a multislice CT in right lateral and then LAO views,
showing how the RVOT (in green) curves around the left ventricular outflow tract (in yellow) and aorta (in red) such that the “septum” is not in a single
“flat” plane as suggested by the angiographic image, but actually runs from the anterior RVOT inferiorly to the posterior RVOT superiorly. The course of
the RVOT is highlighted by the dotted lines in the three images on the right. The impression of the aorta can also be seen on the virtual endoscopic view on
the far right.
terest.13 If insufficient points are taken in forming a map the
map will not be accurate and may underestimate the chamber
size and be of little use. If sufficient force is applied, then the
chamber may well become deformed, and thus the surface
and volume will be an overestimate of the reality.14 It is im-
portant to remember that the information put into a mapping
system determines what it puts out. Thus, in nonanatomic
ablation with re-entry, an intimate knowledge of electrophys-
iological principles is still required to differentiate from any
number of potential circuits. For example, in corrected con-
genital hearts where typical isthmus-dependent flutter and
one or more actual or potential scar re-entry circuits may
coexist, entrainment maneuvers are often necessary. Con-
versely, in some cases where entrainment is possible over a
wide area, a mapping system is very useful for delineating
a narrow isthmus for ablation. A mapping system is often
very useful for delineating conduction block over an isthmus
line, especially in the case of a nonconventional isthmus.15
In some cases, though, fluoroscopy may still have some ben-
efit while using a mapping system, for instance in assisting
with localization of the true PV ostium—left atrium (LA)
junction,16 although real-time image integration and other
modalities, such as impedance maps, may be useful in this
context. Some systems are ideally used with hemodynam-
ically stable, sustained tachycardias, e.g., CARTO, NavX,
and RPM, while others are suited for single beat mapping
or mapping of unstable tachycardias, e.g., EnSite.1 While
some studies have continued to show relatively long proce-
dure and fluoroscopy times, these have been attributed to the
complexity of the cases being attempted. In direct compara-
tive studies the procedures are not prolonged, but fluoroscopy
times are significantly shorter than those where fluoroscopy
alone is used, even for relatively straightforward procedures
such as AVNRT and AVRT.17 This benefit is even greater in
more complex procedures such as atrial flutter where there is
also relative cost neutrality in certain cases.18 Despite some
remaining questions, groups still feel that these mapping sys-
tems provide significant benefit, particularly in the congenital
heart disease patient,1,19 where anatomical and intellectual
challenges are often severe and combined.
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Preoperative Standalone CT and MRI Imaging
The recent use of CT and MRI as stand alone modalities
has reminded us of the importance of anatomy and anatomic
variables, for example, in LA-PV anatomy. They have also
helped in the planning of ablations in more complex anatomy
by providing road maps for the procedure.20 While CT is tech-
nically simpler in that it is quicker and easier to obtain images
of the beating heart, MRI potentially has more applications.
MRI has the ability to obtain images with similar spatial
resolution and detail to those obtained with CT, without the
ionizing radiation or nephrotoxic contrast agents.
Interventional Cardiac MRI
The development of MR intervention means that proce-
dures may, in the near future, be guided by MR, thus obviating
the risk from ionizing radiation. In the case of electrophysi-
ology, more work needs to be done on MRI compatible elec-
trodes, but these are in development21 while other technical
challenges, such as real-time multislice acquisition and 3D
display, amongst many others, still remain. A number of pre-
liminary studies and a limited number of cases have been
performed using these systems. In the interim, a number of
hybrid X-ray MRI (XMR) suites combining these technolo-
gies have been installed.21,22
Image Fusion with Nonfluoroscopic Mapping Systems
The ability to combine CT or MRI reconstructions with
nonfluoroscopic mapping systems, such as with CARTO in
CARTOMerge, and with the EnSite-NavX system with DIF
(digital image fusion) has further improved the accuracy of
the virtual anatomies on which electrophysiologists are work-
ing, and allows for real-time navigation in these improved
virtual anatomies. DICOM images are imported into a map-
ping system, following which software, as has been described
elsewhere,3 is used to segment the 3D geometries of the dif-
ferent cardiac chambers from the volume as a whole. Further
software is then required to perform registration, which per-
forms a fit between the electroanatomical map formed and the
3D reconstruction. This is usually performed by linking a set
number of points on both images that are easily identifiable
(landmark registration), followed by surface registration in
order to create the smallest average distance between the two
data sets. There are limitations to these systems, and while
accuracies in the order of a few millimeters can be obtained
(with surface to surface errors of 2–3 mm3,14), these levels
of accuracy cannot be reproduced in all cases. A number of
factors contribute to inaccuracy in image registration: inaccu-
racies in the electroanatomical map; inaccurate or poor qual-
ity scans; physiologic differences such as different rhythms
during the scan and the electrophysiological study; differ-
ences in the respiratory phase at which images are acquired;23
changes in fluid status; and registration errors. As mentioned,
some of the differences in registration may occur due to in-
correct identification of registration points on either the scan
image or the electroanatomical map made and may be less
with the use of certain structures such as the aorta,24 or pos-
sibly other vascular structures such as the venae cavae, the
pulmonary artery, or PV branches.14 Solutions may exist in
being able to use CT/MRI images overlaid with fluoroscopy
and then combined with nonfluoroscopic mapping systems,
further increasing the accuracy of maps.25,26 Complications
frequently relate to extracardiac structures,27 and the ability
to include the esophagus, phrenic nerve, and coronary arter-
ies on reconstructions made using CT or MRI may further
improve safety by decreasing complications. What we do not
have in large numbers are trials with image integration in
nonfluoroscopic mapping systems that confirm the impres-
sions noted above. Early studies using these newly available
integrated image and mapping systems have not confirmed
significantly shorter radiation times nor have they shown im-
proved outcome, but these have been mainly feasibility stud-
ies.28 What we hope is that being able to navigate an area like
the narrow ridge between the left-sided PV and the left atrial
appendage will prove useful and improve outcome while de-
creasing complications such as perforation of the left atrial
appendage (LAA) or ablation within the PV in an attempt to
avoid the LAA. Newer software versions are also able to show
impedance maps and fractionation and dominant frequency
maps in atrial fibrillation—all utilities to improve safety and
improve success rates particularly as regards AF ablation.
Intracardiac Echocardiography (ICE)
ICE allows for real-time 2D imaging of anatomy with the
possibility for some assessment of catheter position, catheter-
wall contact and for controlling delivery of energy. ICE
has proven very useful in positioning mapping and ablation
catheters relative to the PV ostia.29 It has already been used to
assess both anatomy and lesions formation, particularly when
combined with the use of myocardial contrast agents.30,31
Both radiofrequency and cryoablation lesions can clearly be
visualized, and this technology could be used to confirm po-
sitioning of lesions so as to ensure complete linear lesion
sets are formed. While on-line 3D transthoracic and trans-
esophageal echocardiography is already available and prov-
ing useful,32 on-line 3D intracardiac echocardiographic
imaging is still in development. When available, it could
herald a new era in real-time, real anatomy imaging in elec-
trophysiology. At present, 3D-ICE requires off-line recon-
struction and thus has less utility than other 3D image sets.
Intracardiac MRI
In a similar way to intracardiac ultrasound, intravascu-
lar and, more particularly, intracardiac MRI may also prove
useful in the future as a method of obtaining real-time 3D
anatomic images of the heart. In addition, its ability to char-
acterize tissue may also be extremely valuable in real-time
assessment of lesion formation allowing for formation of lin-
ear lesions without gaps. Following the evolution of lesions
during ablation may confirm that sufficient energy is given
without causing too much damage, in order to prevent the
occurrence of complications. Already, MRI has been used to
assess lesions quantitatively as well as qualitatively after ab-
lation,33 and intravascular MRI has been used to assess vessel
wall histology.34
Rotational Angiography
While high speed rotational angiography may be useful
for the coronary arterial and venous anatomy,35 it is unlikely
to be useful for imaging of the chambers.
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Real-Time 3D Imaging
The advent of increasingly sophisticated imaging forms
with improvements in echocardiography, CT, and MRI have
enabled us to acquire reasonable online 2D images using
echocardiography, and good 3D off-line imaging using CT
and MRI. However, the ultimate goal must be on-line, real-
time 3D imaging that we can use to navigate through the heart,
to position our catheters, and to visualize our lesions.28 In
addition, the ability to show myocardial contraction, viability,
scar, and other physiological parameters may further enhance
the utility of and may possibly replace some features already
present in the nonfluoroscopic mapping systems.
3D Image Visualization
Of course, the problem with any 3D image is projecting
it on a 2D screen, where it undoubtedly loses some of its po-
tential. Virtual reality labs using holograms have been used
to visualize other 3D data sets, allowing the physician to
“enter” the image of interest. In these labs an animated holo-
gram is created, and, by wearing special glasses, the physician
can have depth perception. The physician can then interact
with the image in a number of ways. Recently, its use has
been demonstrated in data sets acquired using 3D transtho-
racic echocardiography.36 While presently requiring use of
a “small” room, this will certainly develop and miniaturize.
Other potential approaches include use of a head-mounted
display with tracking cameras that has been used to allow for
potential CT-guided interventions.37
Navigation
Having good imaging and efficient energy forms is of lit-
tle use if we are unable to navigate our catheters to the re-
quired position and then maintain stable catheter contact on
this tissue.38 While our standard catheters have undoubtedly
developed, they still are relatively thick and inflexible. The
diameter of the catheters is dictated to some extent by the
need for electrical connections between the tip and the con-
nector in order to acquire the signals used for diagnosis and
positioning of therapy. In the case of standard catheters, there
is an additional requirement for a steering mechanism. In EP
catheters this is by the use of one or more pull wires. The ne-
cessity to steer the catheter means that the shaft is relatively
stiff. In cases where the anatomy is complex, for example,
in patients who have undergone Mustard, Senning, or Fontan
repairs, there may be a significant part of the circuit or a focus
that is poorly accessible to a standard ablation catheter, thus
increasing the complexity of ablation or precluding or de-
creasing the chance of success for ablation.39,40 In addition,
using inflexible catheters in a constantly moving heart may
predispose to catheter movement during ablation, with the
formation of elongated or “brush” lesions with a risk of com-
plications and destruction of unnecessary tissue. There have
been a number of recent developments in terms of delivering
catheters to difficult anatomic areas.
Remote Magnetic Navigation
A remote magnetic navigation system (Niobe, Stereotaxis,
St. Louis, MO, USA) has been developed that uses large ex-
ternal magnets to form a stable magnetic field in which an
extremely flexible catheter with magnetic mass in the tip and
distal shaft can be maneuvered. This system has been de-
scribed extensively elsewhere.41 In short, the Niobe system
is managed by a computer interface system (Navigant) that
changes the magnet orientation and the magnetic field and
thus the catheter tip orientation. The catheter is advanced
and retracted by a mechanical advancer system (Cardiodrive).
Using these components in association with a dedicated flu-
oroscopy system, one can move the catheter in extremely
small increments of 1◦ and 1 mm within the constraints of
the heart. Once catheters are in the heart, all further catheter
maneuvering can be performed in a fully remote fashion from
the control room. Magnetic vectors used, and areas targeted,
can be saved, and this detail used at a later stage to return to
points of interest. This can be extremely useful. The highly
flexible catheters can be navigated throughout all chambers
after an initial, relatively steep learning curve, and perfora-
tion has never been described using this system. The system
has proven to be equal to standard ablation for the manage-
ment of such supraventricular tachycardias (SVT) as AVNRT
and AVRT,41-44 as well as in idiopathic VT.45 More recently,
publications have emerged showing its feasibility in the more
complex field of ablation of AF, both in experimental models
and in humans.38,46 This system has now been combined with
an electroanatomic mapping system (CARTO RMT), which
was specially modified to be able to function in this magnetic
environment (Fig. 2). With the inclusion of the Merge facility
within CARTO RMT, one is able to combine all the features
mentioned above under imaging with a remote navigation
system. With this combination system, information is sent
between systems so that particular points can be targeted. A
function called “design line” can be used to fill in areas on a
Figure 2. A CARTO RMT biatrial map. This map was made in 2 stages, the
second stage with the LA map has 95 points and took just over 10 minutes to
make. The map was made using an automated mapping function present in
the Navigant software specifically made for mapping of the LA. Additional
points have been taken manually in the area of interest accounting for the
clustering of points in that area.
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map and potentially to plan ablation lines. “Click and go” is a
utility whereby a point on the CARTO map is highlighted and,
via feedback through both systems, the magnetically navi-
gated catheter is moved accurately to this point. In their paper
on AF ablation using this system,38 Pappone et al. felt that the
combined system was very useful for constructing an accu-
rate electroanatomical map while acquiring more points in the
time usually taken for a map made by hand. Although there is
an extremely steep initial learning curve, the soft catheters can
be navigated precisely and safely in the LA even in challeng-
ing sites, while reducing fluoroscopy exposure for the oper-
ator. Procedure times were a little longer than manual cases,
but this was again early in their learning curve. It was felt
that AF ablation using this system is less operator dependent
than when performed manually. Although some have found
a retrograde approach to the left heart difficult,38 this again is
part of a learning curve. We have been able to access the left
ventricular (LV) in all patients in whom this was attempted,
and more recently to access the left atrium both for mapping
(Fig. 3) and for ablation of a focal tachycardia in the roof of the
left atrium. It is entirely plausible that AF ablation could be
performed in a retrograde transaortic fashion, either as an al-
ternative approach or as first line therapy. Also, maneuvering
a catheter around complex congenital anatomy may be pos-
sible. In addition, in a recent animal series, we have seen bet-
ter delineation of lesions without the “brush” phenomenon,
Figure 3. Retrograde access to the right inferior pulmonary vein (RIPV). Having gained access via the aortic valve and through the mitral valve to the left
atrium, presets in the Navigant system have been used to gain access to the PV. Left above is an area indicating the vector used by the preset to access the
RIPV while below are RAO and LAO fluoroscopic images taken over from the X-ray system.
suggesting that catheter stability during cardio-respiratory
movement is superior to that with manual catheters, and may
increase the selectivity of the tissue that we ablate and thus
decrease collateral damage and complications.
Robotic Navigation
The Hansen robotic system uses a different philosophy for
navigation of catheters in 3D geometry, although it also aims
to provide fine catheter control, to access complex anatomy,
to easily repeat procedure steps, and to maintain catheter sta-
bility. In this system, a robotic catheter control system, essen-
tially a steerable sheath, is used to navigate within the cardiac
chambers. This system can also be maneuvered remotely with
a slave system at the patient’s side that then steers the catheter
control system. Through the sheath a standard catheter is
placed in order to perform mapping and/or ablation. The sys-
tem can be fitted in existing labs, is significantly smaller than
the magnetic navigation system, and thus requires no special-
ized construction. It is relatively mobile and can be moved be-
tween labs. Potential drawbacks could include a risk of perfo-
ration from the relatively stiff steerable sheath (a risk inherent
in all steerable sheaths), the risk of thrombus formation within
the sheath lumen, and the requirement for a standard catheter
to be placed through the sheath that potentially could limit any
remote ablation capability. To date, only a limited number of
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feasibility studies in animal models and a small number of hu-
mans have been published, with no complications having oc-
curred.47,48
Both of the above technologies have elicited a signifi-
cant amount of interest, and further large-scale studies are
awaited.
Lesion Formation
Having navigated to the area of interest, we must be able
to apply a safe, reliable, and effective energy form with a high
chance of success and a low risk of complications.
Cooled Radiofrequency Ablation
In the case of complex congenital heart disease, partic-
ularly late postoperative, lesion formation can be problem-
atic. Reasons may include hypertrophied and fibrosed my-
ocardium; and particularly in those where chamber function
is very poor, blood flow (and thus catheter tip cooling) may
be especially poor, making it difficult to deliver adequate en-
ergy to the tissue to allow for sufficient lesion dimensions
to ensure successful ablation.15,19 The use of passive cooled
(8 or 10 mm tip), or active cooled (irrigated tip) catheters has
certainly proved useful in this regard, as well as in the treat-
ment of ventricular tachycardia49 and atrial flutter.50 There
is some evidence to suggest that irrigated tips may be better
than long tips in low flow states as regards energy delivery to
tissue,2 and a number of studies have suggested benefit from
the use of especially open irrigated tip catheters (frequently in
association with a mapping system) for the ablation of intra-
atrial re-entrant tachycardias post cardiac surgery for con-
genital heart disease.15,19,51 The use of these catheters may
be associated with a risk of more collateral damage due to
deeper lesions, but this has not been confirmed; and although
the incidence of pops is higher, this does not seem to be as-
sociated with a significant increase in the risk of perforation
and tamponade. Some degree of uncertainty still remains as
to whether open or closed irrigation are similar in efficacy and
complication rate. A recent animal study suggested that lower
blood-tissue interface temperature, thrombus and steam pop
occurred with open irrigation especially in low flow situations
such as would be expected in heart failure and in atria after
surgery, while lesion depth and surface area were similar.52
This might suggest more clinical safety with open irrigation,
although this clearly needs to be studied further.
Cryoablation
Electrophysiologists are increasingly ablating near nor-
mal conducting tissue or where collateral damage to coro-
nary arteries, and extra cardiac tissue such as the esophagus,
bronchus, and phrenic nerve, is possible. With the use of ra-
diofrequency energy, especially in the coronary sinus, dam-
age to coronary arteries has been described.53 While much of
the narrowing that has been seen is asymptomatic, the long-
term outcome following such narrowing is still not known,
and given the frequency with which it can be induced in
the experimental laboratory, it is well worth watching out
for.54 With the attention given more recently to ablation near
the mitral annulus and, quite frequently, within the coronary
sinus in patients undergoing ablation for atrial fibrillation,
especially the chronic forms,55 we might expect to see an-
other complication of this type of ablation appearing. It has
been shown that the use of cryoablation within the coronary
sinus, while associated with similar size lesions as well as
medial necrosis of the circumflex artery, is only associated
with mild intimal hyperplasia without significant stenosis as
yet.54 Clearly, with expansion of ablation to more and more
pediatric patients and to sites closer to the normal conducting
system, the potential benefits of cryomapping before ablation
have been looked at. In AVNRT ablation in the pediatric pop-
ulation the success rates were similar while the recurrence
rates were a little higher, although this did not reach signifi-
cance.56 No complications occurred, although we know that
there is a small but well-known risk of atrioventricular (AV)
conduction block using radiofrequency energy, which can be
avoided using cryothermal ablation. In septal accessory path-
ways the use of cryothermy has decreased some of the fears
associated with using radiofrequency in this area, with similar
success rates to those using radiofrequency.5 Although in this
study there were no cases of AV block in either the RF or cryo
group, a 4% incidence of AV block during RF application in
this area is quoted. While safety is potentially improved, a
somewhat more disturbing figure is the recurrence rate that
was significantly higher in the cryotherapy group. This was
felt by the authors possibly to relate to lesion characteris-
tics, with more focused necrosis with cryoablation. As the
authors note, though, recurrence is much less of a clinical
problem than permanent AV block. Most recently, the use
of cryoablation has been described for ablation of right ven-
tricular outflow tract tachycardia where it seems, at least in
the short term, to be comparable to radiofrequency but with
the advantage of virtual absence of pain associated with the
ablation.57
Balloon-Delivered Ablation Therapy
Balloons are being combined with newer energy sources
such as microwave and ultrasound in the pursuit of circum-
ferential lesions around the PV. However, as these energy
sources also generate heat, and a balloon can easily advance
into the PV if not correctly sized and positioned, there is a
potential for PV stenosis and there remain some issues before
these balloons and energy forms become fairly mainstream.
The balloon-energy source that has been fairly widely used
in the last 2 years is the Arctic Front (Cryocath Technolo-
gies, Inc., Kirkland, Canada) cryoballoon. While there is en-
couraging animal data on the use of cryoballoons for PV
isolation,58 there are no published clinical data outside of ab-
stracts. Judging from data discussed at congresses and from
our own experience with this balloon, the results are encour-
aging. The ability to isolate all 4 PV with a limited number
of applications using the balloon is an advantage of the bal-
loon technology, although some questions must remain about
the level of the isolation within the PV-LA junction, and the
long-term results. As with all of the balloons, there is a risk of
damaging the right phrenic nerve during isolation of the right
upper PV; and techniques have been used, such as intermit-
tent pacing of the phrenic nerve, to detect this and then to stop
the application immediately, after which recovery usually oc-
curs (Fig. 4). The risk of PV stenosis with cryoablation seems
extremely small, and this is a potential advantage. Whether
there is a decreased risk of atrio-esophageal fistula remains
open to conjecture. Short and medium to longer term data
should become available in the near future.
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Figure 4. An Arctic Front cryoballoon can be seen inflated within the ostium
of the right upper PV but inside the heart shadow in the RAO fluoroscopic
projection. A quadripolar catheter can be seen at the high right atrium-
superior vena cava junction, and is being used to stimulate the phrenic nerve
to identify any phrenic nerve injury early. A multipolar circular mapping
catheter is lying free within the left atrium and a decapolar catheter is
present in the coronary sinus.
Other Advances
Not to be forgotten are developments in accessing the heart
and certain chambers in the case of limited standard access,
especially in patients with corrected as well as uncorrected
congenital heart disease.
Epicardial Access
In many cases, circuits or foci are epicardial or partly
so both in ischemic and nonischemic VT, and thus the de-
velopment of epicardial approaches has also been a major
advancement.1,59 In addition, some SVTs have parts of their
circuits epicardially, and the presence of ganglionic plexuses
in the epicardial fat pads of the atria mean that an epicardial
approach may also be required for mapping and ablation of
some SVTs.60 Damage to the phrenic nerve and epicardial
vessels is a risk, and there is also a risk of pericarditis, but
with adequate precautions the risk of the first two can be
minimized.61
Alternative Methods for Access to Cardiac Chambers
In patients with congenital heart disease, especially those
with prior surgery, access to some chambers may be dif-
ficult or almost impossible, and in addition the number of
catheters that can be placed may be severely reduced. The use
of alternate access sites may involve transhepatic puncture to
obtain venous access when the inferior vena cava (IVC) is
occluded,62 and puncture of conduits or baffles. Access to
the pulmonary venous atrium in patients with lateral Fontan
tunnels has also been obtained by direct transthoracic punc-
ture.39 While this sounds risky and has been associated with
both hemo- and pneumothorax, it does provide an alternative
for some patients.
Conclusions
Generally what are required are good studies to confirm
what we feel: that these new technologies are not just toys, but
add significantly to the success rates of increasingly complex
rhythm problems, while improving safety and decreasing ra-
diation exposure for physician and patient. Also of impor-
tance of course in the days of financial constraints is show-
ing that these technologies are cost effective by increasing
turnover in the lab, decreasing costly complications, and im-
proving efficacy of this therapy. It will become increasingly
important when considering this long list of extremely ex-
pensive hardware and software that we prove which of these
systems gives us the most “bang for our buck” and which is
appropriate in a particular situation.
Even more intriguing is the possibility that using these
technologies may, as has been stated by others,11,38 be an
equalizer, leveling the playing field and allowing for more
complex procedures to be carried out by less experienced
operators in low volume laboratories with similar success and
complication rates to those of highly experienced operators
in high volume centers.
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 SuMMARy AND CoNCluSIoNS
The aims of this thesis were to summarise the status of catheter ablation with conventional 
approaches in atrial flutter and fibrillation and to understand the problems related to this con-
ventional approach. With this starting point we then investigated the role of remote magnetic 
navigation in the domain of cardiac catheter ablation. 
In Chapter 2 we discuss clinical aspects of atrial arrhythmias and their accurate diagnosis 
allowing for practical decisions on therapy. The differential diagnosis between atrial tachycar-
dia, atrial flutter and atrial fibrillation (AF) is not always easy. The presence of an underlying 
cardiomyopathy influences the clinical picture and requires more intensive therapy, including 
anticoagulation. In patients with congenital heart disease, especially the operated group, it is 
often difficult to characterise the circuit of macro-reentrant atrial tachycardia and its location. 
The objective of Chapter 3 was to compare the acute success and short-term follow-up of 
ablation of atrial flutter using 8 mm tip radiofrequency (RF) and cryocatheters. The acute suc-
cess rate for RF was slightly (but not significantly) higher than for cryo. Procedure times were 
similar although fluoroscopy time was longer with RF. More applications were given with RF, 
but indicators for myocardial damage were similar. The isthmus tended to be longer in the 
failed procedures. Recurrences and complaints in the successful patients were similar for both 
groups, with a very low recurrence of atrial flutter after initial success, in comparison to some 
groups who have reported higher initial success rates but also higher recurrence rates. 
In chapter 4 we allude to the fact that despite what some electrophysiologists might think, in 
atrial flutter the ongoing publication of studies aiming to improve success rates suggests that 
we do need further study to improve the outcome in ablation of atrial flutter, while improving 
patient safety and the efficacy of this ablation technique. In the meantime such attempts have 
been undertaken with maximal voltage guided ablation and we feel that this should also be 
studied with remote magnetic navigation using the new high power catheters.
In chapter 5 we describe our early experience with ablation for AF. The two most frequently 
used techniques at that time were segmental pulmonary vein isolation and left atrial circum-
ferential ablation. We discuss our approach using pulmonary vein antrum isolation guided by 
phased-array intracardiac echocardiography (ICE) and its initial results. Of the patients with 
paroxysmal AF, 69% were without recurrences after one procedure at a mean follow-up of 201 
days. No major complications occurred with this technique, which was however associated with 
a very long procedure and radiation time despite the use of ICE. The promise of high power and 
irrigated magnetically enabled catheters means that we can hopefully investigate the use of 
magnetic navigation in AF in the near future.
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Following this look at some conventional approaches to ablation we move on to the use of 
remote magnetic navigation in the field of clinical cardiac electrophysiology. 
Chapter 6 is a brief review of the problems of conventional ablation methods. The very early 
experience with remote magnetic navigation is also described. We also look at the potential 
for its use in clinical cardiac electrophysiology and cardiac resynchronisation therapy for the 
management of heart failure.
In chapter 7 the lesions formed by remote magnetic navigation and standard catheters in the 
right atrium or right ventricle of a porcine in-vivo model were compared. Transmural macro-
scopic lesions with magnetic navigation were more often oval or round (versus elongated after 
standard ablation) suggesting less potential for “brush” lesions and more precise lesion forma-
tion. The microscopic assessment revealed no significant differences. However, the lesions with 
magnetic navigation could be achieved with lower energy and impedances, possibly suggest-
ing more effective energy delivery. The need for a different in-vitro model taking into account 
cardiorespiratory movement is highlighted.
Chapter 8 then describes our very early work with the system in one of the easily accessible 
arrhythmias – atrioventricular nodal re-entry tachycardia (AVNRT). Our aims were to assess the 
feasibility of magnetic navigation to Koch’s triangle and reliable ablation of AVNRT. Consecu-
tive patients were mapped and ablated with early generation magnetically enabled catheters 
with one or three magnets at the tip. The catheter was remotely advanced with the Cardio-
driveTM system and orientated with the NavigantTM control system. After initial positioning 
with the external magnets, adjustments were made in small steps. Success rates, procedure, 
and fluoroscopy times were analysed, and compared with a local contemporary series of 
conventional AVNRT ablations. Magnetic navigation was always feasible. Targets were easily 
reached. Catheters remained stable in position during accelerated junctional rhythms. Ablation 
was successful in 90% of procedures. No significant complications occurred. Median patient 
fluoroscopy time was 12 min, while median physician fluoroscopy time was 4 min. Fluoroscopy 
times tended to be shorter than those in the conventionally treated group. Procedure duration 
decreased significantly over time, and the median procedure time was similar to that in the 
conventional group.
Navigation, mapping, and ablation in the right ventricular outflow tract (RVOT) can be difficult. 
The purpose of the study in Chapter 9 was to assess the feasibility of RVOT tachycardia ablation 
using remote magnetic navigation to allow for more accurate mapping and ablation. Mapping 
and ablation were performed in eight patients with outflow tract ventricular arrhythmias. 
Tachycardia mapping was undertaken with a 64-polar basket catheter, followed by remote 
activation and pace-mapping using a magnetically enabled catheter. The area of interest was 
Summary and conclusions 179
localized on the basket catheter and remote navigation of the magnetic catheter to this area 
was followed by pace-mapping. Ablation was performed at the site of good pace-mapping, 
with earliest activation if possible. Acute success was achieved in all patients with a median of 
four applications. No complications occurred. One recurrence occurred during 1 year of follow-
up. Remote magnetic navigation permitted low fluoroscopy exposure for the physician and the 
long-term results are promising with very accurate, high resolution mapping being facilitated 
by remote magnetic navigation.
Ablation of idiopathic left ventricular fascicular tachycardia can be aided by electroanatomic 
mapping, and the addition of a floppy, magnetically enabled ablation catheter improved 
manoeuvring in a case of fascicular tachycardia. In Chapter 10, both these modalities were 
used in a sequential fashion. Mechanically induced arrhythmias and mechanical block could 
be avoided. Integration of these modalities would have proved even more helpful, and this has 
since become available.
We evaluated the feasibility of mapping and ablation of left-sided accessory pathways (APs) 
using the retrograde transaortic approach with this system in Chapter 11 in the hope that 
this might open the gate to retrograde ablation of left atrial arrhythmias. Twenty consecutive 
patients were included and two magnetic catheters with different magnetic mass and different 
flexibility were used. Ablation was acutely successful in 60% of the patients using the Helios II 
and in 80% using the Celsius RMT. Median procedure time was comparable to conventional 
approaches. Physician fluoroscopy time was only 4 minutes. In the last 10 patients, procedure 
times became significantly shorter. There was a very steep initial learning curve, with the 
success rate increasing from 50% in the first half to 80% in the second half. Different catheter 
configurations may influence the outcome. Transseptal approaches clearly remain of value 
and a transseptal remote magnetic approach is presently being compared to this retrograde 
magnetic approach.
Occasionally recurrences appear after successful procedures, sometimes shortly after the end 
of the procedure. In Chapter 12 we describe successful ablation of a very early recurrence of 
accessory pathway conduction while the patient was still in the electrophysiology laboratory. 
We used remote magnetic navigation with a single catheter, and targeted the accessory path-
way using the stored magnetic vectors from the initial applications. 
Left atrial access for electrophysiological procedures may not always be possible using a 
transseptal approach. Alternative approaches need to be developed. As a further step in the 
assessment of the feasibility of this approach, in Chapter 13,  access to the left atrium and 
pulmonary veins was undertaken via a retrograde approach using a magnetically enabled 
ablation catheter and remote magnetic navigation. Once in the left atrium we cannulated 
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the pulmonary veins using the preset vectors in the system and were repeatedly successful 
in a small series of patients. The mean time needed to advance the catheter from the aorta to 
the left atrium and for subsequent cannulation of all the pulmonary veins was acceptable. No 
complications occurred. 
In Chapter 14, ablation was successful in the roof of the left atrium in a patient with focal left 
atrial tachycardia, who refused transseptal puncture, using the approach described in the 
previous chapter. This adds to our work looking at the feasibility of left atrial ablation for atrial 
tachycardia and potentially atrial fibrillation using an alternate approach should transseptal 
puncture be contraindicated or problematic.
The next chapters summarise the early work done using remote magnetic navigation (chapter 
15) as well as many other new innovations in clinical cardiac electrophysiology (chapter 16). 
In the work put forward in this thesis we have shown that new innovations in terms of image 
integration and energy sources can prove useful in improving outcomes in clinical electrophysi-
ology when using fairly conventional equipment. In the later studies we have shown that an 
approach using remote magnetic navigation is at least equivalent to a conventional approach. 
Some potential advantages were shown in these early studies such as the ability to perform 
remote mapping and ablation thereby decreasing physician radiation exposure and the need 
for heavy lead aprons; the ability to reproducibly and easily return to a previously assessed site, 
the ability to perform accurate and high resolution mapping; and finally, the ability to access 
otherwise potentially inaccessible areas of the heart such as the left atrium when transseptal 
puncture is contraindicated or areas of the heart which are difficult to access in operated con-
genital heart patients.
In the future the opportunity exists, with image integration, for fully automated remote 
mapping and potentially ablation. This would clearly be of potential benefit in ablation for 
atrial fibrillation and in other complex arrhythmias such as macro-reentry atrial or ventricular 
arrhythmias after cardiac surgery. The potential also exists for remote assistance whereby an 
experienced operator with a set-up elsewhere could assist with mapping or ablation should 
that become necessary. Clearly, more complex substrates may become ablateable increasing 
the pool of patients with arrhythmias who may benefit from ablation. Increasing the patient 
pool, while improving success rates and keeping the risk low are obviously all beneficial. As 
mentioned in the introduction, these new innovations may allow less experienced and less 
busy electrophysiology centres to perform complex ablations with similar success and risk as 
more experienced electrophysiology laboratories. The unresolved question, to quote one of 
the articles, is determining how much “bang we get for our buck” with these new technologies. 
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This will only be determined in the future and with trials involving both high and low volume, 
and experienced and less experienced operators. 
ovERzICHt EN bESluItEN
Het doel van deze thesis is een overzicht te geven van de status van katheterablatie met 
conventionele benaderingen bij ritmestoornissen als o.a. atriale flutter en fibrillatie en de 
problemen te beschrijven die gerelateerd zijn aan deze conventionele benadering. Vanuit dit 
uitgangspunt hebben wij de rol van stuurbare magnetische navigatie in het spectrum van 
cardiale katheterablatie onderzocht.
In hoofstuk 2 bespreken wij de klinische aspecten van atriale ritmestoornissen en de accurate 
diagnose ervan met een praktische discussie over therapie. De differentiale diagnose tussen 
atriale tachycardie, atriale flutter en atriale fibrillatie (AF) is niet altijd gemakkelijk. Het bestaan 
van onderliggende hartziekten beïnvloedt het klinisch beeld en vereist individueel aange-
paste therapie, zoals anticoagulatie. In patienten met congenitale hartafwijkingen, vooral de 
geopereerde groep, is het vaak moeilijk het circuit van `macro-reentrant` atriale tachycardie te 
onderscheiden en te lokaliseren.
Het onderwerp van hoofdstuk 3 is het acute succes en de opvolging op korte termijn van 
ablatie van atriale flutter, bestudeerd in een vergelijking van een 8 mm radiofrequentie (RF) 
en een gelijkaardige 8 mm cryothermiekatheter. Het acute succes voor RF was iets (maar niet 
signifikant) beter dan voor cryo. Proceduretijden waren vergelijkbaar, maar fluoroscopietijden 
met RF waren langer. Er zijn meer applicaties gegeven met RF, maar indicatoren voor myocard-
schade waren vergelijkbaar. Bij de mislukte procedures leek de isthmus langer te zijn. Terugval 
en klachten bij de succesvolle patiënten waren vergelijkbaar in beide groepen, met een zeer 
lage terugval naar atriale flutter na het initiële succes, in vergelijking tot sommige groepen die 
meer initieel succes maar ook meer terugval hebben gerapporteerd.
In hoofdstuk 4 stellen we dat, ondanks wat sommige elektrofysiologen misschien denken, er wel 
degelijk meer studies nodig zijn om het resultaat bij atriale flutterablatie te verbeteren en om 
tegelijk de patiëntveiligheid te verhogen. Ondertussen zijn dergelijke pogingen ondernomen 
met ablatie gericht door het maximale voltage, en ons gevoel is dat dit onderzocht zou moeten 
worden met stuurbare magnetische navigatie en de nieuwe katheters met geïrrigeerde tip.
In hoofdstuk 5 beschrijven we onze vroege ervaring met AF ablatie. De twee meest gebruikte 
behandelmethodes waren toen segmentale pulmonaire vene isolatie en linker atriale circum-
ferentiële ablatie. We bespreken onze benadering met gebruik van pulmonale antrum isolatie 
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begeleid met intracardiale echografie (ICE) en de eerste resultaten hiervan. Van de patienten 
met paroxysmale AF, hadden 69% geen recidieven tijdens een gemiddelde opvolging van 
201 dagen na een procedure. Er waren geen grote complicaties als gevolg van deze techniek, 
maar deze benadering ging wel gepaard met lange procedure- en stralingstijden ondanks het 
gebruik van ICE. De recente beschikbaarheid van magnetisch stuurbare katheters met geïr-
rigeerde tip betekent dat we in de nabije toekomst het gebruik van magnetisch navigatie voor 
AF kunnen onderzoeken.
Na deze analyse van conventionele benaderingen van ablatie gaan we verder het gebruik van 
magnetische navigatie voor klinische elektrofysiologie bespreken.
Hoofdstuk 6 geeft een kort overzicht van de complicaties van conventionele ablatiemethodes. 
De eerdere ervaring met stuurbare magnetische navigatie wordt ook beschreven. We hebben 
ook gekeken naar het potentiele gebruik ervan in cardiale resynchronisatie therapie voor de 
behandeling van hartfalen.
In hoofdstuk 7 is een vergelijking gemaakt van de laesies met gebruik van op afstand stuurbare 
magnetische navigatie en een standaard katheter in het rechte atrium of rechter ventrikel 
van een in-vivo varkensmodel. De transmurale macroscopische laesies onder magnetische 
navigatie waren vaker ovaal of rond (tegen geëlongeerd bij standaardablatie) wat potentieel 
minder kans geeft voor “brush” laesies en meer voor precieze laesievorming. Microscopisch 
onderzoek naar de diepte van de laesie heeft geen significante verschillen laten zien. De laesies 
met magnetische navigatie werden bereikt met lagere energie en impedantie, wat betere 
energieoverdracht naar het weefsel suggereert.  
Hoofdstuk 8 omschrijft ons eerdere werk met het magnetische navigatiesysteem in een 
gemakkelijk te bereiken ritmestoornis – atrioventriculaire nodale re-entry tachycardie (AVNRT). 
Ons doel was de haalbaarheid van het magnetisch navigeren naar de driehoek van Koch te 
onderzoeken en de betrouwbaarheid van ablatie. Twintig opeenvolgende patiënten werden 
in kaart gebracht en behandeld met gebruik van met magneten uitgeruste katheters met één 
of drie magneten in het distale deel. De katheter werd op afstand naar voor of naar achter 
bewogen door middel van het `CardiodriveTM systeem` en georiënteerd met gebruik van het 
`NavigantTM ` controle systeem. Na initiële positionering met de externe magneten, werden 
veranderingen in positie gemaakt in kleine stappen. Succes, procedure- en fluoroscopietijden 
werden geanalyseerd en vergeleken met een lokale eigentijdse reeks conventionele AVNRT 
ablaties. Magnetische navigatie was altijd mogelijk. Het vooropgezette doel was gemakkelijk te 
bereiken. Katheters bleven stabiel op hun plaats tijdens geaccelereerde junctieritmes. Ablatie 
was een succes in 90% van de gevallen. Er werden geen significante complicaties gezien. De 
mediane fluoroscopietijd voor de patiënt was 12 min, voor de interventiearts slechts 4 min. Er 
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was een tendens naar kortere fluoroscopietijden vergeleken met  de conventioneel behandelde 
groep. De proceduretijd nam significant af in de loop van de studie, en de mediane procedure-
tijd was vergelijkbaar met deze van de conventionele groep.
Navigatie, mappen en ablatie van de rechter ventriculaire outflow tract (RVOT) kan moeilijk 
zijn. Daarom was de bedoeling van hoofdstuk 9 om te kijken naar de haalbaarheid van RVOT 
tachycardie-ablatie met gebruik van op afstand bestuurde magnetisch navigatie. Mapping en 
ablatie werd uitgevoerd in acht patienten met kamer-ritmestoornissen uit het uitstroomge-
bied. De tachycardie werd in kaart gebracht met een 64-polige `basket`-katheter, gevolgd door 
een van op afstand gestuurde, met magneten uitgeruste katheter om de vroegste activatie te 
vinden en pace-mapping te doen. Acuut succes werd bereikt bij alle patiënten met een medi-
aan van 4 applicaties. Er waren geen complicaties. Er was één recidief gedurende gemiddeld 
één jaar follow-up.  
Ablatie van idiopathische linker ventriculaire fasciculaire tachycardie kan ook vergemakkelijkt 
worden door elektro-anatomische mapping. Het gebruik van een zachte, magnetisch geacti-
veerde, ablatiekatheter verbeterde de stuurbaarheid in een geval van fasciculair tachycardie 
(hoofdstuk 10). Mechanisch geïnduceerde ritmestoornissen en mechanisch block konden ver-
meden worden. Integratie van deze modaliteiten zou  behulpzamer zijn geweest, en is intussen 
ook beschikbaar.
We hebben de haalbaarheid van mappen en ablatie van linkszijdige accessoire bundels 
met gebruik van een retrograde trans-aortische benadering met dit systeem ge-evalueerd 
in hoofdstuk 11, in de hoop dat dit de weg zou kunnen openen naar retrograde ablatie van 
ritmestoornissen van het linker atrium. Twintig op elkaar volgende patiënten werden hierbij 
bestudeerd en twee magnetisch katheters met verschillende magnetische massa en flexibiliteit 
werden gebruikt. Ablatie was succesvol bij 60% van de met de Helios II  katheter behandelde 
patiënten en bij 80% behandeld met de Celsius RMT katheter. De mediane proceduretijd was 
vergelijkbaar met conventionele benaderingen. De fluoroscopietijd van de interventiearts was 
maar 4 minuten. Bij de laatste 10 patiënten werden de proceduretijden significant korter. Er 
was in het begin een steile leercurve met successen van 50% in de eerste helft van de studie, 
tot 80% in de twede helft. Verschillende katheterconfiguraties hebben mogelijk invloed op het 
resultaat. Transseptale benaderingen blijven duidelijk waardevol  en op dit moment wordt een 
transseptale, op afstand bestuurbare benadering vergeleken met deze retrograde magnetische 
benadering.
Af en toe ziet men na een succesvolle procedure de abnormale geleiding terug optreden. In 
hoofdstuk 12 beschrijven wij de succesvolle ablatie  van een accessoire bundel met reconductie, 
terwijl de patiënt nog steeds in het elektrofysiologisch lab was. Met magnetische navigatie en 
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één enkele katheter hebben wij de bundel teruggevonden met gebruik van de geregistreerde 
vectoren van de oorspronkelijke applicaties.
Toegang tot het linker atrium is niet altijd mogelijk via de transseptale benadering.  In hoofd-
stuk 13, werd retrograde toegang tot het linker atrium en de pulmonaalvenen gezocht via  een 
met magneten uitgeruste katheter, en op afstand bestuurbare magnetische navigatie. Eénmaal 
in het linker atrium, werden de pulmonaalvenen gecannuleerd met gebruik van de vooraf 
geprogrammeerde vectoren van het systeem. We waren telkens succesvol in een kleine serie 
patiënten. De gemiddelde tijd om de katheter van de aorta naar het linker atrium te brengen 
en voor de daarop volgende cannulatie van alle pulmonaalvenen was acceptabel. Er waren 
geen complicaties.
In hoofdstuk 14 blijkt ablatie in het dak van het atrium te slagen met gebruik van de benadering 
uit het voorgaande hoofdstuk bij een patiënt met focale atriale tachycardie. Deze laatste twee 
hoofdstukken dragen bij aan ons doel om te bekijken of mapping en ablatie van linkszijdige 
atriale tachycardie en atriale fibrillatie via deze alternatieve magnetische benadering haalbaar 
is. 
De volgende hoofdstukken geven een overzicht van vroeger werk dat verricht werd met gebruik 
van op afstand stuurbare magnetische navigatie (hoofdstuk 15), en van andere vernieuwingen 
in de klinische elektrofysiologie van het hart (hoofdstuk 16).
In het werk in deze thesis hebben we laten zien dat innovaties op het gebied van beeldinte-
gratie en energiebronnen de resultaten in klinische elektrofysiologie kunnen verbeteren zelfs 
wanneer tamelijk conventionele middelen worden gebruikt. In de latere studies hebben wij 
laten zien dat een benadering met van op afstand  stuurbare magnetische navigatie minstens 
even goed is als een conventionele benadering. Sommige potentiele voordelen zijn hierbij de 
verminderde blootstelling aan straling van de arts, en de verminderde noodzaak een zware 
loodschort te dragen; de mogelijkheid om herhaaldelijk en gemakkelijk te kunnen terugkeren 
naar eerder behandelde gebieden in het hart; het vermogen om accuraat en met hoge resolutie 
het hart in kaart te brengen; de mogelijkheid om naar anders niet zo toegankelijke delen van 
het hart zoals het linker atrium te gaan, wanneer transseptale punctie niet gewenst is, of bij 
geopereerde congenitale hartpatiënten.
In de nabije toekomst wordt (met beeldintegratie) geheel geautomatiseerde mapping en 
potentieel ablatie op afstand mogelijk. Dit zou duidelijk een voordeel zijn bij ablatie van 
atriale fibrillatie en bij andere complexe ritmestoornissen zoals macro re-entry, of atriale of 
ventriculaire ritmestoornissen na hartchirurgie. Ook bestaat de mogelijkheid voor assistentie 
op afstand waarbij een ervaren operator, met een systeem op een andere plaats zou kunnen 
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assisteren bij mapping of ablatie. Het is duidelijk dat meer complexe substraten behandelbaar 
worden. Toename van het aantal behandelbare patiënten, en tegelijk een grotere kans op suc-
ces met behoud van een laag interventierisico, biedt duidelijke voordelen voor de zorg. Zoals 
reeds gezegd, zouden deze innovaties minder ervaren en minder drukke elektrofysiologische 
centra de mogelijkheid geven om complexe ablaties uit te voeren met vergelijkbaar succes en 
risico als meer ervaren elektrofysiologische labaratoria. Hier is uiteraard nog veel onderzoek 
voor nodig, en ook is de meerwaarde van deze dure technologieën nog steeds niet helemaal 
duidelijk.
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